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Yerba mate (Ilex paraguariensis A.St.-Hil.) tea is growing in popularity around 
the world and contains several classes of constituents mainly caffeoyl derivatives, 
xanthines, flavonoids and triterpenoid saponins that have been associated with cancer 
prevention. However, which constituents of yerba mate are involved in the protective 
effects against colon carcinogenesis is not clearly understood. The objective of this study 
was to evaluate the dietary prevention of colon carcinogenesis by identifying novel 
constituents in yerba mate. The first aim was to investigate the potential anti-
inflammatory effect of yerba mate tea (MT) extracts, its constituents and their 
interactions in LPS-induced RAW 264.7 macrophages. MT extract, decaffeinated MT 
extract, chlorogenic acid (CHA), caffeine from MT (matein), mate saponins, quercetin, 
ursolic and oleanolic acids were tested by measuring their ability to inhibit COX-2/PGE2 
and iNOS/NO pathways. Quercetin was the most potent inhibitor of pro-inflammatory 
responses at a concentration 10 times lower than the concentrations used of other 
compounds (IC50 = 11.6 μM for NO, 7.9 μM for iNOS, and 6.5 μM for PGE2). Mate 
saponins (IC50 = 20 μM) and oleanolic acid (IC50 = 80 μM) significantly inhibited 
iNOS/NO pathways, whereas ursolic acid showed low or no inhibition at 100 μM. 
Combination of quercetin/ mate saponins (0.001:0.004, molar ratio) resulted in 
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synergistic interaction inhibiting both NO and PGE2 production and suppressed IL-6 and 
IL-1β production, which resulted in inhibition of nuclear translocation of NF-κB. MT 
extract did not have a potent anti-inflammatory effect, perhaps due to the antagonistic 
effect of some of its components. However, whole MT consumption still has a promising 
anti-inflammatory outcome mainly through the PGE2/COX-2 pathway.  
The second aim was to quantify and purify constituents from yerba mate that are 
not commercially available and assess their anti-inflammatory and anti-colon cancer 
capabilities in vitro. Matesaponins were partially purified and quantified by preparative 
chromatography, HPLC and LC/ESI-MS-MS. Yerba mate contained 10–15 mg/g dry 
weight total saponins. Mate saponins significantly inhibited iNOS, PGE2 and COX-2 and 
reduced nuclear translocation of NF- κB subunits p50 (49.8%) and p65 (49.0%). Mate 
saponins inhibited cell proliferation of HT-29 (IC50 = 201.8 μM) and RKO (IC50 = 181.0 
μM), arrested cells at G1 to S phase through upregulating p21 and p27 proteins, caused 
cells to undergo apoptosis through an increase of the ratio of Bax:Bcl-2 protein 
expression and activated caspase-3 activity. Mate saponins induced apoptosis and 
cytotoxicity in human colorectal cancer cells independent of p53 status due to the 
capability of induction of p53 in mutated p53 cells (HT-29). Mate saponins have potent 
chemopreventive properties and they specifically upregulated the p53 cascade. 
Dicaffeoylquinic acids (diCQAs) were purified from yerba mate using flash 
chromatography, resulting in two fractions one containing 3,4- and 3,5-diCQAs and the 
other 4,5-diCQA with NMR-confirmed structures. Both diCQA fractions inhibited LPS-
induced RAW 264.7 macrophage inflammation by suppressing NO/iNOS and 
PGE2/COX-2 pathways through inhibiting nucleus translocation of NF-κB subunits, p50 
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and p65. The diCQA fractions inhibited RKO and HT-29 cell proliferation by inducing 
apoptosis in a time- and concentration-dependent manner, through increased the 
activation of caspase-8 leading to cleavage of caspase-3.The results suggest that diCQAs 
in yerba mate could be potential anti-cancer agents and could mitigate other diseases also 
associated with inflammation. 
The third aim was to assess the effect of yerba mate aqueous extract and mate 
saponins on the development of colon pre-neoplastic lesions, aberrant crypt foci (ACF), 
in the azoxymethane (AOM)-induced model using male F344 rats. The animals received 
a basal diet and a mate aqueous extract (2% w/v) as drinking fluid, or mate saponins 
(0.01%, w/w) mixed with the basal diet 2 weeks before AOM injection and throughout 
the experimental period 6 weeks after first AOM injection. The mate aqueous extract (2% 
w/v) significantly decreased the number of AOM-induced ACF when compared to the 
control (21.1% reduction, p < 0.05) by downregulating NF-κB p65 activity (88.8% 
inhibition), decreasing iNOS (54.5% inhibition) and COX-2 (56.6% inhibition) 
proinflammatory mediators and β-catenin pathways by increasing GSK-3β activity 
(41.1% induction) suggesting its potential preventive role. Mate saponins did not reduce 
the number of ACF (p > 0.05), but significantly suppressed iNOS and COX-2 
expressions through inhibition of NF-κB p65 activation (81.7% inhibition).  
In conclusion, the results of this research demonstrate for the first time, the anti-
inflammatory and anti-colon cancer potential of yerba mate and its isolated constituents 
and provide the foundation for future studies of the benefits of yerba mate and its 
potential role in preventing colon carcinogenesis. 
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CHAPTER 1 
OVERVIEW 
Although several studies in vitro have shown yerba mate tea and its constituents 
are linked to cancer prevention, combinations of these compounds remains under-
investigated. Chronic inflammation plays a major role in the process of carcinogenesis 
including colon cancer. Current strategies for the prevention and early detection of 
colorectal cancer (CRC) in patients are based on the inflammation-neoplasia-carcinoma 
sequence. The present research is seeking to explore the role of natural compounds from 
yerba mate tea in preventing CRC by exerting its anti-inflammatory and pro-apoptotic 
properties in colon cancer cells. The experiments in this research will determine the 
molecular targets of mate tea, its constituents and combinations of its constituents in 
CRC. The first aim of this reaserch demonstrated the efficacy, interactions, and 
mechanism of yerba mate tea extract, its constituents, and the combinations of some of its 
constituents in inhibiting pro-inflammatory responses through the NF-κB pathway using 
LPS-induced inflammation RAW 264.7 macrophages. Quercetin and mate saponins are 
the most potent inflammation inhibitors in mate tea and, when combined, they have a 
synergistic effect. The quercetin and saponin combination, at a concentration found in 
one cup of mate tea, inhibited inflammation through suppression of NF-κB pathways. 
Mate tea extract did not have a potent anti-inflammatory effect, perhaps due to the 
antagonistic effect of some of components. However, whole mate tea consumption still 
has a promising anti-inflammatory outcome mainly through the PGE2/COX-2 pathway. 
This is the first study demonstrating the efficacy, interactions, and mechanisms of some 
mate tea phytochemicals in inhibiting pro-inflammatory responses.The resulting 
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information helped define which components should be considered in isolation or in 
combination when developing dietary strategies to reduce chronic inflammation, cancer 
risk and/or modify tumor behavior. Aim 2 of this research was to isolate constituents of 
yerba mate that are not commercially available and determine their capability in anti-
inflammatory and anti-colon cancer activities in vitro. Saponins and dicaffeoylquinic 
acids (diCQAs) were purified from yerba mate leaves using flash chromatography and 
preparative column chromatography, and their anti-inflammatory capacity assessed using 
LPS-induced inflammation RAW 264.7 macrophages and cytotoxicity in different human 
colon cancer cell lines (HT-29 and RKO). Mate saponins and diCQAs possessed anti-
inflammatory activity through NF-κB pathways and inhibited colon cancer cell 
proliferation by promoting apoptosis. These findings suggest the possible value of mate 
saponins and diCQAs from yerba mate as potential anti-cancer agents and might even 
mitigate other diseases associated with inflammation. Aim 3 was to evaluate the potential 
of yerba mate aqueous extract and mate saponins to prevent colon carcinogenesis using in 
vivo models on signaling via NF-κB and Wnt/β-catenine cascade. Yerba mate aqueous 
extract and mate saponins decreased inflammation through the NF-κB pathway and 
modulated the Wnt/β-catenin signaling pathways. Since the concentration of the mate 
aqueous extract was comparable to that commonly consumed by the people, these 
findings suggest a potential preventive role of yerba mate tea and its saponin constituents 
against colon carcinogenesis. In summary, we expect that the results of this research 
would provide a better understanding of the mechanisms by which yerba mate can be 
used to prevent colorectal carcinogenesis. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Biologically active constituents of Yerba mate (Ilex paraguariensis St. Hilaire).  
Yerba mate (Ilex paraguariensis A.St. Hilaire) is a plant native to South America 
that is widely consumed traditionally as a hot aqueous infusion, generally known as yerba 
mate tea. Yerba mate is one of the most commercialized plants in that region, growing 
naturally or as a cultivated crop in Argentina, Brazil, Uruguay and Paraguay. The leaves 
of mate contain significant amounts of purine alkaloids (caffeine), caffeolyquinic acid 
derivatives (caffeic acid, chlorogenic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic 
acid and 4,5-dicaffeoylquinic acid), flavonoids (quercetin and rutin) and triterpenoid 
saponins [1] as shown in Figure 1.   
       
    
Figure 2.1 Yerba mate plant, bioactive compounds and an example of a commercial 
product (adapted from de Mejia, E.G., Puangpraphant, S., Eckhoff, R. Tea and 
Inflammation. In: Preedy V.R. (Ed.) "Tea in Health and Disease Prevention". Elsevier. In 
Press, 2012)  
1 Theobromine (1% dw) 
2, 3, 5 Chlorogenic acid (4% dw) 
4 Caffeine (3% dw) 
6 3,4-dicaffeoylquinic acid (1% dw) 
7 3,5-dicaffeoylquinic acid (3.2% dw)  
8 Rutin 
9 4,5-dicaffeoylquinic acid (3% dw) 
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Yerba mate tea has been reported to have various biological activities that have 
been related to its high content of polyphenols. Some of the pharmacological properties 
attributed to yerba mate include antioxidant capacity [2-5], vasodilatation [6], anti-
inflammation [7], anti-microbial [8], inhibition of glycation and atherosclerosis [9], anti-
obesity effects [10], proteasome inhibitor [11], and beneficial effects on glucose 
absorption and metabolism [12]. In vitro and animal experiments have shown that yerba 
mate extracts have a chemopreventive activity against certain types of cancers. Yerba 
mate extracts induced cytotoxicity in the human squamous carcinoma cell line SCC-61 
[13], in the premalignant human skin keratinocytes cell line HaCaT and in the human 
hepatoma cell line HepG2, with potential inhibition of topoisomerase II activity [14], as 
well as in human colorectal adenocarcinoma cells CaCo-2 and HT-29 [15]. Yerba mate 
tea administered during the initiation phase of carcinogenesis induced by 
diethylnitrosamine inhibited DNA damage and the development of preneoplastic and 
neoplastic lesions in the esophagus and liver of male Wistar rats [16]. Yerba mate tea 
reduced colon carcinogenesis in 1,2-dimethylhydrazine-induced prenoeplastic lesions, 
and aberrant crypt foci (ACF) in female Swiss mice [17]. However, the active 
compounds were not identified and no mechanism of action has been proposed. This was 
identified as a gap in the literature which we aimed to fill. 
Individual compounds found in mate have been studied for their chemopreventive 
properties. Quercetin and rutin have been shown to exert distinct cytotoxicity to colon 
cancer cells [18-26]. Saponins purified from various plant sources have been suggested to 
be potential antitumor agents [27-34]. The reported mechanism of saponin modulation of 
cancer is by induction of apoptosis [35], and inhibition of cancer cell proliferation [33]. 
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However, at the cellular level, it is unclear which compounds in mate tea are responsible 
for its anticancer effect. Although these compounds are found in small concentration in 
yerba mate they may be major contributors to mate anticancer potential. In spite of these 
in vitro investigations, the in vivo anti-tumorogenic action of mate saponins against colon 
carcinogenesis needs further studies and the underlying mechanism of action remains to 
be elucidated.  
2.2 Colorectal cancer 
Colorectal cancer (CRC) is a multistep pathway of colonic mucosal genetic 
mutations. Recent statistics suggest that 142,570 new cases of CRC were identified 
leading to an estimated 51,370 deaths in 2010 making it the third most common cancer 
[36]. Mutation in adenomatous polyposis coli (APC) and a loss in tumor suppressor gene 
p53 are common genetic defects as colon cancer progresses [37]. Loss of p53 protein 
activity has been observed in 70-80% of colon adenocarcinomas suggesting that 
functional loss of p53 occurs late in tumorigenesis. Besides genetic alterations, the loss of 
controlled cell cycle progression, increased cell survival signaling, and repression of 
apoptosis are common in colon cancer progression [38-41].The treatment options for 
CRC are surgery, chemotherapy and radiotherapy [42]. Platinum-based chemotherapeutic 
agents including cisplatin, carboplatin, and oxaliplatin have been used clinically for 
treatment of malignant diseases including CRC [43]. The mechanisms of action of 
platinum-based drugs include the formation of DNA adducts, which leads to impairment 
of DNA replication and RNA transcription, and apoptosis [44]. However, these treatment 
regimens cause severe toxicity and side effects. Hence, more effective and safer 
therapeutic strategies are still needed. CRC is associated with dietary patterns and 
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lifestyle and can be prevented. Furthermore, cancer prevention is considered to be a 
better and more effective way to decrease cancer-related death in comparison with 
traditional cancer chemotherapies. Thus, one approach is to prevent CRC by dietary 
agents or supplements that can overcome genetic defects and serve as potential treatment 
for CRC. 
2.3 Inflammation and colon cancer 
Inflammation is an essential and complex response to protect tissues from injury, 
infection, or disease. The process of the inflammatory response involves release of pro-
inflammatory cytokines and recruitment and activation of circulating leukocytes at the 
inflamed site [48]. Pro-inflammatory cytokines are involved in the formation of toxic 
peroxynitrite by increasing the activity of inducible nitric oxide synthase (iNOS). 
Prostaglandin E2 (PGE2) is also an important mediator of inflammatory reaction produced 
by the enzyme cyclooxygenase-2 (COX-2). Uncontrolled activation of the COX-2/PGE2 
pathway is associated with inflammation and wide-spread in human neoplasia. 
The inflammatory molecules iNOS and COX-2 have been considered to be 
involved in colonic carcinogenesis. Overexpression of iNOS and COX-2 enzymes during 
inflammatory conditions and in human colonic tumors, as well
 
as in animals can 
contribute to promoting tumorigenesis by induction of inflammation, abnormal cell 
proliferation and decreasing apoptosis [46]. Hence, suppression of enzyme induction and 
the activities of iNOS/COX-2 is an important approach to preventing carcinogenesis in 
several organs including the stomach and colon [47].The inflammatory response is 
resolved by the release of anti-inflammatory cytokines [45]. The balance and 
interrelationship between key inflammatory mediators determines the degree of 
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inflammation. However, persistent infections, immune-mediated inflammatory diseases, 
or prolonged exposure to toxic reagents results in persistent accumulation and activation 
of leukocytes that cause chronic inflammation [48]. Chronic inflammation is widely 
recognized as a major link to inflammation related diseases including cardiovascular 
disease, bone, muscular and skeletal disease, neurological disorders, metabolic disease, 
and carcinogenesis including colon cancer as shown in Figure 2.2 [49-51]. The link 
between chronic inflammation and disease is through the production of mediators of 
inflammation by macrophages and neutrophils. The ubiquitous transcription factor that 
regulates inflammatory mediators in immune and inflammatory responses is nuclear 
factor-κB (NF-κB) [49]. 
 
Cardiovascular 
Diseases 
 
Diabetic 
Complications 
 
Chronic 
Inflammatory 
Diseases 
 
Cancer 
Metabolic disorder 
complications 
Type 2 Diabetes 
Obesity 
 
Chronic 
Inflammation 
Bone, muscular, 
skeletal disease 
 
NFκB, MCP-1, CRP, IL-
1β, IL-6, IL-8, IL-23, 
Nrf2/HO-1 
Neurological 
Disorders 
Figure 2.2 Inflammatory-related diseases and biochemical markers involved (adapted 
from de Mejia, E.G., Puangpraphant, S., Eckhoff, R. Tea and Inflammation. In: Preedy 
V.R. (Ed.) "Tea in Health and Disease Prevention". Elsevier. In Press, 2012) 
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Studies have shown that chronic inflammation can lead to the development of 
several types of cancer [52]. Administering agents that cause colitis in healthy rodents or 
genetically engineered cancer-prone mice accelerates the development of colorectal 
cancer [46]. These observations support a role for inflammation in carcinogenesis. Anti-
inflammatory properties of phytochemicals such as quercetin [22, 53] and saponins [54] 
are well documented. Thus, it can be hypothesized that mate tea prevents cancer through 
its phytochemicals serving as anti-inflammation mediators. We therefore chose to study if 
mate tea and its combination have anti-inflammatory effect. 
2.4 Inflammatory pathways 
Nuclear factor-κB (NF-κB) is a transcription factor that regulates many genes 
involved in immunity, inflammation, and apoptosis and promotes the expression of 
cytokines such as interleukin IL-1β, IL-6, TNFα and upregulates inflammatory enzymes 
such as COX-2 and iNOS [47]. NF-κB is highly regulated by multiple pathways and 
through interaction within clusters of other transcription factors. Activation of the NF-κB 
pathway in leukocytes (as well as in resident macrophages and endothelial cells) plays a 
central role to initiate and promote the inflammatory response [49].  
Figure 2.3 shows activation of NF-κB signaling pathway. NF-κB can be activated 
by many types of stimuli such as cytokines, oxidants and viruses and then directs DNA to 
produce inflammatory cytokines. The NF-κB proteins are localized in the cytosol and are 
consecutively bound to a family of inhibitory proteins known as inhibitor of κB (IκB). 
The IκB proteins are normally bound to NF-κB sub units, p50 and p65, and block their 
nuclear localization signal. Once stimuli initiate signaling cascades through ligation of 
cell receptors, activation is through phosphorylation of IκB by IκB protein kinase (IKK) 
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leading to degradation of IκB. Degradation of IκB releases the NF-κB (p65 and p50) 
resulting in translocation of released NF-κB into the nucleus which then regulates 
transcription of target genes, such as COX-2, iNOS, IL-1β, IL-6 [49].   
NF-κB contributes to development and/or progression of malignancy by 
regulating expression of genes involved in cell growth and proliferation, antiapoptosis, 
angiogenesis, and metastasis [55]. NF-κB may inhibit apoptosis in CRC cells through 
activation of expression of antiapoptotic genes, Bcl-2 [56]. Thus, NF-κB is an emerging 
target for prevention and/or treatment of cancer and inflammation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Activation of NF-κB pathway 
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2.5 Cell cycle arrest, apoptosis and cancer 
 Cell cycle deregulation is a common event of human cancer. Cyclin-dependent 
kinases (CDKs) are key regulators of the cell cycle [57]. CDK activity requires binding 
of cyclins to form CDK-cyclin complexes that drive the cell cycle. Genetic mutations of 
cancers often deregulate certain CDK-cyclin complexes resulting in unscheduled 
proliferation of the cell cycle [57]. Inhibition of cell cycle progression is therefore an 
important strategy to control cancer cell growth. CDK-cyclin complex is regulated by 
CDK inhibitors such as p21 and p27. CDK inhibitors can inhibit the activities of cyclin-
CDK complexes and negatively regulate cell-cycle progression. The CDK inhibitor p21 
is one of the major transcription targets of p53 tumor suppressor, which is responsible for 
p53-dependent cell-cycle arrest. CDK inhibitor p21 suppresses cell-cycle progression 
mainly by inhibiting cyclin E/CDK2 activity [57].  
A defect in the apoptotic pathway is another common event in many types of 
cancers, including CRC [41, 58]. Apoptosis can be induced either by extrinsic (death 
receptor) or by intrinsic (mitochondrial) pathways [59]. Caspases are enzymes that 
belong to the cysteine family that cleave their substrates at aspartic acid residues and play 
a key role in apoptosis [60]. Caspases are present as procaspases, which are inactive 
zymogens. These caspases once activated can lead to activation of apoptotic initiators, 
caspase-8 and-9 and apoptotic executioners, caspase-3 and-7 [61]. Caspase activation 
triggers in two apoptotic pathways, the death-receptor pathway and the mitochondrial 
pathway as shown in Figure 2.4 [62].  
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Figure 2.4 The intrinsic and extrinsic apoptosis pathways 
The mitochondrial pathway is controlled by the members of the Bcl-2 family, 
which can be initiated by intracellular reactive oxygen species, DNA damage and 
deprivation of growth factors [63]. The Bcl-2 protein family consists of the major anti-
apoptotic proteins, Bcl-x(L) and Bcl-2, and the major pro-apoptotic proteins Bax and Bak 
[64]. Bax controls mitochondrial permeability and cytochrome c release and increased 
Bax:Bcl-2 ratio triggers release of cytochrome c from mitochondria into the cytoplasm 
and contributes to activation of caspase-3, which is a key step in the initiation of 
apoptosis [60]. The death receptor-mediated pathway is initiated by interaction of the 
ligand with its death receptor, leading to cleavage and activation of initiator caspase-8 
and -10, which in turn cleave and activate executioner caspase-3, -6, and -7, terminating 
in apoptosis. 
Depending on the cell type and conditions, p53 regulates either the cell cycle 
arrest or apoptosis. Cellular stresses and DNA damage typically trigger the p53 tumor 
suppressor gene to mediate a series of antiproliferative strategies by inducing both cell 
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cycle arrest and apoptosis. One important link between p53 and apoptosis is based on 
transcriptional control of proapoptotic members of the Bcl-2 family, such as Bax. 
2.6 Azoxymethane-induced rat model of colon cancer 
Azoxymethane (AOM) has been used extensively by investigators to induce colon 
tumors in chemoprevention studies. AOM is a potent carcinogen causing a high incidence 
of colon tumors in rodents that have similar biological properties to human colon tumors. 
The AOM-induced model is cost efficient and reliably to causes epithelial cells to 
undergo pathogenesis from pre-neoplastic lesions, aberrant crypt foci (ACF), to 
adenomas and malignant adenocarcinomas. Although genetically engineered mouse 
models of CRC are available, AOM induces gene and protein expression changes that 
also occur in human CRC and enhances expression of COX-2 and iNOS, as well as 
adenomatous polyposis (APC) mutations [65]. In rats, AOM is metabolized by 
cytochrome P450, specifically isoform CYP2E1. The first step is the hydroxylation of the 
methyl group of AOM to form methylazoxymethanol (MAM). MAM is then broken 
down by alcohol dehydrogenase in the liver, colon, kidney, and lung, into formaldehyde 
and a highly reactive alkylating methyldiazonium ion. This reaction forms DNA adducts 
resulting in GC to AT transitions and mutagenesis in colonic enterocytes [65].  
Aberrant crypt foci (ACF) as colonic pre-neoplastic lesions in colons of 
carcinogen treated mice were first described by Bird in 1987 [66]. ACF are hypothesized 
to be early, pre-neoplastic changes and accepted as morphologic markers of 
carcinogenesis. In methylene or alcian blue stained colonic mucosa, ACF can be 
distinguished from adjacent, normal crypts by their strong uptake of the blue stain. There 
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are also elevation of the foci above the mucosal surface, large luminal diameters, 
elliptical luminal openings, and thicker epithelial linings surrounding the foci [67]. 
The AOM-induced colon cancer model activates several pathways including K-
ras, β-catenin and TGFβ. K-ras is a small G-protein that regulates both mitogen-activated 
protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/Akt intracellular 
pathways which regulate cell growth, proliferation and glucose metabolism. Activation of 
PI3K/Akt can increase cell survival pathways via phosphorylation of downstream targets, 
including NFκB, and Bcl-xl [68]. PI3K/Akt also blocks p53 and the Forkhead family of 
transcription factors/Fas-ligand to decrease apoptosis [69]. In the cell cycle pathway, 
PI3K/Akt deactivates glycogen synthase kinase 3 (GSK-3) and promotes cyclin D1 and 
myc to increase cell proliferation. Downstream of PI3K/Akt, COX-2 has also been shown 
to be involved in the carcinogenesis of AOM [69].  
β-Catenin is a multifunctional protein that regulates proliferation, differentiation 
and apoptosis in intestinal epithelial cells and is commonly dysregulated in colon ACF 
and tumors [70, 71]. β-Catenin is a downstream effector and functions as a transcription 
factor of the canonical Wnt/β-catenin/T-cell factor (Tcf) signaling pathway (Figure 2.5). 
Several studies have reported that over expression and nuclear accumulation of β-catenin 
is an early event in colon carcinogenesis [71, 72]. AOM causes β-catenin mutations at 
codon 33 and 41, which are the serine and threonine residues that are targets for GSK-3β 
phosphorylation. In normal cells, cytoplasmic β-catenin levels are kept low through 
continuous degradation by the ubiquitin-proteasome pathway, which is controlled by a 
complex containing GSK-3β, adenomatous polyposis coli (APC), and axin [73]. 
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Figure 2.5 The canonical Wnt/β-catenin/T-cell factor (Tcf) signaling pathway 
In malignant cells, the binding of Wnt proteins inhibits GSK-3β phosphorylation 
activity, which prevents β-catenin ubiquitination and degradation, so that β-catenin 
accumulates in the cytoplasm and translocates to the nucleus. This β-catenin is then free 
to bind to transcription factors from the LEF/Tcf family, and activates the transcription of 
a variety of target genes, such as cyclin D1 and c-Myc, which are growth-promoting 
genes. β-Catenin that lacks GSK-3β phosphorylation sites is associated with cancer. 
Studies link mutations in β-catenin, APC, or axin as an early critical event in the 
development of colon carcinogenesis, suggesting that activated GSK-3β complexes may 
function as tumor suppressors in normal cells by promoting β-catenin degradation. 
Dysregulation levels of GSK-3β have been found both in human colon cancer cell lines 
and in primary colon tumors. Thus, the inactive expression of GSK-3β may promote 
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neoplastic transformation by promoting cytosolic β-catenin accumulation and subsequent 
translocation into the nucleus to regulate transcription of genes. 
In summary, there is a potential role for yerba mate tea in preventing colon 
carcinogenesis through inhibition of chronic inflammation; however, this pathway needs 
to be studied. Therefore, the overall objective of this research was to evaluate the anti-
inflammatory and anti-colon cancer potential of yerba mate tea and its constituents using 
in vitro and in vivo models. We expect that the results of this research will provide a 
better understanding of the mechanisms by which yerba mate can be used to prevent 
inflammation and therefore colon carcinogenesis.  
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CHAPTER 3 
OBJECTIVE AND HYPOTHESES 
3.1 Objective: To evaluate the dietary prevention of colon carcinogenesis by identifying 
novel bioactive compounds in yerba mate using a targeted molecular approach, that will 
improve efficacy and selectivity.   
3.2 Central Hypothesis: Yerba mate tea, its components and their combinations will be 
able to prevent colon carcinogenesis by inhibiting inflammation and will bring out 
interactions giving a more pronounced effect in modulating colon cancer.  
3.3 Specific Aims: 
Aim 1 (Chapter 4): To determine the anti-inflammatory effect of yerba mate tea 
extract, its components and their interactions. 
Hypothesis:  Yerba mate tea, its constituents and their combinations will inhibit 
lipopolysaccharide (LPS)-induced inflammation through inhibition of NF-κB pathway in 
a RAW 264.7 macrophage model.  
Objectives: 
1.1 To evaluate the effect of yerba mate tea, combinations of its constituents, and 
the potential interaction of its constituents on their ability to suppress LPS-
induced inflammation in RAW 264.7 macrophages. 
1.2 To determine the mechanism of action of the most potent combination that 
inhibits LPS-induced inflammation using RAW 264.7 macrophages as an in vitro 
model. 
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Aim 2 (Chapters 5, 6 and 7): Assess the potential for yerba mate tea, its constituents 
and their combination to inhibit cell proliferation and stimulate apoptosis in colon 
cancer cells in vitro. 
Hypothesis: Yerba mate tea, its constituents and their combinations will inhibit colon 
cancer by promoting apoptosis through caspase-mediated pathways and will not affect 
the viability of human normal colon cells.  
Objectives:   
2.1 To determine the cytotoxic effect of yerba mate tea, mate saponins, and di-
caffeoylquinic acids in HT-29 and RKO colon cancer cells. 
2.2 To determine the mechanism of action in inhibiting colon cancer cells.  
Aim 3 (Chapter 8): Assess the effect of yerba mate tea and mate saponins on the 
prevention of colon carcinogenesis in vivo using a F344 rat model.  
Hypothesis: Yerba mate tea and mate saponins will inhibit colon carcinogenesis in a 
well-characterized rat model by decreasing appearance of aberrant crypt foci (ACF), 
altering the cell cycle, reducing cell proliferation and inflammatory regulators, and 
inducing apoptosis. 
Objectives: 
3.1 To determine the effect of yerba mate tea and mate saponins on the formation 
of aberrant crypt foci (ACF) in azoxymethane (AOM)-induced colon cancer in 
F334 rats.  
3.2 To evaluate the mechanism of action regarding cell proliferation, 
inflammatory parameters, cell cycle distribution and apoptosis.  
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CHAPTER 4 
SAPONINS IN YERBA MATE TEA (ILEX PARAGUARIENSIS A. ST.-HIL.) AND 
QUERCETIN SYNERGISTICALLY INHIBIT iNOS AND COX-2 IN 
LIPOPOLYSACCHARIDE-INDUCED MACROPHAGES THROUGH NF-κB 
PATHWAYS 
1 
4.1 Abstract 
Yerba mate tea (Ilex paraguariensis) is growing in popularity around the world. 
The objective of this study was to investigate the potential anti-inflammatory effect of 
yerba mate tea (MT) extracts as well as some of its phytochemicals and their interactions. 
MT and decaffeinated MT extracts [1-300 μM chlorogenic acid (CHA) equiv]; CHA, 
caffeine from MT (matein), and mate saponins (1-300 μM); quercetin (1-200 μM); and 
ursolic and oleanolic acids (1-100 μM) were tested by measuring their ability to inhibit 
COX-2/PGE2 and iNOS/NO pathways in LPS-induced RAW 264.7 macrophages. Mate 
saponins (IC50 = 20 μM) and oleanolic acid (IC50 = 80 μM) significantly inhibited 
iNOS/NO pathways, whereas ursolic acid showed low or no inhibition at 100 μM. 
Quercetin was the most potent inhibitor of pro-inflammatory responses at a concentration 
10 times lower than the concentrations used of other compounds (IC50=11.6 μM for NO, 
7.9 μM for iNOS, and 6.5 μM for PGE2). Combination of quercetin/ mate saponins 
(0.001:0.004, molar ratio) resulted in synergistic interaction inhibiting both NO and PGE2 
production. It also suppressed IL-6 and IL-1β production and resulted in reduction of 
LPS-induced nuclear translocation of nuclear factor-κB subunits. MT extract did not have 
1 
This chapter is part of the paper; Puangpraphant, S., & Gonzalez de Mejia, E. (2009). Saponins in 
yerba mate tea (Ilex paraguariensis A. St.-Hil.) and quercetin synergistically inhibit iNOS and COX-2 
in lipopolysaccharide-induced macrophages through NFκB pathways. Journal of Agricultural and 
Food Chemistry, 57, 8873-8883. Permission granted by ACS Publications. 
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a potent anti-inflammatory effect perhaps due to the antagonistic effect of some of its 
compounds. However, whole MT consumption still has a promising anti-inflammatory 
outcome mainly through the PGE2/COX-2 pathway. To the authors’ knowledge, this is 
the first study demonstrating the efficacy, interactions, and mechanisms of some MT 
phytochemicals in inhibiting pro-inflammatory responses. 
4.2 Introduction 
Yerba mate tea (Ilex paraguariensis) (MT) is rich in many phytochemical 
compounds such as theobromine, caffeine (matein), caffeoylquinic acid derivatives, 
dicaffeoylquinic acid derivatives, rutin, luteolin, quercetin, and saponins [1]. Figure 4.1 
presents the chemical structures of some of the important phytochemicals in MT. Several 
studies have shown that flavonoids in MT have anti-inflammatory activity; this has 
important health implications because chronic inflammation can develop into several 
diseases such as arteriosclerosis, cancer, diabetes, and neurodegenerative diseases [2-5]. 
Published reports suggest that MT has chemopreventive activity against some types of 
cancer [6-8]. However, at the cellular level, it is unclear which compounds in MT are 
responsible for this effect. Administering agents that cause colitis in healthy rodents or 
genetically engineered cancer-prone mice accelerated the development of colorectal 
cancer [9]. These observations support the role of inflammation in carcinogenesis. Anti-
inflammatory properties of phytochemicals such as quercetin [10-13] and saponins [14] 
are documented. However, the anti-inflammatory mechanism of MT and its components 
has not been studied. Pro-inflammatory cytokines are involved in the formation of toxic 
peroxynitrite by increasing the activity of inducible nitric oxide synthase (iNOS). 
Prostaglandin E2 (PGE2) is also an important mediator of inflammatory reaction produced 
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by the enzyme cyclooxygenase-2 (COX-2). COX-2 and iNOS are induced during 
inflammatory conditions and are overexpressed in colonic tumors in humans, as well as 
in animals [9]. iNOS has been shown to be involved in regulating COX-2 production, 
which plays an important role in colon tumorigenesis. Hence, suppression of enzyme 
induction and the activities of iNOS/COX-2 is an important approach to preventing 
carcinogenesis in several organs including the stomach and colon [15]. Interleukin (IL)-
1β and IL-6 are pro-inflammatory cytokines that can promote acute to chronic 
inflammation through activation of nuclear factor-κB (NF-κB). NF-κB is a transcription 
factor that has five protein subunits: RelA (p65), Rel B, c-Rel, NF-κB1 (p50), and NF-
κB2 (p52). These subunits may form homo- or heterodimers. The activated NF-κB is a 
heterodimer and consists of p65 and p50. In human cells, NF-κB is bound to the inhibitor 
κBα (IκBα) in the cytoplasm [15]. IκB kinase complex (IKK) can be activated in 
response to many different signals which result in phosphorylation of IκBα followed by 
its ubiquitination and proteosomal degradation, causing the IκBα to dissociate from NF-
κB. Degradation of IκBα releases NF-κB (p65 and p50), resulting in translocation of the 
activated NF-κB into the nucleus, which then regulates the transcription of target genes 
[16]. NF-κB regulates several genes involved in immunity, inflammation, and apoptosis 
and promotes the expression of cytokines such as IL-1β, IL-6, and TNFα, and up-
regulates inflammatory enzymes such as COX-2 and iNOS. Thus, NF-κB is an emerging 
target for the prevention of cancer and inflammation [15]. For instance, ursolic acid 
reduces pro-inflammation cytokines through downregulation of NF-κB [17]. We 
hypothesized that phytochemicals present in MT will be able to inhibit inflammation 
through NF-κB pathways. The objective of this research was therefore to determine the 
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effect of selected MT phytochemicals for their ability to suppress inflammation. The anti-
inflammatory properties of MT extract, decaffeinated MT extract, chlorogenic acid 
(CHA), quercetin, matein, mate saponins, ursolic acid, and oleanolic acid were evaluated 
in vitro using lipopolysaccharide-induced RAW 264.7 macrophages. COX-2/PGE2 and 
iNOS/NO pathways as well as the interaction between MT phytochemicals in inhibiting 
NO and PGE2 production were investigated. On the basis of the results, a mechanism of 
action was suggested. 
4.3 Materials and Methods 
Chemicals. Chlorogenic acid (≥ 95% CHA), ursolic acid (≥ 90%), quercetin (≥ 98%), 
oleanolic acid (≥ 97%), sodium nitrite, sulfanilamide, N-1-(naphthyl) ethylenediamine-
diHCl, and lipopolysaccharide (LPS) from Escherichia coli O55:B5) were purchased 
from Sigma (St. Louis, MO). Macrophage RAW 264.7 cell line and Dulbecco’s Modified 
Eagle Medium with L-glutamine (DMEM) were purchased from American Type Culture 
Collection (Manassas, VA). Fetal bovine serum was purchased from Invitrogen (Grand 
Island, NY). COX-2, iNOS, NF-κB p50, and NF-κB p65 mouse monoclonal antibodies 
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-mouse IgG 
conjugated horseradish peroxidase secondary antibody was purchased from GE 
Healthcare (Buckinghamshire, U.K.). Luciferase assay kit and Trans Fast transfection 
reagent were purchased from Promega (Madison WI) and pNF-κB luciferase vector 
(pNF-κB luc vector) was purchased from Clontech (Mountain View CA). All other 
chemicals were purchased from Sigma, unless otherwise specified. 
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Mate Tea Preparation. Organically grown mate (Ilex paraguariensis) leaves from 
Paraguay were kept in plastic bags and refrigerated at 4 C until used. MT was prepared 
by using the traditional North American procedure of preparing tea. Briefly, 2.5 g of dry 
tea leaves (DL) was soaked in 250 mL of boiling water for 10 min. The infusion was 
cooled to room temperature before filtration using Whatman paper no. 2 to eliminate dry 
tea leaves and then freeze-dried in a Labconco, Shell Freeze System (Fisher Scientific, 
Pittsburgh, PA). The freeze-dried material called MT extract, equivalent to instant tea, 
was kept at -20 °C protected from light. The phytochemical composition of MT under 
investigation was previously published by Heck et al. [35].  
Preparation of Decaffeinated Mate Tea. Matein and decaffeinated MT were obtained 
by supercritical CO2 extraction of MT leaves. The supercritical extraction apparatus was 
provided by the U.S. Department of Agriculture (Peoria, IL). Matein was extracted from 
organic MT using a water-saturated CO2 supercritical extraction. The temperature for the 
extraction vessel was 70°C with a pressure of 398 bar. The temperature of the receiver 
vessel was 50 °C with a pressure of 75 bar. The flow rate was 466 mL/min of liquid CO2. 
A total of 1.5 kg of MT leaves was placed in the CO2 supercritical extractor, and it took 
approximately 8 h for the total procedure (18). The final product was freeze-dried.  
Extraction and Purification of Mate Saponins. Mate saponins were isolated from the 
MT infusions as performed by Gnoatto et al. (19). Briefly, MT infusion was prepared by 
boiling 15 g of dry leaves for 10 min in 100 mL of water. The infusion was then filtered, 
brought to 100 mL with water, treated with hydrochloric acid, and then refluxed for 3 h. 
Mate saponins were extracted four times with 50 mL of chloroform. The chloroform 
fraction was evaporated to dryness (77.6 mg). A 1050 Hewlett-Packard (Palo Alto, CA) 
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gradient liquid chromatograph equipped with a 1050 HP autosampler, a gradient pump, 
and a photodiode array detector was used to estimate saponin concentration. HPLC 
analysis was performed using a C18 RP guard column and a C18 RP Phenomenex 
Prodigy ODS column (250 mm x 4.6 mm x 5 μm). The variable-wavelength detector was 
set at 203 nm. The mobile phase consisted of acetonitrile/water (70:30 v/v). Flow rate = 
1.0 mL/min and sensitivity = 0.001 AUFS. Mate saponins were calculated to have 73% 
purity. A molecular mass of 1,000 g/mol was used in the calculation of the molar 
concentration of mate saponins.  
Macrophage Culture and Cell Viability Assay. Macrophage cell line RAW264.7 was 
cultured in growth medium containing DMEM, 1% penicillin/streptomycin, 1% sodium 
pyruvate, and 10% fetal bovine serum at 37 °C in 5% CO2/95% air. The cell viability 
assay was conducted using the CellTiter 96 Aqueous One Solution proliferation assay kit 
using the novel tetrazolium compound 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)- 2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS), and an 
electron coupling reagent, phenazine ethosulfate (PES) (Promega Corp., Madison, WI). 
Briefly, 5x10
4
 cells were seeded in a 96-well plate, and the total volume was adjusted to 
200 μL with growth medium. Cells were allowed to grow for 24 h at 37 °C in 5% 
CO2/95% air. Cells were then treated with different concentrations of MT phytochemicals 
for 24 h, the growth medium was replaced by 100 μL of fresh growth medium, and 20 μL 
MTS/PES was added to each well. The plate was incubated for 2 h at 37 °C, and the 
absorbance was read at 515 nm. The percentage of viable cells was calculated with 
respect to cells treated with 0.3% DMSO (for MT extract, decaffeinated MT extract, 
CHA, matein, quercetin, ursolic acid, oleanolic acid) and 0.3% 1:1 DMSO/methanol (for 
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mate saponins). Solvents used at these concentrations showed no cytotoxicity (viability > 
80%). DMSO at ≤ 0.3% presented 95.8% cell viability.  
Treatments. Cell treatment was conducted by seeding 2x10
5
 cells in a 6-well plate, and 
cells were allowed to grow for 48 h at 37° C in 5% CO2/ 95% air. After 48 h of 
incubation, the cells were treated with different concentrations of MT phytochemicals (1, 
10, 100, 200, 300 μM) and 1 μg/ mL of LPS for 24 h. All MT phytochemicals were 
sterilized using 0.22 μm nylon filters before the cells were treated. After 24 h of 
treatment, the spent medium was collected and analyzed for NO, PGE2, IL-6, and IL-1β. 
Cell lysates were used to study the effect of MT phytochemicals on the expressions of 
COX-2 and iNOS.  
Nitrite and PGE2 Measurement. After 24 h of treatment and LPS induction, culture 
supernatant was collected. For nitrite measurement, 100 μL of the spent medium was 
plated in 96-well plate and an equal amount of Griess reagent (1% sulfanilamide and 
0.1% N-1-(naphthyl)ethylenediamine- diHCl in 2.5% H3PO4) was added. The plate was 
incubated for 5 min, and the absorbance was measured at 550 nm. The amount of NO 
was calculated using sodium nitrite standard curve. For PGE2 measurement, ELISA kit 
monoclonal was used following the manufacturer’s instructions (Cayman Chemical, Ann 
Arbor, MI).  
Interaction Study and Isobolographic Analysis. Possible interactions between MT 
phytochemicals in inhibiting NO and PGE2 production by LPS-induced RAW 264.7 were 
tested. The molar ratio of phytochemicals tested was approximately equal to its 
concentration in one cup of tea (1.5 g of DL/150 mL of water); 2.3:0.86 (CHA/matein), 
2.3:0.004 (CHA/ mate saponins), 2.3:0.001 (CHA/quercetin), 0.004:0.001 (mate 
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saponins/quercetin), 0.004:0.86 (mate saponins/matein), 0.001:0.86 (quercetin/matein). 
Calculated and experimental percent inhibition values from combination studies were 
compared to determined expected interactions. Experimental values that were 
significantly different from the calculated values at 95% confidence interval were defined 
as synergistic or “more than additive” interactions as previously reported (20). To further 
understand the interactions, an isobolographic analysis was performed (20). IC35 values 
for MT phytochemicals were used in constructing isobolograms. A straight line 
connecting the IC35 values of these MT phytochemicals predicts the IC35 value of an 
additive effect. If results of the isobolographic analysis deviated significantly to the left 
of the additivity line with 95% confidence interval, the interaction was confirmed as a 
synergy; when it deviated to the right, the interaction was antagonistic. If it fell within the 
confidence limit for the additivity line, the interaction was said to be additive [20]. The 
IC35 and IC50 values for MT phytochemicals were calculated by linear regression using 
Prism 4.0 (GraphPad Software, San Diego, CA).  
Measurement of iNOS and COX-2 Protein Expressions. COX-2 and iNOS 
expressions were determined in cell lysates. Briefly, treated cells were washed with ice-
cold DMEM and ice-cold phosphate-buffered saline before treatment with 200 μL of 
Laemmli buffer (Bio-Rad Laboratories, Hercules, CA) with 5% β-mercaptoethanol as 
lysing buffer. The cell lysates were boiled for 5 min, and approximately 25 μg of proteins 
was loaded in 4-20%Tris-HCl ready gels (Bio-Rad Laboratories) for protein separation. 
Separated proteins were transferred in PVDF membrane and blocked with 5% nonfat dry 
milk in 0.1% Tris-buffered saline Tween 20 (TBST) for 1 h at 4 C. After blocking, the 
membrane was washed with 0.1% TBST (five times, 5 min each) and incubated 
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overnight with either COX-2 or iNOS mouse monoclonal antibody (1:1000) at 4 C. The 
membrane was washed again and incubated with anti-mouse IgG antibody conjugated to 
horseradish peroxidase secondary antibody for 3-4 h at room temperature. After 
incubation and repeated washings, the expression of COX-2 and iNOS was visualized 
using a chemiluminescent reagent (GE Healthcare) following the manufacturer’s 
instructions. The membrane picture was taken with a Kodak Image station 440 CF 
(Eastman Kodak Co., New Haven, CT).  
IL-6 and IL-1β Measurement. For IL-6 and IL-1β measurements, a Bio-Plex singleplex 
cytokine assay was used (Bio-Rad Laboratories). Briefly, a 96-well filter plate was 
prewetted with 100 μL of assay buffer and the buffer was removed by vacuum filtration. 
Then, 50 μL of the bead working solution (IL-6 and IL-1β) was added, and the buffer was 
removed by vacuum filtration. The plate was washed with 100 μL of wash buffer, and 50 
μL of diluted standard or sample was added to each well. The plate was then covered 
with sealing tape and aluminum foil and incubated at room temperature for 30 min with 
shaking. After incubation, the buffer was removed and washed with 100 μL of wash 
buffer three times. Twenty five microliters of detection antibody was added, and the plate 
was incubated at room temperature for 30 min with shaking. The plate was washed again, 
and 50 μL of streptavidin-PE was added and incubated for 10 min at room temperature 
with shaking. After incubation with streptavidin PE, the plate was washed three times 
withwash buffer, and the beads were resuspended with 125 μL of assay buffer. The plate 
was then read using a Bioplex suspension array system using high photomultiplier tube 
setting standards measuring 100 beads per region. The concentrations of IL-6 and IL-1β 
were calculated using IL-6 and IL-1β standard curves, respectively. 
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Transfection of RAW 264.7 Macrophage Cell Line with pNFKB- Luciferase Vector. 
RAW264.7 macrophage cell line was transiently transfected with a pNF-κB-luciferase 
vector or pTAL-Luc vector (Clontech) using TransFast transfection reagent (Promega) 
following the manufacturer’s protocol. The pNF-κB-luciferase vector contained the 
firefly luciferase gene from Photinus pyralis, whereas the pTAL-Luc vector served as a 
negative control. Briefly, 5x10
4
 cells were plated in a 24-well plate and allowed to grow 
to 80-90% confluency for 24 h at 37 °C in 5% CO2/95% air. The day before transfection, 
the transfection reagent was resuspended in 400 μL of nuclease-free water and stored at -
20 °C overnight. The cells were then treated with 200 μL of DNA-Transfast reagent 
mixture and incubated for 1 h at 37 °C in 5% CO2/95% air. After 1 h of incubation, each 
well was then overlaid with 1 mL of complete growth medium, and transfection was 
carried out for 48 h at 37 °C in 5% CO2/95% air.  
Measurement of Luciferase Activity. After transfection, cells were treated with 
quercetin (1 μM), mate saponins (4 μM), quercetin/mate saponins combination (1:4 μM), 
and 1 μg/mL LPS for 24 h. Luciferase activity from the cells was measured using a 
luciferase assay system (Promega) following the manufacturer’s protocol and a 
Femtomaster FB 12 luminometer (Zylux Corp.). Briefly, growth medium was removed 
and the cells washed with 1mL of ice-cold PBS. After complete removal of ice-cold PBS, 
100 μL of passive lysis buffer was added and the plate was incubated at room 
temperature for 15 min with shaking. After incubation, luciferase activity was measured 
by adding 20 μL of cell lysate in100 μL of luciferase assay reagent and immediately 
reading the flash using the Femtomaster luminometer. Luciferase activity was normalized 
on the basis of protein content as determined by Bio-Rad protein assay.  
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Western Blotting of NF-κB p50 and p65 Protein Expression. NF-κB p50 and p65 
expressions were determined in cell cytoplasm and nucleus. Nuclear and cytoplasmic 
proteins were isolated with a buffer extraction system and centrifugation NE-PER nuclear 
and cytoplasmic extraction reagents (Pierce Biotechnology, Rockford, IL) according to 
the manufacturer’s recommendations. Briefly, RAW264.7 macrophages were plated at a 
density of 2 x10
5
 cells per well and allowed to confluence for 48 h at 37 °C in 5% 
CO2/95% air. Confluent cells were then treated with quercetin (1 μM), mate saponins (4 
μM), and quercetin/mate saponins combination (1:4 μM) and 1 μg/mL LPS for 24 h. 
After 24 h of treatment, cells were harvested in 200 μL of 0.25% trypsin solution. The 
lysates were then transferred in a 1.5 mL microcentrifuge tube and pelleted by 
centrifugation at 500g for 2-3 min. After centrifugation, the cell pellet was treated with 
200 μL of ice-cold cytoplasmic extraction reagent I, vortexed for 15 s, and incubated on 
ice for 10 min and then with treated 11 μL of ice-cold cytoplasmic extraction reagent II, 
vortexed for 5 s, and incubated on ice for 1 min. After incubation, the tube was vortexed 
for 5 s and centrifuged at 16000 g for 5 min at 4 C. The supernatant (cytoplasmic extract) 
was immediately transferred to a clean prechilled 1.5 mL microcentrifuge tube. The pellet 
was then resuspended in 100 μL of nuclear extraction reagent, vortexed for 15 min, and 
incubated on ice for 40 min with vortexing for 15 s every 10 min. The mixture was 
centrifuged at 16000g for 10 min at 4 °C, and the supernatant (nuclear extract) was 
collected. Both cytoplasmic and nuclear extracts were stored at -80 °C until use for 
Western blot analysis. For the determination of p50 and p65 nuclear translocation, 
approximately 50 μg of protein was loaded in 4-20% Tris-HCl ready gels (Bio-Rad 
Laboratories) for protein separation. The separated proteins were transferred in PVDF 
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membrane and blocked with 5% nonfat dry milk in 0.1% Tris-buffered saline Tween 20 
(TBST) for 1 h at 4 °C. After blocking, the membrane was washed with 0.1% TBST (five 
times, 5 min each) and incubated overnight with either p50 or p65 mouse monoclonal 
antibody (1:200) at 4 °C. The membrane was washed again and incubated with anti-
mouse IgG horseradish peroxidase conjugate secondary antibody for 3-4 h at room 
temperature. After incubation and repeated washing, the expression of p50 and p65 was 
visualized using chemiluminescent reagent (GE Healthcare) following the manufacturer’s 
instructions. The membrane picture was taken with a Kodak Image station 440 CF 
(Eastman Kodak Co.).  
Statistical Analysis. Data are presented as means ± SD for the indicated number of 
independently performed experiments. Data were analyzed using one-way ANOVA, and 
means were considered to be significantly different at p < 0.05 as determined by least 
significant differences (LSD). 
4.4 Results 
Effect of Different Mate Tea Phytochemicals on Viability of RAW 264.7 Cells. Cells 
showed a survival rate of > 80% when incubated with MT extract (92.8%), decaffeinated 
MT extract (93.5%), CHA (91.2%), matein (91.2%), and mate saponins (82.7%), at a 
concentration 300 μM. Therefore, in this study, a concentration of 1-300 μM was used to 
treat the cells and thus prevent the compounds from having a cytotoxic effect. 
Concentrations ranging from 1 to 200 μM, from 1 to 100 μM, and from 1 to 100 μM were 
used for quercetin, ursolic acid, and oleanolic acid, respectively, because their survival 
rates were 96.4, 80.8, and 87.6%, respectively. 
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Effect of Different Mate Tea Phytochemicals on NO Production and iNOS 
Expression by LPS-Induced RAW 264.7 Cells. Figure 4.2 shows the effect of different 
concentrations of MT phytochemicals on NO production (A1, B1, C1) and iNOS 
expression (A2, B2, C2) by LPS-stimulated RAW 264.7 cells. MT extract, decaffeinated 
MT extract, and matein did not show any effect on NO production (Figure 4.2 A1) but 
inhibited iNOS expression (Figure 4.2 A2) at the conditions tested. Mate saponins and 
oleanolic acid significantly decreased NO production at 10 and 1 μM, respectively 
(Figure 4.2 B1). Mate saponins and oleanolic acid significantly inhibited iNOS 
expression (80%) at 1 and 100 μM, respectively (Figure 4.2 B2). Ursolic acid did not 
present a significant inhibition of NO and did present an extremely low inhibition for 
iNOS. Quercetin significantly inhibited NO production, in a dose-dependent manner, 
starting at a very low concentration (1 μM) (Figure 4.2 C1). CHA had no effect in 
reducing NO production. Quercetin significantly inhibited iNOS expression (60%) at 10 
μM, whereas CHA inhibited only 30% at a higher concentration (200 μM) (Figure 4.2 
C2).  
Effect of Different Mate Tea Phytochemicals on PGE2 Production and COX-2 
Expression by LPS-Induced RAW 264.7 Cells. Figure 4.3 shows the effect of different 
concentrations of MT phytochemicals on PGE2 production (A1, B1, C1) and COX-2 
expression (A2, B2, C2) by RAW264.7 macrophages induced by LPS.  MT extract (> 
50%), decaffeinated MT extract (20%), and matein (50%) inhibited PGE2 production at 
200, 300, and 200 μM, respectively (Figure 4.3 A1). MT extract significantly inhibited 
COX-2 expression (30%) at 100 μM, but decaffeinated MT extract (30%) and matein 
(25%) inhibited at concentration of 300 μM (Figure 4.3 A2). Ursolic acid significantly 
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decreased PGE2 production (20%) at 10 μM, whereas mate saponins (90%) and oleanolic 
acid (10%) showed inhibition at higher concentrations (300 and 100 μM, respectively) 
(Figure 4.3 B1). Mate saponins (50%), ursolic acid (20%), and oleanolic acid (40%) 
inhibited COX-2 expression at concentrations of 200, 100, and 100 μM, respectively 
(Figure 4.3 B2). Quercetin significantly inhibited PGE2 production (80% at 10 μM) 
(Figure 4.3 C1) and COX-2 expression (25% at 10 μM), whereas CHA showed PGE2 
inhibition (50%) at higher concentration (200 μM) (Figure 4.3 C1). Tables 4.1 and 4.2 
present the concentrations (μM) of each MT phytochemical that resulted in 10, 35, and 
50% reductions against pro-inflammatory parameters. Quercetin was the most potent 
inhibitor of pro-inflammatory responses at a concentration 10 times lower than the 
concentrations used for the other compounds (IC50 = 11.6 μM for NO, 7.9 μM for iNOS, 
and 6.5 μM for PGE2). Mate saponins had a high capacity in preventing inflammation 
through the NO/iNOS pathway (IC50 = 20.8 μM for NO and 8.4 μM for iNOS). Among 
the eight MT phytochemicals studied, quercetin and mate saponins exhibited the lowest 
IC50 values for inhibition of iNOS, NO, and PGE2 production, indicating that they are the 
most potent phytochemicals in MT in preventing inflammation.  
Interaction Study and Isobolographic Analysis. Figures 4.4 and 4.5 show the effect of 
combined MT phytochemicals on the production of NO (A1, B1, C1) and PGE2 (A2, B2, 
C2) by LPS-induced RAW 264.7. More than additive effect was observed in the 
inhibition of NO production when CHA and quercetin were combined (Figure 4.4 A1). 
Additive effects in inhibiting PGE2 production were observed in the combination of 
CHA/quercetin (Figure 4.4 A2). Combinations of CHA/mate saponins (Figure 4.4 B1, 
B2) and CHA/matein (Figure 4.4 C1, C2) resulted in an antagonistic effect in inhibiting 
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NO and PGE2 production. Combinations of quercetin/matein (Figure 4.5 A1) resulted in 
an antagonistic effect in inhibiting NO production but resulted in an additive effect in 
PGE2 production (Figure 4.5 A2). Combinations of quercetin/mate saponins (Figure 4.5 
B1, B2) resulted in synergistic effects in inhibiting both NO and PGE2 production. More 
than an additive effectwas observed in the inhibition of NO production whenmate 
saponins/matein were combined (Figure 4.5 C1). A slight decrease between the 
combinations of mate saponins/matein in inhibiting PGE2 production was also shown but 
was not statistically significant (Figure 4.5 C2). Interactions were confirmed by 
isobolographic analysis as shown in Figure 6. Quercetin and mate saponins 
synergistically interacted to inhibit NO (Figure 4.6 A1) and PGE2 (Figure 4.6 A2), 
whereas CHA/mate saponins (Figure 4.6 B1) and CHA/matein (Figure 4.6 B2) presented 
an antagonistic interaction.  
Effect of Mate Saponins and the Combination of Quercetin and Mate Saponins on 
IL-1β and IL-6 Protein Levels and on the Transcriptional Activity of NFκB and 
NFκB Nuclear Translocation by LPS-Induced Macrophages. Mate saponins and the 
combination of quercetin and mate saponins significantly inhibited IL-1β (Figure 4.7 A) 
and IL-6 (Figure 4.7 B). Transient transfection experiments using the NFκB vector 
indicated that quercetin and mate saponins inhibited the transcriptional activity of NFκB 
but that the combination of quercetin and mate saponins showed no statistical differences 
by measuring firefly luciferase activity (Figure 4.8 A). Quercetin, mate saponins, and 
their combination significantly inhibited nucleus translocation of the NFκB p65 subunit 
(Figure 4.8 B). Although quercetin and mate saponins did not statistically inhibit the 
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nucleus translocation of NFκB p50 subunit (Figure 4.8 C), their combination significantly 
inhibited the nucleus translocation of this subunit.  
4.5 Discussion 
MT has been reported to have several biological functions, mostly related to 
antioxidant activity [6, 7, 21-26], interfering with glucose absorption, which might help 
lower the risk for type 2 diabetes [27] and obesity [28]. Although a recent paper has 
shown that MT could be useful as an anti-inflammatory agent in lungs damaged by 
cigarette smoke exposure [29], the anti-inflammation mechanism of MT has not been 
studied yet. To our knowledge, this is the first study that evaluated and compared the 
inflammatory properties of different MT phytochemicals and investigated the potential 
interactions between phytochemicals using iNOS/NO and COX-2/PGE2 mechanistic 
pathways. The results suggest that different MT phytochemicals have different capacities 
in inhibiting inflammation through iNOS/ NO and COX-2/PGE2 pathways. MT extract, 
decaffeinated MT extract, and matein showed no reduction of NO production and a slight 
inhibition of iNOS expression in a concentration-dependent manner. The observed slight 
inhibition in iNOS expression showed that these compounds are capable of inhibiting the 
translation of the enzyme. However, the amount of NO produced was not significantly 
inhibited by these compounds, which might be attributed to their incapability of 
inhibiting the enzyme activity. Even though the expression of iNOS was slightly 
inhibited, the enzyme was still present and as such NO was still produced. In addition, 
matein did not show a potent anti-inflammatory effect. Thus, the inhibitory effect on pro-
inflammatory responses by MT may not be attributed to matein. Recently, caffeine (5-50 
mg/kg) did not show an inhibitory effect on PGE2 synthesis in inflamed tissue of male 
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Sprague-Dawley rats [30]. MT contains a significant amount of triterpenoid saponins, 
which exist as ursolic and oleanolic acid [19]. Our results showed that mate saponins and 
ursolic acid inhibited inflammation through the iNOS/NO pathway more than through the 
COX-2/PGE2 pathway. Sur et al. [14] found that two saponins (10 mg/kg) isolated from 
aqueous alcohol extract of tea root had an anti-inflammatory effect by inhibiting 
carrageenan-induced paw edema in rats. Crude saponin extracts and purified saponin 
extracts (100 mg/kg) of Hedera colchica were shown to be potent inhibitors of acute and 
chronic inflammation in carrageenan- and cotton pellet-induced inflammation models in 
rats [31]. It has been reported that ursolic acid (100 μM) suppressed the expression of 
LPS-induced pro-inflammatory mediators in RAW264.7 macrophages that resulted from 
inhibition of NFκB activation [17, 32]. Although ursolic acid is known to have numerous 
pharmacological activities, the potency of ursolic acid is relatively weak [32], an 
observation in accordance with our results. CHA had a weak inhibition on pro-
inflammatory markers in RAW264.7 cells, even though it showed a very strong 
antioxidant capacity in vitro. These results are in agreement with those of Wang and 
Mazza [33] using the same model system. We found that CHA inhibited only the COX-
2/PGE2 pathway; this is consistent with the findings of Shan et al. [34]. COX-2 can be 
activated by both AP-1 and NFκB, but iNOS is activated only by NFκB and negatively 
regulated by AP-1. This may explain why CHA did not alter LPS-induced iNOS 
expression. Quercetin revealed a very potent anti-inflammatory effect via inhibition of 
NO/iNOS pathway. This finding is in accordance with Mu et al. [10], who showed that 
quercetin (10 μM) significantly reduced LPS-induced RAW 264.7 macrophage NO 
production in a concentration-dependent manner through down-regulating the expression 
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of iNOS. Furthermore, Liang et al. [11] found that quercetin (12.5 μM) slightly enhanced 
the COX-2 protein level, but significantly inhibited iNOS protein level expression in 
LPS-induced macrophages. They suggested that the two OH groups on the B ring (Figure 
1) decrease the inhibitory potency of quercetin on COX-2 activity [11]. Our results 
showed that quercetin had less capacity to inhibit COX-2 expression. However, quercetin 
has been shown to suppress COX-2 expression in J774A.1 macrophages (50 μM) [12] 
and in rat aberrant crypt foci formation (4.5 g/kg) [13]. The combined concentrations of 
MT phytochemicals used in this study were equivalent to the concentrations in one cup of 
tea (1.5 g of DL/150 mL of water). We found that the mixture of quercetin/mate saponins 
exhibited the highest potency in inhibiting pro-inflammatory responses, among other 
combinations tested. The presence of quercetin in the mixture resulted in higher potency 
as compared to individual MT phytochemicals, suggesting a possible synergistic and/or 
additive effect. On the other hand, combination of CHA/mate saponins and CHA/matein 
resulted in an antagonistic inhibition of NO and PGE2 production. The MT extract not 
having a potent anti-inflammatory effect may be due to the antagonistic effect of some of 
its compounds. However, whole MT consumption still has a promising anti-inflammatory 
effect mainly through the PGE2/COX-2 pathway. The data suggest that the anti-
inflammatory effect of MT might be due to the presence of quercetin andmate saponins 
even though their concentration in MT is low [35]. The synergistic or antagonistic effects 
of the mixtures may depend on the chemical structures of the molecules and the possible 
formation of stable intermolecular complexes [36]. These interactions could be due to 
attachment between the aromatic ring of phenolic acid and the B ring of flavonol, and 
hydrogen-bonding effects would also help to form the complex. Further studies in vivo 
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are important to determine the bioavailability and the potential adverse effects [37]. Mate 
saponins and the combination of quercetin and mate saponins had a strong anti-
inflammatory activity due to their ability to inhibit the overexpression of 
proinflammatory cytokine IL-1β, suggesting inhibition in the activation IKK, the enzyme 
responsible for the phosphorylation of IκB protein kinase. In addition, quercetin, mate 
saponins, and their combination inhibited the nuclear translocation of NFκB p65 in 
accordance with the decrease in NO and PGE2 and reduced production of IL-6 by 
saponins and the mixture. Quercetin and mate saponins reduced significantly (p < 0.05) 
the activation of NFκB in transiently transfected RAW 264.7 macrophages, suggesting a 
reduction in the binding of NFκB to its target DNA, so inhibiting transcription of genes 
with proinflammatory properties. Furthermore, the combination significantly inhibited 
nuclear translocation of NFκB p50. In summary, our results suggest that quercetin and 
mate saponins are the most potent inflammation inhibitors in MT and, when combined, 
they have a synergistic effect. The quercetin and saponin combination, at a concentration 
found in one cup of MT, inhibited inflammation through suppression of NFκB pathways 
by inhibiting production of IL-1β, thereby suggesting prevention in the activation of IκB 
kinase, by blocking the translocation of p50 and p65 NFκB subunits resulting in the 
decreased production of IL-6, PGE2, and NO. To our knowledge this is the first study 
demonstrating the efficacy and interactions of phytochemicals in MT inhibiting pro-
inflammatory markers. 
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4.7 Figures and Tables 
A                          B  
                  Chlorogenic acid                                 Caffeine 
C  
            Quercetin 
D  
        Ursolic acid   Oleanolic acid 
Figure 4.1 Chemical structure of (A) chlorogenic acid, (B) caffeine (matein), (C) 
quercetin, (D) ursolic acid, and (E) oleanolic acid. 
 
 
E 
47 
 
 
Figure 4.2 Effect of different concentrations of MT phytochemicals on NO (1) 
production and iNOS (2) expression by LPS-induced RAW 264.7 cells: (A) MT extract, 
decaffeinated MT extract, matein; (B) mate saponins, ursolic acid, oleanolic acid; (C) 
CHA, quercetin. The data represent the mean ±SD from two independent experiments 
and at least a triplicate analysis. Different letters indicate significant differences, P < 
0.05. 
 
 
48 
 
 
Figure 4.3 Effect of different concentrations of MT phytochemicals on PGE2 production 
(1) and COX-2 expression (2) by LPS-induced RAW 264.7 cells: (A) MTextract, 
decaffeinatedMT extract,matein, (B)mate saponins, ursolic acid, oleanolic acid, (C) 
CHA, quercetin. The data represent the mean (SD from two independent experiments and 
at least a triplicate analysis. Different letters indicate significant differences, P < 0.05. 
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Figure 4.4 Inhibition (%) of NO (1) and PGE2 (2) production by LPS-induced RAW 
264.7 macrophages after treatment with (A1, A2) CHA (200 μM), quercetin (1 μM), and 
combination of CHA:Quercetin (2.3:0.001); (B1, B2) CHA (200 μM), saponins (4 μM), 
and combination of CHA:Saponins (2.3:0.004); (C1, C2) CHA (200 μM), matein (200 
μM), and combination of CHA:Matein (2.3:0.86). The data represent the mean ± SD from 
two independent experiments and at least a triplicate analysis. Significant differences 
between observed values and additive interaction are reported at P < 0.05. 
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Figure 4.5 Inhibition (%) of NO (1) and PGE2 (2) production by LPS-induced RAW 
264.7 macrophages after treatment with (A1, A2) quercetin (1 μM), matein (200 μM), 
and combination of Quercetin:Matein (0.001:0.86); (B1, B2) quercetin (1 μM), saponins 
(4 μM), and combination of Quercetin:Saponins (0.001:0.004); (C1, C2) saponins (4 μM), 
matein (200 μM), and combination of Saponins:Matein (0.004:0.86). The data represent 
the mean ± SD from two independent experiments and at least a triplicate analysis. 
Significant differences between observed values and additive interaction are reported at P 
< 0.05. 
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Figure 4.6 IC35 isobolograms for the synergistic interaction of (A) quercetin and mate 
saponins in inhibiting NO (1) and PGE2 (2) production and for the antagonistic 
interaction of (B1) CHA and mate saponins, (B2) CHA and matein in inhibiting PGE2 
production by LPS-induced RAW 264.7 cells. The line of additivity (solid line) is shown 
with its 95% confidence interval (dotted lines). 
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Figure 4.7 Effect of quercetin, mate saponins and their combination on (A) IL-1β and (B) 
IL-6 production by LPS-induced RAW 264.7 macrophages. The data represent the mean 
± SD from two independent experiments. Different letters indicate significant differences, 
P < 0.05. 
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Figure 4.8 Effect of quercetin, mate saponins and their combination on NFκB 
transactivation by LPS-induced RAW 264.7 macrophages as measured by luciferase 
assay (A). Effect of quercetin, mate saponins and their combination on (B) p65 nuclear 
translocation and (C) p50 nuclear translocation by LPS-induced RAW 264.7 
macrophages. The data represent the mean ± SD from two independent experiments. 
Different letters indicate significant differences, P < 0.05. 
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Table 4.1 IC10, IC35, and IC50
 
of mate tea compounds against NO and iNOS production and expression 
a
. 
 
Compound 
NO
b (μM) iNOSb (μM) 
IC10 IC35 IC50 IC10 IC35 IC50 
Mate tea extract >300 >300 >300 16.5 ± 10.2 198 ± 10.2 >300 
Decaffeinated Mate tea extract >300 >300 >300 24.8 ± 3.5 208 ± 3.5 >300 
Chlorogenic acid 123.4 ± 1.6 >300 >300 198.8 ± 0.8 250.8 ± 0.8 >300 
Matein >300 >300 >300 147.5 ± 0.3 203 ± 0.3 223.7 ± 0.3 
Quercetin 0.5 ± 0.3 1.5 ± 0.3 11.6 ± 0.3 1.1 ± 0.1 4.5 ± 0.1 7.9 ± 0.1 
Mate saponins 4.8 ± 0.5 10.1 ± 0.5 20.8 ± 0.5 2.3 ± 0.5 6.2 ± 0.5 8.4 ± 0.5 
Ursolic acid 101.5 ± 1.6 >100 >100 81.2 ± 0.5 >100 >100 
Oleanolic acid 16.7 ± 5.4 37.8 ± 5.4 79.7 ± 5.4 8.3 ± 0.5 22.6 ± 0.5 30.9 ± 0.5 
a
  IC10, IC35, and IC50 are the concentrations (μM) that resulted in 10%, 35%, and 50% reduction, respectively, of 
production/expression of pro-inflammatory responses (mean ± SD, n =2). 
b 
Abbreviations: NO, nitric oxide; iNOS, inducible nitric 
oxide synthase. 
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Table 4.2 IC10, IC35, and IC50
 
of mate tea compounds against PGE2 and COX-2 production and expression 
a
. 
Compound 
PGE2
b (μM) COX-2b (μM) 
IC10 IC35 IC50 IC10 IC35  IC50 
Mate tea extract 173.6 ± 2.0 220 ± 2.0 280.6 ± 2.0 111.8 ± 0.2 206.3 ± 0.2 >300 
Decaffeinated Mate tea extract 225 ± 3.2 >300 >300 205.5 ± 2.5 >300 >300 
Chlorogenic acid 100.1 ± 2.4 130.6 ± 2.4 231.6 ± 2.4 186.4 ± 0.2 >300 >300 
Matein 137.5 ± 0.5 215.6 ± 0.5 252.6 ± 0.5 213.7 ± 0.5 >300 >300 
Quercetin 0.5 ± 2.2 1.5±2.2 6.5 ± 2.2 52.2 ± 0.2 179.9 ± 0.2 >200 
Mate saponins 122.7 ± 16.3 208.7 ± 16.3 227.1 ± 16.3 153.3 ± 0.4 209.6 ± 0.4 227.7 ± 0.4 
Ursolic acid 74.2 ± 12.5 >100 >100 >100 >100 >100 
Oleanolic acid >100 >100 >100 >100 >100 >100 
a
  IC10, IC35, and IC50 are the concentrations (μM) that resulted in 10%, 35%, and 50% reduction, respectively, of 
production/expression of pro-inflammatory responses (mean ± SD, n =2). 
b
 Abbreviations: PGE2, prostaglandin E2; COX-2, 
cyclooxygenase-2. 
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CHAPTER 5 
MATE (ILEX PARAGUARIENSIS ST. HILAIRE) SAPONINS INDUCE 
CASPASE-3-DEPENDENT APOPTOSIS IN HUMAN COLON CANCER CELLS 
IN VITRO 
2 
5.1 Abstract 
Saponins are naturally occurring metabolites associated with several health benefits. The 
objectives were to quantify and purify saponins from mate dry leaves, and to assess their 
anti-inflammatory and apoptotic mechanisms in human colon cancer cells in vitro. Mate 
saponins were extracted with methanol from dry leaves, partially purified and quantified. 
Leaves contained 10–15 mg/g dry weight total saponins, predominantly matesaponins 1 
and 2. HPLC and LC/ESI-MS-MS identified saponins in six preparative chromatographic 
fractions (A, B, C, D, E, and F). Major matesaponins were identified as 1 [M–H]- = 911 
and 2 [M–H]- = 1057, with trace amounts of 3 [M–H]- = 1073, 4 [M–H]- = 1219, and 5 
[M–H]- = 1383. Fractions D, E, and F significantly inhibited iNOS (IC35 = 36.3, 29.5, 
43.7 μM), PGE2 (IC35 = 23.1, 22.3, 11.7 μM) and COX-2 (IC35 = 45.7, 32.4, 17.0 μM). 
Fraction F reduced nuclear translocation of nuclear factor- κB subunits p50 (49.8%) and 
p65 (49.0%) and induced apoptosis through suppression of Bcl-2 and increased Bax 
protein expressions and activated caspase-3 activity. Saponins in leaves of yerba mate 
prevent inflammation and colon cancer in vitro. 
 
2 
This chapter is part of the paper, Puangpraphant, S.; Berhow, M.; de Mejia, E.G. Mate (Ilex 
paraguariensis St. Hilaire) saponins induce caspase-3-independent apoptosis in human colon cancer 
cells in vitro. Food Chem. 2011, 125, 1171-1178. Permission granted by ELSEVIER. 
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5.2 Introduction 
The Ilex paraguariensis St. Hilaire tree is native to South America and its dried 
leaves are used to prepare a traditional beverage called Yerba Mate tea. The leaves of 
Yerba mate contain significant amounts of purine alkaloids, caffeolyquinic acid 
derivatives, flavonoids and triterpenoid saponins [1]. The primary saponins identified 
from Ilex paraguariensis are matesaponin 1–5 [2-4]. These saponins have ursolic acid as 
the triterpenoidal aglycone. Two minor saponins have also been identified from Ilex 
paraguariensis that contain an oleanolic acid as the triterpenoid aglycone [5]. Several 
health benefits of saponins from various plant sources have been reported including 
hypocholesterolemic effect [6], cancer inhibition [7, 8], induction of apoptosis [9], 
inhibition of cancer cell proliferation [10], antimutagenic action [11] and anti-
inflammatory properties [12, 13]. Recently, we found that a chloroform extract prepared 
by partitioning a mate tea aqueous extract contained 73% saponins and had anti-
inflammatory activity in vitro using macrophages [14]. There is limited information about 
the anti-inflammatory properties and potential anti-cancer effect of a more purified 
saponin extract from mate leaves. Chronic inflammation is considered a critical factor in 
many human diseases, including cancer [15-17], cardiovascular disease, obesity and type 
2 diabetes [18, 19]. Nuclear factor-kappa B (NF-κB) is a pro-inflammatory transcription 
factor that regulates expression of multiple genes, which mediate cell survival, cell 
adhesion, inflammation, cell growth and contributes to pathogenesis of various diseases, 
including cancer [20]. NF-κB can be activated by many stimuli, including pro-
inflammatory cytokines, where this activation contributes to malignant progression and 
therapeutic resistance in most of the major human cancers [21]. Macrophages produce 
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pro-inflammatory response cytokines such as TNF-a, IL- 1b which activate NF-κB, 
leading to expression of inflammatory genes, such as cyclooxygenase (COX) and 
inducible nitric oxide synthase (iNOS). Induced iNOS results in the production of the 
inflammatory agent nitric oxide (NO) [22], a diatomic free radical, and NO-derived 
reactive nitrogen species, inducing oxidative and nitrosative stress are considered as pro-
inflammatory mediators which lead to DNA damage [23]. Prostaglandin E2 (PGE2) is a 
proinflammatory mediator generated at inflammatory sites by COX-2 and contributes to 
the development of chronic inflammatory diseases, such as cardiovascular disease and 
cancer [24, 25]. The use of anti-inflammatory drugs, which inhibit COX-2 activity, has 
been shown to be beneficial in preventing and treating these diseases [24, 26]. Inhibition 
of pro-inflammatory cytokines and inhibition of NF-κB activation or function are 
important targets for anti-inflammatory drug development. Pro-inflammatory cytokines 
can be detected in colorectal cancer. There is now evidence that inflammatory cytokines, 
which can be produced by the tumour cells and/or tumourassociated leucocytes and 
platelets, may contribute directly to malignant progression. Examples are tumour necrosis 
factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-8 [15, 18, 21-26]. Recently, it has been 
suggested that anti-inflammatory capacities of bioactive compounds could contribute to 
cancer prevention. Nevertheless, the mechanisms of anti-cancer capacity remain poorly 
understood. We hypothesised that saponins purified from mate leaves will prevent 
colorectal carcinogenesis by suppressing inflammation and promoting apoptosis. To test 
this hypothesis, RAW 264.7 macrophage cells were treated with different concentrations 
of purified saponins from mate leaves, inflammation biomarkers such as COX-2 and 
iNOS expression, concentration of PGE2, NO and activation of NF-κB pathway were all 
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measured. Moreover, we measured the anti-colon cancer potential of saponins using HT-
29 colon cancer cells. Their capability to promote apoptosis was also measured. Cell 
cytotoxicity was performed and apoptosis was evaluated by expression of proteins 
associated to apoptosis, such as caspase-3 activity. In the present study, we have 
identified, quantified and purified saponins from mate dry leaves, assessed their anti-
inflammatory action and the corresponding underlying mechanism in vitro. We also 
investigated the mechanism of apoptosis inducing activity of mate saponins in human 
colon cancer cells. 
5.3 Materials and Methods 
Chemicals 
Sodium nitrite, sulphanilamide, N-1-(naphthyl) ethylenediamine-diHCl and 
lipopolysaccharide (LPS) from Escherichia coli O55:B5) were purchased from Sigma (St. 
Louis, MO, USA). Macrophage RAW 264.7 cell line, colon cancer cell line HT-29, 
normal colon fibroblast CCD-33Co, McCoy 5A medium, Eagle’s Minimum Essential 
Medium and 0.25% (w/v) Trypsin 0.53 mM EDTA and Dulbecco’s Modified Eagle 
Medium with L-glutamine (DMEM) were purchased from American Type Culture 
Collection (Manassas, VA). Fetal bovine serum was purchased from Invitrogen (Grand 
Island, NY, USA). Cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), 
NF-κB p50, NF-κB p65, Bcl-2, Bax, and actin mouse monoclonal antibodies were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and antimouse IgG 
conjugated horseradish peroxidase secondary antibody was purchased from GE 
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Healthcare (Buckinghamshire, UK). All other chemicals were purchased from Sigma, 
unless otherwise specified. 
Extraction and purification of mate saponins 
Saponins were extracted and fractionated from mate (Ilex paraguariensis) leaves, 
organically grown in Paraguay following the method by Berhow et al. [27]. Briefly, 1 kg 
of powdered Mate dry leaves was extracted with methanol in a Soxhlet extractor for 72 h. 
The extracts were reduced by rota-evaporation (40 ºC), pooled and concentrated by 
evaporation (37 ºC) under the hood. The dried material was re-suspended in methanol for 
preparative flash chromatography. 
Preparative chromatography for purification of saponins 
Six Fractions (A, B, C, D, E, F) were collected from preparative flash chromatography 
based on UV absorbance peaks at 210 nm. Fractions as follows: A (900 mg; eluted 
between 5 and 15 min), B (250 mg; eluted between 15 and 20 min), C (120 mg; eluted 
between 20 and 25 min), D (100 mg; eluted between 25 and 30 min), E (80 mg; eluted 
between 30 and 35 min), and F (75 mg; eluted between 35 and 45 min). 
Analytical HPLC methodology 
Mate saponin fractions D, E and F were dissolved in methanol at 2 mg/ml. An aliquot 
was then removed from the vial and filtered through a 0.45 μM nylon 66 filter for HPLC 
analysis of saponins. HPLC analysis was conducted using a Shimadzu (Columbia, MD) 
HPLC System (two LC 20AD pumps; SIL 20A autoinjector; DGU 20As degasser; SPD-
20ºA UV–VIS detector; and a CBM-20A communication BUS module) running under 
the Shimadzu EZStart Version 7.3 software. The column was a C18 Inertsil reverse phase 
column (250 x 4.6 mm; RP C-18, ODS-3, 5u; with a Metaguard guard column; Varian, 
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Torrance, CA). Initial chromatographic conditions were 30% acetonitrile and 0.025% 
trifluroacetic acid (TFA) in water, at a flow rate of 1 ml per minute. The effluent was 
monitored at 210 nm. After injection (typically 25 μL), the column was developed to 
50% acetonitrile and 0.025% TFA in a linear gradient over 45 min. A standard curve, 
based on nanomoles injected, was prepared using a purified soyasaponin I as standard. 
Matesaponins, for cell culture studies, were prepared by weight using 10 mg/mL DMSO 
as an initial stock and then diluted the initial stock with culture medium to different 
concentrations (1–100 μM) using the molecular weight of saponins equal to 1,000 to 
calculate μM equivalent concentrations. 
LC/ESI-MS analysis for confirmation of saponins 
To confirm the identity of the matesaponins found in the mate extract fractions, aliquots 
were injected on a Q-TOF LC-MS. Samples were run on an Applied Biosystems/MDS 
Sciex QStar Elite QTOF mass spectrometer (MS) with a Turbo ionspray 
electrospraysource, and a Agilent 1100 series HPLC system (G1379A degasser, G1357A 
binary capillary pump. G1389A autosampler, G1315B photodiode array detector, and a 
G1316A column oven all running under Applied Biosystems Analyst 2.0 (build 1446) 
LC-MS software were used. The MS was calibrated at least once daily with a standard 
calibration mixture recommended by Applied Biosystems and the signal detection was 
optimised as needed. The data were acquired in the MOF MS negative mode. The MS 
parameters were as follows: accumulation time 1 s, mass range 400–2000 daltons, source 
gas 1–50 units, source gas 2–35 units, curtain gas 20 units, ion spray voltage was 4200 V, 
source heater 250 ºC, declustering potential 80, focusing potential 265, declustering 
potential 2–15, ion release delay 6, ion release width 5. The column used was an Inertsil 
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ODS-3 reverse phase C-18 column (3 μM, 150 x 3 mm, with a Metaguard column, from 
Varian). The initial HPLC conditions were 60% acetonitrile and 40% 0.25% formic acid 
in water, at a flow rate of 0.3 ml per min, and then to 80% acetonitrile over 60 min. The 
effluent was also monitored at 210 nm on the PDA. 
Macrophages culture and cell viability assay and treatments 
Macrophage cell line RAW 264.7 was cultured and cell viability assay was conducted 
using the CellTiter 96 Aqueous One Solution proliferation assay kit (Promega 
Corporation, Madison, WI, USA) as previously indicated [14]. The cells were treated 
with different concentrations of matesaponin fractions (1–100 µM) for 24 h. The 
percentage of viable cells was calculated with respect to cells treated with 0.1% DMSO. 
Solvents used at these concentrations showed no cytotoxicity on cell viability (>80%). 
DMSO at <0.1% presented 95.8% cell viability. Cell treatment was conducted by seeding 
2 x 10
5
 cells in a 6-well plate and cells were allowed to grow for 48 h at 37 ºC in 5% 
CO2/95% air. After 48 h incubation, cells were treated with different concentrations of 
matesaponins fractions (1, 10, 25, 50 µM) and 1 µg/mL of LPS for 24 h. After 24 h 
treatment, the spent medium was collected and analysed for NO and PGE2. Cell lysates 
were used to study the effect of matesaponins fractions on the expressions of COX-2 and 
iNOS. 
Nitrite, PGE2, iNOS and COX-2 measurements 
After 24 h of treatment and LPS induction, culture supernatant was collected and 
measured to determine nitrite and PGE2.COX-2 and iNOS expressions were determined 
in cell lysates as previously described [14]. 
Western blot of NF-κB p50 and p65 protein expression 
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NF-κB p50 and p65 expressions were determined in the cell cytoplasm and nucleus as 
previously discussed [14]. Briefly, RAW 264.7 macrophages were treated 24 h with 
different concentrations of matesaponins fraction F (1, 10, 25, 50 µM) and 1 µg/mL of 
LPS. Nuclear and cytoplasmic proteins were isolated with a buffer extraction and 
centrifugation system NE-PER® (Pierce Biotechnology, IL) according to the 
manufacturer’s recommendations. 
HT-29 and CCD-33co culture and cell proliferation assay 
HT-29 cells were cultured in growth medium containing McCoy 5A, 1% 
penicillin/streptomycin, 1% sodium pyruvate and 10% faetal bovine serum at 37 ºC in 
5% CO2/95% air. CCD-33Co colon fibroblasts were cultured in Eagle’s Minimum 
Essential Medium containing 10% FBS and 1% penicillin/streptomycin. Cell 
proliferation was determined using CellTiter 96 Aqueous assay kit (Promega, Madison, 
WI) as previously indicated [14]. For CCD-33Co, 1 x 10
3
 cells per well were seeded in a 
96-well plate and allowed to grow to confluency for one week with replacement of the 
medium every other day. For HT-29, 5 x 10
4
 cells per well were seeded in a 96-well plate 
and total volume was adjusted to 200 μl with growth medium and allowed to grow for 24 
h. Both cells were then treated with different concentrations of matesaponins fraction F 
(1, 10, 25, 50 µM) for 24 h. 
Analysis of Bax and Bcl-2 expression and caspase-3 activity in HT-29 cells 
HT-29 cells were seeded at a density of 2 x 10
5
 cells per well in a six-well plate for 24 h 
at 37 ºC in 5% CO2/95% air. After 24 h incubation, cells were treated with matesaponins 
fraction F (1 to 50 µM) for 24 h. After treatment, cells were trypsinised and suspended in 
lysis buffer composed of 62.5 mM Tris–HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% 
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bromophenol blue, 5% b-mercaptoethanol and protease inhibitor cocktail (Thermo 
Scientific, Rockford, IL). Cell suspension was then used for Western blot for actin, Bax 
and Bcl-2 using antibodies (1:200). Caspase-3 activity was measured using a 
fluorescence assay kit (Cayman Chemicals, Ann Arbor, MI) according to the 
manufacturer’s protocol. HT-29 cells were seeded in a 96-well plate in 100 µl of culture 
medium at a density of 5 x 10
4
 cells/well and incubated at 37 ºC in a CO2 cell culture 
incubator overnight. Cells were treated with matesaponins fraction F, quercetin and 
cisplatin (1–50 µM) for 24 h in a 37 °C incubator. Relative fluorescent intensity was then 
measured with a plate reader FLx800tbi (Biotek, Winooski, VT) (excitation = 485 nm; 
emission = 535 nm). 
Statistical analysis 
Data are presented as means ± SD for the indicated number of independently performed 
experiments. Data were analysed using one-way ANOVA and means were considered to 
be significantly different at p < 0.05 as determined by least significant differences (LSD). 
5.4 Results and discussion 
Identification of saponins extracted from mate dry leaves 
We obtained six fractions (A, B, C, D, E, F) of complex mixtures that absorbed UVlight 
at 210 nm. The presence of saponins was confirmed in only fractions D, E, and F. Table 1 
lists the identified saponins, their retention times (RT), major mass ions, fragment ions, 
name and concentration. Fig. 5.1 shows LC-MS of an analytical run of matesaponins 
fraction F. Under these chromatographic and mass analysis conditions, mate saponins 
form adducts with formic acid, giving a characteristic mass identification pattern of [M-
1]- and [M + 46]-. It appears to be two isomeric forms of matesaponin 2, which is 
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consistent with the observations of Martinet et al. [5]. Saponins in Yerba mate leave 
extracts gave a total concentration of 11.7 ± 0.37mg/g dry weight (dw) (matesaponin 1, 
5.04 ± 0.16mg/g dw; matesaponin 2a, 3.55 ± 0.11 mg/g dw; matesaponin 2b, 3.08 ± 0.09 
mg/g dw). Matesaponins 3, 4, and 5 were found only in trace amounts. Yerba mate leaves 
were shown to contain 1.2 g of saponins per 100 g of dry leaves, mostly in the form of 
matesaponins 1 and 2. It is important to note that saponins are not as soluble in water as 
they are in organic solvents, so the levels of extractable saponins in mate teas will be 
much lower than what is actually present in the leaves. Two recent reports [28, 29] 
provided information on the levels of saponins in mate leaves and plant tissues. Borré et 
al. [28] have reported an estimate of 45 mg/g (4.5%) total saponin content in leaves based 
on an aqueous ethanol extraction and a summation of absorbing peaks at 210 nm. This 
method appears to overestimate the levels of saponins in the tissues as the ten individual 
peaks being summed have not been confirmed by the authors to be saponins. In contrast, 
Coelho et al. [29] have determined a range of 0.3 to 1 mg/g (0.1%) based on the 
determination of matesaponins 1, 2, and 3 in hot aqueous extracts of mate leaves. 
Comparison of our results indicates that the tea preparation may extract about 10% of the 
available saponins. 
Effect of matesaponin fractions on NO, PGE2 production and iNOS, 
COX-2 expression in LPS-induced RAW 264.7 cells Macrophages showed a survival rate 
of > 90% when incubated with matesaponin fractions at a concentration ≤ 50 µM. 
Therefore, in this study, a concentration of 1–50 lM was used to treat the cells and thus 
prevent the compounds from having cytotoxic effect. Fractions A, B and C had no effect 
on NO production and did not reduce iNOS and COX-2 expressions (data not shown). 
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This may be due to the absence of saponins and high content of sugars. Fig. 5.2 shows 
that fractions D and E did not significantly reduce NO production (Fig. 5.2A), but 
showed inhibition of iNOS expression in a dose-dependent manner (Fig. 5.2B). Fraction 
F significantly reduced NO production at 50 µM (Fig. 5.2A) and inhibited iNOS 
expression in a dose – dependent manner (Fig. 5.2B). Fraction D significantly inhibited 
COX-2 expression at 25 µM (Fig. 5.2C) and reduced PGE2 production at 10 µM (Fig. 
5.2D). Fraction E significantly reduced COX-2 expressions at 25 μM and PGE2 
production at 1 µM. While fraction F significantly reduced COX-2 expression in a dose–
response manner starting at 10 µM and PGE2 production at 10 µM. Table 5.2 presents the 
calculated concentration (based on the aglycone in µM) of matesaponins in fractions D, 
E, and F that resulted in a 35% reduction on pro-inflammatory parameters. Matesaponins 
in fraction D, E, and F inhibited COX-2/PGE2 pathway. Fraction E and F seem to be 
more potent than fraction D in inhibiting pro- inflammatory markers. This may be due to 
different chemical composition in fraction D, which contains dicaffeoylquinic acids 
(Table 5.1). Fraction F showed more potent anti-inflammation activity than fraction E 
even though the latter had a higher saponin concentration. Excessive production of NO, 
especially in macrophages, can lead to cytotoxicity, inflammation, carcinogenicity, and 
autoimmune disorders. Therefore, modulation of NO and iNOS could prevent 
inflammatory diseases. In this study, matesaponins fraction Fwas found to significantly 
suppress LPS-induced NO production in RAW 264.7 cells, due to its ability to inhibit the 
expression of iNOS. Inhibition of iNOS/NO signalling pathway is one strategy for anti-
inflammatory drug development. Fraction F showed higher activity in inhibiting 
inflammation than fractions D and E, probably due to more aglycone in this fraction, as 
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shown in the UV chromatogram (Fig. 5.1). Many plant natural products exhibit 
bioactivities only after the loss of their glycosides. Studies have shown that the 
deglycosylation of saponins increases their pharmacological activity in vivo [12]. 
Inhibition of the protein expression of COX-2 has been widely accepted as one of the 
important molecular targets of anti-inflammatory agents [26, 30]. Inhibition of the pro-
inflammatory cytokines production is believed to be one of the pathways by which 
matesaponins exert their anti-inflammatory effect [14]. The interaction between NO 
signalling and COX-2 is well documented and is a significant contributor to chronic 
inflammation which leads to carcinogenesis [22]. It has been shown that a combination of 
COX-2 and NO inhibitors enhances the effect of chemoprevention of colon 
carcinogenesis [31]. Matesaponins fractions D, E, and F inhibited the inducible enzymes, 
iNOS and COX-2, suggesting that saponins may have additional chemopreventive 
potential. It has been reported that saponins suppress the expression of COX-2 and iNOS, 
resulting in a marked lowering of PGE2 levels [32], the assumed precursor for formation 
and growth of malignant tumours. Manipulations of PGE2 pathways, and their impact on 
cancer growth and treatment, have become an important aspect of cancer prevention 
research [33]. 
Effect of matesaponin fraction F on NF-κB nuclear translocation by 
LPS-induced RAW 264.7 cells Fraction F reduced nucleus protein expressions of NF-κB 
subunits p65 (Fig. 5.3A) and p50 (Fig. 5.3B) at a concentration of 25 µM, and showed no 
change expression in cytoplasm. Fraction F was able to inhibit nuclear translocation of 
NF-κB subunits at 25 µM. We also found that fraction F inhibited NF-κB translocation 
more on the p50 subunit than on the p65 subunit. Inhibition of NF-κB nuclear 
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translocation resulted in decreased expression of both COX-2 and iNOS, as well as 
reduced production of PGE2 and NO. This observation suggests that chemical 
constituents in fraction F may reduce the binding of NF-κB to its target DNA thus 
inhibiting transcription of genes with pro-inflammatory properties. NF-κB is known to 
play a critical role in the regulation of cell survival genes and to induce the expression of 
inflammatory enzymes and cytokines, such as iNOS, COX-2, TNF-α, IL-1b, and IL-6 
[34]. Blocking the NF-κB transcriptional activity in the macrophage nucleus can suppress 
the expression of iNOS, COX-2, and pro-inflammatory cytokines. A number of saponins 
have been studied in vitro and in vivo to clarify their effects on inflammation [12, 13, 32, 
35-40]. Taken together, our results suggest that saponins from mate dry leaves may be 
beneficial in preventing inflammation and thus potentially reducing colon cancer. The 
molecular mechanisms are considered to be closely related to the inhibition of iNOS and 
COX-2 protein expression and through inhibition of NF-κB nuclear translocation. 
Effect of matesaponin fraction F on cell proliferation of HT-29 colon cancer cells 
Fig. 5.4 shows that matesaponins in fraction F caused a dosedependent inhibition of HT-
29 colon cancer cells proliferation. At a concentration of 50 µM, matesaponins in fraction 
F inhibited 12.7% of viable HT-29 cells when compared to cells not treatedwith 
matesaponins. At the highest concentration tested (100 µM), matesaponins caused a 
48.6% inhibition. Matesaponins did not cause any cytotoxicity to CCD-33co normal 
colon fibroblasts up to 100 µM (data not shown). Several studies have shown that 
saponins in plants are associated with a reduced risk of colorectal cancer by inducing 
cytotoxicity and apoptosis [41-43]. Matesaponins have an ursolic acid aglycone; it has 
been shown that ursolic acid has strong anti-proliferative and apoptotic effects on HT-29 
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cells [44]. We examined the anti-proliferative effect of matesaponins fraction F on human 
colon cancer HT-29 cells at various concentrations (1–100 µM). Matesaponins fraction F 
significantly decreased the proliferation of HT-29 cells by 48.6% at 100 μM. This 
inhibition concentration of matesaponins to HT-29 proliferation is closely to quercetin 
which showed IC50 to HT-29 at 81 µM. Thus, matesaponins fraction F could be a 
potential anti-cancer agent in colon cancer therapy. It is known that the bioavailability of 
saponins from various plant sources is low (1–4 %) because of their poor oral absorption 
and gastrointestinal metabolism [45-49]. However, saponins could be hydrolysed in the 
intestinal tract and the aglycone, ursolic and/or oleanolic acids, go through the colon. 
Ursolic and oleanolic acids have been shown to have a protective affect against colon 
carcinogenesis in vivo [50]. After oral intake of saponins (100 mg/kg body weight), the 
concentration in plasma of mice was 1063 ng/ml after 0.5 h [48]. Also, eight healthy 
women ingested 434 µmol soyasaponin, and its metabolite was found (36.3 µmol) in a 5-
d fecal sample [47]. They also showed no cytotoxic effect of saponin on Caco-2 cells at 
concentrations up to 3 mM. 
Effect of matesaponin fraction F on Bcl-2/BAX protein expression and caspase-3 
activity in HT-29 colon cancer cells 
Fig. 5.5 shows that matesaponin fraction F significantly inhibited the expression of Bcl-2 
at 100 µM (Fig. 5A), and significantly increased the expression of Bax at 25 µM (Fig. 
5.5B). Fig. 5C shows that the activity of the major apoptotic factor caspase-3 was 
increased significantly with matesaponin fraction F (25 µM). Caspase-3 activity was 
elevated in HT-29 cells by matesaponins fraction F treatment in a similar dose-dependent 
manner as quercetin. To investigate the mechanism of action of these results, we analysed 
70 
 
the apoptosis induction of HT-29 cells treated with matesaponins fraction F compared 
with quercetin and cisplatin, by assaying the protein expression of apoptosis mediators. 
Members of the Bcl-2 family of proteins are critical regulators of the apoptotic pathway, 
controlling mitochondrial permeability and cytochrome c expression [51, 52]. These 
proteins consist of the major anti-apoptotic proteins, Bcl-x(L) and Bcl-2, and the major 
pro-apoptotic proteins Bax and Bak. Following exposure to matesaponins fraction F, Bax 
expression increased while Bcl-2 expression decreased. Bax controls mitochondrial 
permeability and cytochrome c expression.The release of cytochrome c from 
mitochondria to the cytoplasm is a key step in the initiation of apoptosis. As a 
downstream product of cytochrome c, caspases are critical mediators of the principle 
factors found in apoptotic cells. Among them, caspase-3 is a frequently activated death 
protease, catalysing the specific cleavage of many key cellular proteins [53]. In the 
present study, matesaponins fraction F induced the activity of caspase-3 at 50 μM, similar 
to quercetin and cisplatin. Thus, matesaponins inhibited colon cancer cells proliferation 
by inducing apoptosis through activating caspase-3 activity. These could contribute to 
cancer chemotherapy and the inhibition of tumor growth. 
5.5 Conclusions 
In the current study we found mate leaves contained 12 mg/g (1.2%) extractable saponins 
mostly in the form of matesaponins 1 and 2. The matesaponins processed anti-
inflammatory activity through NF-κB pathways. Our results also showed that 
matesaponins inhibit colon cancer cell (HT-29) proliferation. Matesaponin containing 
fraction F activates a specific intracellular apoptosis pathway in HT-29 cells. This 
saponin fraction also increased the expression of the pro-apoptotic protein Bax, decreased 
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the expression of anti-apoptotic protein Bcl-2; and subsequently activated caspase-3. 
These findings suggest that apoptosis induction in matesaponins-treated HT-29 cells 
could be associated with a caspase-dependent cascade that involves the activation of the 
mitochondrial pathway, initiated by the inhibition of Bcl-2 and the activation of Bax. Our 
findings suggest the possible value of matesaponin fraction F against human colon cancer 
by promoting apoptosis of cancer cells. 
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5.7 Figures and Tables 
 
Figure 5.1 LC-MS of an analytical run of matesaponins fraction F.  The traces are 
fragment ion for m/z values of 947, 957, 1093 and 1103, respectively. 
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Figure 5.2 Effect of different concentrations of matesaponins fractions D, E and F on (A) 
NO production and (B) iNOS expression of LPS-induced RAW 264.7 cells. (C) COX-2 
expression and (D) PGE2 production of LPS-induced RAW 264.7 cells. The data 
represent the mean ± SD of a triplicate from three independent experiments. Different 
letters indicate significant differences, p < 0.05. 
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Figure 5.3 Effect of different concentrations of matesaponins fraction F on (A) p65 
nuclear translocation and (B) p50 nuclear translocation in LPS-induced RAW 264.7 
macrophages. The data represent the mean ± SD of a triplicate from three independent 
experiments. Different letters indicate significant differences, p < 0.05.  
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Figure 5.4 Dose-response curve of matesaponins fraction F on proliferation of HT-29 
cells. Means with different letters are significantly different from each other (n = 3, p < 
0.05) 
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Figure 5.5 Effect of different concentrations of matesaponins fraction F on (A) protein 
expression of Bcl-2 and (B) Bax in HT-29 were assessed using western blots. Actin was 
used as a protein loading control. (C) Activation of caspase-3 in HT-29 cells in response 
to matesaponins fraction F, quercetin and cisplatin treatments. The data represent the 
mean ± SD of a triplicate from three independent experiments. Different letters indicate 
significant differences, p < 0.05. 
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Table 5.1  Fractions identified in methanol extract of mate dry leaves. 
 
 
Fraction 
TIC of TOF MS 
Possible compound 
Concentr
ation 
(mg/g) 
Total 
matesapon
ins (%) 
Peak 
Retention 
Time 
(min) 
 [M-H]- 
(m/z) 
[M+HC
OO]+ 
(m/z) 
Fraction D 11.00 515 537 
Dicaffeoylquinic 
acid   
 56.24 911 957.56 Matesaponin 1 22.1 7.1 
 55.28 1057 1103.53 Matesaponin 2a 24.9  
    Matesaponin 2b 22.1  
 60.37 1073  Matesaponin 3 1.0  
 60.15 1219  Matesaponin 4 1.0  
 60.27 1383  Matesaponin 5  trace  
        
Fraction E 56.24 911  Matesaponin 1 34.3 12.0 
 55.28 1057  Matesaponin 2a 50.3  
    Matesaponin 2b 35.1  
 60.37 1073  Matesaponin 3  trace  
 60.15 1219  Matesaponin 4  trace  
 60.27 1383  Matesaponin 5 trace  
        
Fraction F 56.28 911 957.56 Matesaponin 1 28.2 6.0 
 55.39 1057 1103.53 Matesaponin 2a 4.5  
    Matesaponin 2b 28.6  
 60.52 1074  Matesaponin 3  trace  
 60.20 1219  Matesaponin 4 trace  
 53.54 1382  Matesaponin 5 trace  
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Table 5.2 Effect of mate saponin fractions (IC35, µM) on NO, iNOS, PGE2 and COX-2
*
 
 
Fraction NO
**
 iNOS
**
  PGE2
**
 COX-2
**
 
D 
 
> 50 
 
36.3 ± 3.1
c 
 
23.1 ± 4.8
a 
 
45.7 ± 9.5
a 
 
E 
 
> 50 
 
29.5 ± 2.0
b 
 
22.3 ± 3.8
a 
 
32.4 ± 7.1
a 
 
F > 50 43.7 ± 2.4
a
 11.7 ± 1.5
b
 17.0 ± 1.9
b
 
 
*
 IC35 is the concentration (μM) that resulted in 35% reduction of  
production/expression of pro-inflammatory responses (mean ± SD).  
** 
Abbreviations: NO, nitric oxide; iNOS, inducible nitric oxide synthase;  
PGE2, prostaglandin E2; COX-2, cyclooxygenase-2. 
Different letters indicate significant differences, p < 0.05 
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CHAPTER 6 
DICAFFEOYLQUINIC ACIDS IN YERBA MATE (ILEX PARAGUARIENSIS ST. 
HILAIRE) INHIBIT NF-κB NUCLEUS TRANSLOCATION IN MACROPHAGES 
AND INDUCE APOPTOSIS BY ACTIVATING CASPASES-8 AND -3 IN HUMAN 
COLON CANCER CELLS 
3 
6.1 Abstract 
Scope: The biological functions of caffeoylquinic acid (CQA) derivatives from various 
plant sources have been partially elucidated. The objectives were to isolate and purify di-
CQAs from Yerba mate tea leaves and assess their anti-inflammatory and anti-cancer 
capabilities in vitro and explore their mechanism of action. 
Methods and results: Methanol extracts of dried mate leaves were resolved by flash 
chromatography and further purified resulting in two fraction one containing 3,4- and 
3,5-diCQAs and the other 4,5-diCQA with NMR confirmed structures. Both fractions 
inhibited LPS-induced RAW 264.7 macrophages inflammation by suppressing NO/iNOS 
and PGE2/COX-2 pathways through inhibiting nucleus translocation of NF-κB subunits, 
p50 and p65. The diCQA fractions inhibited RKO and HT-29 cell proliferation by 
inducing apoptosis in a time- and concentration-dependent manner, but did not affect the 
protein levels of p21, p27, p53, and Bax:Bcl-2 ratio in RKO cells. In HT-29 cells, 
however, the diCQA fractions increased Bax:Bcl-2 ratio. The diCQA fractions increased 
the activation of caspase-8 leading to cleavage of caspase-3 in both RKO and HT-29 
3 
This chapter is a part of the paper; Puangpraphant, S.; Berhow, M.A.; Vermillion, K.; Potts, G.; de 
Mejia, E. G. Dicaffeoylquinic acids in Yerba mate (Ilex paraguariensis St. Hilaire) inhibit NF-κB 
nucleus translocation in macrophages and induce apoptosis by activating caspases-8 and -3 in human 
colon cancer cells. Mol. Nutr. Food Res. 2011, DOI: 10.1002/mnfr.201100128. Permission granted 
by Wiley-VCH 
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colon cancer cells.  
Conclusion: The results suggest that diCQAs in Yerba mate could be potential anti-
cancer agents and could mitigate other diseases also associated with inflammation. 
6.2 Introduction 
Caffeoylquinic acid (CQA) derivatives are a class of polyphenolic compounds widely 
distributed in plants, such as coffee [1], garland (Chrysanthemum coronarium L.) [2] and 
Yerba mate (Ilex paraguariensis) tea [3]. The structures of CQAs are composed of one or 
more caffeic acid molecules connected to one quinic acid molecule through ester bonds 
(Figure 6.1). The potential biological functions of CQA derivatives from various plant 
sources has been partially elucidated by several investigators, including antioxidant 
capacity [4-6], antiviral effect [7-9], anti HIV effects [7,8], neuroprotective [10, 11], and 
antimutagenic [12]. Yerba mate tea has demonstrated potent antioxidant [13-17], anti-
inflammatory effects [18-20], chemopreventive effect against mammary [21] and colon 
carcinogenesis [13,21]. However, the exact mechanisms of action and the bioactive 
constituents involved in the protective effects of mate tea against carcinogenesis are not 
clearly understood. Chlorogenic acid, 3,4-diCQA, 3,5-diCQAs and 4,5-diCQA are the 
major CQA derivatives in mate tea [22]. Little is known about the relationship between 
the biological functions of diCQAs in Yerba mate tea leaves because of the difficulty 
isolating chemically similar diCQAs and the lack of commercial standards.  
Colorectal cancer (CRC) was the third most common cause of cancer deaths in 
the United States in 2010 [23]. Studies have shown that the risk of developing CRC can 
be prevented by diet [24]. Chronic inflammation can lead to the development of several 
types of cancer [25-27] and is considered as a potential risk factor for colorectal cancer 
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[28]. Because chronic inflammation generates the production of nitric oxide (NO), a 
substrate for formation of reactive oxygen species, stimulates the production of 
inflammatory cytokines leading to DNA damage and triggers the steps to cancer 
progression [27]. Nuclear factor kappa-B (NF-κB) is a transcription factor and essential 
component link between inflammation and cancer. In innate immune pre- neoplastic and 
malignant cells, NF-κB upregulates the expression of inflammatory cytokines and 
enzymes including cyclooxygenase-2 (COX-2) and inducible nitric oxide (iNOS), which 
are important for the synthesis of inflammatory mediators (prostaglandin E2; PGE2 and 
NO respectively). The activation of NF-κB in different cancer cell types has been shown 
to regulate the expression of genes involved in cell growth and proliferation, anti-
apoptosis, angiogenesis, and metastasis [29]. Suppressing chronic inflammation by 
targeting NF-κB has the potential to modulate the risk of developing cancer [30, 31]. 
Uncontrolled proliferation and inhibition of apoptosis is a hallmark characteristic of all 
tumor development, hence the control of cell proliferation and induction of apoptosis are 
targets for therapeutic intervention in all types of cancers [32].  
The objectives of this study were to purify the major diCQAs from Yerba mate 
tea leaves and to evaluate their anti-inflammatory and anti-colon cancer capacities in 
vitro, to further elucidate their mechanism of action. 
6.3 Materials and methods 
Chemicals. Methanol (99.9 %) and acetonitrile were purchased from Fisher Scientific 
(Hanover Park, IL). The standard compounds chlorogenic acid (≥95%), quinic acid 
(≥95%), and caffeic acid (≥97%) were purchased from Sigma Chemical Co. (St. Louis, 
MO, USA). 
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Extraction of the diCQAs from mate dried leaves. The diCQAs were extracted and 
fractionated from mate (Ilex paraguariensis) leaves organically grown in Paraguay, 
following a modification of the general phenolic purification method of Berhow et al. 
[33]. Briefly, 1 kg of powdered Yerba mate dry leaves was extracted with methanol in a 
Soxhlet extractor for 72 h. The extracts were reduced by roto-evaporation (at 40 ºC), then 
pooled and concentrated by evaporation under the hood (25 ºC). The dried material was 
re-suspended in methanol for preparative flash chromatography on a Buchi (Newcastle, 
DE) Sepacore flash chromatography system with dual C-605 pump modules, a C-615 
pump manager, a C-660 fraction collector, and a C-635 UV photometer, with 
SepacoreRecord chromatography software. A Buchi C-670 Cartridge system was used to 
load 40 x 150 mm flash columns with approximately 90 g of preparative C18 reverse 
phase, 125Å, 55-105 µm, bulk packing material (Waters Corp, Milford, MA). The 
column was equilibrated with 30% acetonitrile and 0.5% acetic acid in water for 5 min at 
a flow rate of 30 mL per min. After samples (10-15 mL) were injected, the column was 
developed with a binary gradient to 80% acetonitrile over 30 min. Fractions were pooled 
based on UV absorbance peaks at 210 nm. 
Isolation of the diCQAs from diCQA rich extract. The phenolic fractions were further 
purified using preparative chromatography. Samples of flash fractions (5 mL) were 
injected on a Shimadzu (Columbia, MD) preparative HPLC system with dual 8A pumps, 
SIL 10vp autoinjector, SPD M10Avp photodiode array detector, SCL 10Avp system 
controller all operating under the Shimadzu Class VP operating system, with a 
Phenomenex (Torrance, CA) Luna C18(2) semi-preparative reversed-phase column (10 µ, 
100Å, 250  50 mm). The column was pre-equilibrated with a solvent system consisting 
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of 10% MeOH and 90% water (containing 1% HOAc) at a flow rate of 30 mL per min 
and the eluent was monitored at 210 nm. The column was developed to 100% MeOH 
over 50 min. Five major sub-fraction peaks were detected at 360 nm and collected. This 
procedure was repeated to obtain sufficient pooled material that was evaporated under 
reduced pressure (40 ºC) and the resulting material was freeze-dried, weighed and stored 
at -20 ºC until used. 
Analytical HPLC Methodology. Five semi-purified diCQA fractions were dissolved in 
methanol at 2 mg/mL. An aliquot was removed from the vial and filtered through a 0.45 
µM nylon 66 filter for HPLC analysis. HPLC analysis was conducted with in a Shimadzu 
(Columbia, MD) HPLC System (two LC20AD pumps; SIL 20A autoinjector; DGU 20As 
degasser; SPD-20A UV-VIS detector; and a CBM-20A communication BUS module) 
running under the Shimadzu EZStart Version 7.3 software using a column a C18 Inertsil 
reverse phase column (250 mm x 4.6 mm; RP C18, ODS3, 5u; with a Metaguard guard 
column; Varian, Torrance, CA). For diCQA analysis, the initial conditions were 30% 
acetonitrile and 0.025% acetic acid in water, at a flow rate of 1 ml per min. The effluent 
was monitored at 360 nm. After injection, the column was developed to 50% acetonitrile 
and 0.025% acetic acid in a linear gradient over 45 min.  
LC/ESI-MS and NMR Analysis for confirmation of the diCQAs. To confirm the 
identity of the diCQAs found in the fractions, aliquots were injected on a LC-MS Q-TOF. 
Samples were run on an Applied Biosystems/MDS Sciex QStar Elite Q-TOF mass 
spectrometer with a Turbo ion spray electrospray source, and Agilent 1100 series HPLC 
system all running under Applied Biosystems Analyst 2.0 (build 1446) LC-MS software. 
The data were acquired in the negative ESI-TOF mode. The column used was an Inertsil 
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ODS3 reverse phase C18 column (3 µm, 150 x 3 mm). NMR Analysis 
1
H, COSY, DEPT, 
and 
13
C-NMR spectra were obtained with a Bruker (Billerica, MA) Avance 500 
spectrometer equipped with a 5 mm inverse broadband Z-gradient probe (
13
C NMR, 125 
MHz; 
1
H, 500 MHz). NMR spectra were recorded in methanol-d4, which served as the 
internal reference (
13
C, 49.0ppm, 
1
H, 3.30ppm). The data were analyzed using the 
Advanced Chemistry Development, Inc., SpecManager 1D Processor and the HNMR and 
CNMR Predictor software suite (Toronto, ONT). 
Cell proliferation. Four cell cultures containing mouse macrophage RAW 264.7, normal 
human colon fibroblast CCD-33Co, human colon cancer cells RKO (CRL-2577) and HT-
29 (HTB-38), were purchased from American Type Culture Collection (Manassas, VA). 
Cells were cultured in Dulbecco’s Modified Eagle’s Medium containing 10% fetal 
bovine serum, 1% penicillin/streptomycin, and 1% sodium pyruvate at 37 °C in 5% 
CO2/95% air. CCD-33Co colon fibroblasts were cultured in Eagle’s minimum essential 
medium containing 10% fetal bovine serum and 1% penicillin/streptomycin. The cell 
proliferation assay was conducted using CellTiter 96 Aqueous One Solution Proliferation 
assay kit (Promega, WI) as previously indicated [18]. For RAW 264.7, RKO and HT-29, 
5x10
4
 cells per well were seeded in a 96-well plate for 24 h. For CCD-33Co, 1 x 10
3
 cells 
per well were seeded in a 96-well plate and allowed to grow to confluence for one week 
with replacement of medium every other day. RAW 264.7 cells were treated with 
different concentrations of the diCQAs (1 – 200 µM) for 24 h. CCD-33co, RKO and HT-
29 cells were treated with different concentrations of diCQAs (1-300 µM) for 48 h. After 
diCQAs treatment, cell viability was determined by MTS assay as previously reported 
[18]. The percentage of viable cells was calculated with respect to cells treated with 0.1% 
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DMSO. Solvents used at these concentrations showed no cytotoxicity on cells (> 90%). 
Each test was conducted for at least two independent trials with three replicates for each 
trial.  
Nitrite and PGE2 measurements. RAW 264.7 cells were seeded (2 x 10
5
 cells per well) 
in a 6-well plate for 48 h at 37 °C in 5% CO2/95% air. After 48 h incubation, cells were 
treated with different concentrations of the diCQAs (1-200 µM) and 1 µg/mL of LPS for 
24 h, and then culture supernatant was collected and measured to determine nitrite and 
PGE2 as previously described [18].  
Protein expressions in RAW 264.7, HT-29 and RKO cells by Western blot. 
RAW 264.7, RKO and HT-29 cells were seeded (2 x 10
5
 cells per well) independently in 
a 6-well plate for 48 h. After 48 h incubation, cells were treated with different 
concentrations of the diCQAs fractions (1-200 µM and 1 µg/mL of LPS for RAW 264.7, 
1-100 µM for HT-29 and RKO cells) for 24 h. After treatment, cells were trypsinized and 
suspended in Bio-Rad’s Laemmli sample buffer (Biorad, CA) with 5% β-
mercaptoethanol (Sigma-Aldrich, MO). RAW 264.7 cell lysates were used to determine 
actin, iNOS, COX-2, NF-κB p50 and p65 expressions as previously indicated [18]. 
Nuclear and cytoplasmic proteins of RAW 264.7 were isolated with a buffer extraction 
and centrifugation system NE-PER® (Pierce Biotechnology, IL) according to the 
manufacturer’s recommendations. RKO and HT-29 cell lysates were used to determine 
Bax, Bcl-2, p21, p27, caspase-3 and -8 protein expressions. Equal amount of protein (15 
µg) was loaded in 4-20% Tris-HCL ready gels (Biorad, CA). The separated proteins were 
transferred to PVDF membrane and blocked with 5% non-fat dry milk in 0.1% Tris-
buffered saline Tween-20 for 1 h at 4 ºC. After blocking, the membrane was incubated 
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with actin, iNOS, COX-2, NF-κB p50, NF-κB p65, Bax, Bcl-2, p21, p27, caspase-3, or 
caspase-8 primary antibodies (Santa Cruz Biotechnology, CA) at 4 ºC overnight. The 
membrane was washed and incubated with antimouse IgG conjugated horseradish 
peroxidase secondary antibody (GE Healthcare, Buckinghamshire, UK) for 3 h at 25 ºC. 
The expressions of proteins were visualized using chemiluminescent reagent (GE 
Healthcare). 
Apoptosis of RKO and HT-29 colon cancer cells  
The apoptosis of RKO and HT-29 colon cancer cells was evaluated by flow cytometry 
using an Annexin V-FITC apoptosis detection kit (Sigma-Aldrich, MO). Briefly, 2 x 10
5
 
cell per well were seeded in a 6-well plate and allowed to grow for 48 h. The cells were 
then treated with the diCQA fraction (1-100 µM) for 6 and 12 h at 37 ºC in 5% CO2/95% 
air. After treatment, cells were tripsinized and suspended in binding buffer at a 
concentration of 1 x 10
6
/mL. Five hundred microliters of treated and untreated cells was 
transferred into a plastic test tube and stained with 5 µL Annexin V-FITC and 10 µL 
propidium iodide (PI) solution for 10 min. PI staining was performed concomitantly with 
Annexin V-FITC staining to determine whether any DNA/nuclei were present in the 
colon cancer cells. The cells were analyzed immediately by LSR II flow cytometer (BD 
Biosciences). The analysis was performed at least in duplicate with three replicates for 
each trial. 
Caspases activities 
The activity of caspases-3 and -8 were determined using the caspase colorimetric assay 
kit (Invitrogen) following manufacturer’s protocol. Briefly, RKO and HT-29 cells were 
seeded (2 x10
5
 per well) independently in a 6-well plate and allowed to grow for 48 h at 
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37 ºC in 5% CO2/95% air. Cells were treated with the diCQAs (100 µM) for 0, 2, 4, 6, 8, 
12, and 24 h. After treatment, cells were pelleted and resuspended in 50 mL chilled cell 
lysis buffer and incubated on ice for 10 min. The cells were then centrifuged at 10000 x g 
for 1 min. Approximately 50 µg of protein was assayed for caspase activity analysis by 
adding 50 µL reaction buffer containing 10 mM dithiothreitol and 5 µL of the 4 mM 
corresponding caspase substrates in a 96-well plate. The plate was incubated at 37 ºC in 
the dark for 2 h. The absorbance was read at 405 nm using ELx808 microplate reader 
(Biotek, VT). Analyses were performed in four replicates. 
Statistical Analysis. Data are presented as means ± SD for the indicated number of 
independently performed experiments. Data were analyzed using one-way ANOVA and 
means were considered to be significantly different at p < 0.05 as determined by least 
significant differences (LSD).   
6.4 Results 
Purification and identification of the diCQAs 
Fig. 6.1A presents the analytical HPLC profile of diCQA rich fractions identified as a 
mix of 3,4- and 3,5-diCQAs , while Fig. 6.1B presents the peak identified as 4,5-diCQA. 
We confirmed the molecular mass of the diCQAs by conducting LC-MS analysis using 
negative ESI and absorbance at 360 nm. NMR spectrum analysis confirmed the identity 
of the first fraction as a mix of 3,4- and 3,5-diCQAs and the second fraction as 4,5-
diCQA (Table 6.1). The key assignment in these compounds lies in the identification of 
protons 3, 4 and 5. Spectral simulations show that for all three isomers (3,4-, 3,5- and 4,5-
dicaffoyl quinic acid), the proton at the unsubstituted position will have a shift of about 
4.5 ppm. Both substituted positions will have shifts between 5.0 and 5.5 ppm. From 
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inspection of the proton spectrum it seems that this is one of the asymmetric isomers 
(either 3,4- or 4,5-dicaffoylquinic acid). The NOESY spectrum (data not shown) has a 
strong NOE cross peak that could only occur between protons on the same side of the 
ring. Since the NOE cross peak indicated proximity of the unsubstituted proton at 4.38 
and a substituted one at 5.13 ppm, these must be positions 3 and 4 respectively of the 4,5-
substituted quinic acid. There is an antiphase artifact arising from the strong J-coupling 
between the protons on opposite sides of the ring (protons 4 and 5, 5.13 and 5.63 ppm 
respectively), but no NOE cross peak. The COSY spectrum allows assignment of protons 
2 and 6, through their couplings to protons 3 and 5. Proton pairs 9-10 and 18-19 show a 
coupling of 15.9 Hz, indicating E or trans configuration of the double bond. HMBC 
spectra showed correlations between protons 4 and 5 to carbonyl carbons 17 and 8 
respectively, which allowed the differentiation of the caffoyl moieties. HSQC, HMBC 
and COSY spectra were used to complete the assignment. Their purity determined by 
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with an UV detector using chlorogenic acid as a standard was > 85% (data not 
shown). The two sub-fractions were then assessed for anti-inflammatory and anti-colon 
cancer activities.  
Effect of the diCQA fractions on viability of RAW 264.7 cells 
Macrophages showed a survival rate of > 90% when incubated with the diCQA fractions 
at a concentration ≤ 200 μM (data not shown). Therefore, in this study, a concentration of 
1 – 200 µM of the two diCQA sub-fractions was used to treat the cells and thus prevent 
the compounds from having cytotoxic effect.  
DiCQA reduced NO, PGE2 production and iNOS, COX-2 protein expression  
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Fig. 6.2 shows the effect of quinic acid, caffeic acid, 3,4- and 3,5-diCQAs fraction, and 
4,5-diCQA on NO production and iNOS protein expression in LPS-induced RAW 264.7. 
Caffeic acid was the most effective in significantly reducing NO production (50 μM), 
following by the 3,4- and 3,5-diCQAs fraction and 4,5-diCQA (100 µM) while quinic 
acid was the least potent (200 µM) (Fig. 6.2A). Both 3,4- and 3,5-diCQAs fraction (Fig. 
6.2B), and 4,5-diCQA (Fig. 6.2C) significantly suppressed iNOS expression at 200 μM.  
Fig. 6.3 shows the effect of diCQAs on PGE2 production and COX-2 protein expression 
in LPS-induced RAW 264.7.  Caffeic acid, quinic acid, and 4,5-diCQA significantly 
inhibited PGE2 production at 50 µM while the 3,4- and 3,5-diCQAs fraction significantly 
inhibited at 100 µM (Fig. 6.3A). The 3,4- and 3,5-diCQAs fraction significantly inhibited 
COX-2 protein expression at 50 mM (Fig. 6.3B), however, 4,5-diCQA significantly 
suppressed COX-2 at 200 mM (Fig. 6.3C). Table 6.2 presents the calculated 
concentration (µM) of the diCQA fractions that resulted in 50% reduction on pro-
inflammatory parameters. Both diCQA fractions inhibited PGE2/COX-2 pathway more 
than NO/iNOS pathway. 
The 3,4- and 3,5-diCQAs inhibited nucleus translocation of p50 and p65 NF-κB  
 
The 3,4- and 3,5-diCQAs fraction significantly reduced nucleus protein expressions of 
NF-κB subunits p65 (Fig. 6.3D) and p50 (Fig. 6.3E) at a concentration of  50 µM, 
suggesting that the 3,4- and 3,5-diCQAs fraction was able to inhibit nucleus translocation 
of NF-κB subunits. We also found that the 3,4- and 3,5-diCQAs fraction inhibited NF-κB 
translocation more on the p50 subunit than on the p65 subunit. 
The diCQAs inhibited proliferation of RKO and HT-29 human colon cancer cells 
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The diCQAs fractions did not cause any cytotoxicity to CCD-33co normal colon 
fibroblasts up to 300 µM (data not shown). As shown in Table 6.2, the two diCQA 
fractions inhibited cell proliferation of RKO and HT-29 colon cancer cells. We also 
found that both fractions have a similar efficacy in inhibiting RKO and HT-29 colon 
cancer cells. Thus, we selected the 3,4- and 3,5-diCQAs fraction, to further assess their 
mechanism of action in inhibiting colon cancer cell proliferation.   
The diCQAs promoted apoptosis of RKO and HT-29 colon cancer cells  
Fig. 6.4A shows the percentage of RKO and HT-29 colon cancer cells undergoing 
apoptosis in the presence or absence of the diCQAs after treatment for 6 and 12 h. The 
diCQAs increased the amount of RKO cells undergoing apoptosis from 0.02% 
(untreated) to 3.7%, and 4.3% for cells treated with the 10 and 100 µM diCQAs fraction 
for 6 h, respectively (Fig. 6.4B). RKO cells significantly increased the amount of 
apoptotic cells when treated with the diCQAs fraction for 12 h from 2.4% (untreated) to 
4.7% and 15.1% (10 and 100 µM, respectively) (Fig. 6.4B). The diCQAs increased the 
amount of HT-29 cells undergoing apoptosis from 7.0% (untreated) to 8.8% and 9.0% for 
cells treated with 10 and 100 µM diCQAs fraction for 6 h, respectively (Fig. 6.4C).  HT-
29 cells significantly increased the amount of apoptotic cells when treated with the 
diCQAs fraction for 12 h from 8.9% (untreated) to 9.0% and 10.2% (10 and 100 µM, 
respectively) (Fig. 6.4C). These results suggest that the diCQAs fraction promoted 
apoptosis on RKO and HT-29 colon cancer cells depending on time and concentration. 
The 3,4- and 3,5-diCQAs did not affect p21 and p27 expression in RKO and HT-29  
In order to investigate the mechanism by which the 3,4- and 3,5-diCQAs fraction inhibits 
growth of HT-29 and RKO colon cancer cells by affecting cell cycle, we analyzed protein 
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expression of p21 and p27. The 3,4- and 3,5-diCQAs fraction did not affect p21 protein 
expression in either RKO cells (Fig. 6.5A) nor HT-29 (Fig. 6.5B). However, we found 
that the 3,4- and 3,5-diCQAs fraction slightly increased p21 protein expression in HT-29 
at low concentration (1 μM) and did not affect p21 at higher concentrations. The 3,4- and 
3,5-diCQAs fraction did not significantly affect p27 protein expression in RKO (Fig. 
6.5C) and HT-29 (Fig. 6.5D), suggesting this fraction did not inhibit cell proliferation by 
inducing cell cycle arrest of HT-29 and RKO. We also analyzed cell cycle analysis using 
flow cytometry to confirm that the diCQAs treatment did not affected cell cycle (data not 
shown). 
The 3,4- and 3,5-diCQAs increased Bax:Bcl-2 expression in HT-29 but not in RKO 
cells. 
To determine whether the cell death of HT-29 and RKO are due to apoptosis, we then 
analyzed the apoptosis induction by assaying the protein expression of apoptosis 
mediators, Bax and Bcl-2. Figure 6.5 showed effect of the 3,4- and 3,5-diCQAs fraction 
on the ratio of Bax:Bcl-2 protein expression. The 3,4- and 3,5-diCQAs fraction at 100 
µM did not change in RKO (Fig. 6.5E), but significantly increased the Bax:Bcl-2 ratio of 
HT-29 (Fig. 6.5F).  
The 3,4- and 3,5-diCQAs increased caspase-3 and -8 expression and activity in RKO 
and HT-29  
Fig. 6.6 shows that the diCQAs fraction increased the expression of cleaved caspase-3 
and caspase-8 in RKO and HT-29 colon cancer cells. The expression of cleaved caspase-
3 significantly increased by 4.9-fold in RKO colon cancer cells when treated with the 
diCQAs fraction at 50 µM (Fig. 6.6A). For HT-29 colon cancer cells, the diCQAs 
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fraction significantly increased by 2.0-fold at 100 µM (Fig. 6.6B). The diCQAs fraction 
significantly increased the expression of caspase-8 in RKO by 2.1-fold at 50 µM (Fig. 
6.6C) and for HT-29 was significantly increased by 1.4-fold at 100 µM (Fig. 6.6D). Fig. 
6.7 shows the time course of the diCQAs fraction-inducing caspase-3 and -8 activities in 
RKO and HT-29 colon cancer cells. Caspase-3 and -8 activities began to rise in RKO and 
HT-29 after 2h of incubation and increased more than two times after 6 h of incubation. 
The diCQAs fraction (100 µM) increased by 2.0-fold the activity of caspase-3 and 
reached its maximum activity at 4 h in RKO (Fig. 6.7A) and at 6 h in HT-29 (Fig. 6.7B). 
The activity of caspase-8 increased to its maximum at 6 h in both RKO and HT-29 colon 
cancer cells by 2.8-fold and 2.4-fold, respectively (Fig. 6.7C, D). 
6.5 Discussion    
Fractions 3,4-diCQA and 3,5-diCQA, and 4,5-diCQA were isolated from a methanol 
extract of yerba mate tea leaves powder. The negative ESI mass spectrum of the diCQAs 
showed a molecular ion at m/z 515 [M – H]- corresponding to a molecular formula 
C25H24O12. Both 3,4-diCQA and 3,5-diCQA eluted at the same time which made it 
difficult to separate these two isomers. We were able to separate 4,5-diCQA from 3,4- 
and 3,5-diCQAs. Thus, we studied these two sub-fractions anti-inflammatory capacity 
using LPS-induced RAW 264.7 macrophages and anti-colon cancer using RKO and HT-
29 cell lines.  
              Both the 3,4- and 3,5-diCQAs fraction and the 4,5-diCQA fraction were shown 
to have anti-inflammatory effect by suppressing the COX-2/PGE2 and iNOS/NO 
pathways. The diCQAs fractions reduced NO production (IC50 >200 µM for both 
fractions) by inhibiting iNOS enzyme (IC50 =145.5 µM for the 3,4-and 3,5-diCQAs 
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fraction, and 150.0 µM for the 4,5-diCQA). The capacity in reducing NO production of 
the diCQAs fractions was comparable to caffeic acid. We found that the two diCQA 
fractions inhibited pro-inflammatory parameters more potently than chlorogenic acid in 
RAW 264.7 macrophages [18]. Uncontrolled activation of COX-2/PGE2 pathway is 
associated with inflammation and widely spread in human neoplasia. The diCQAs 
fractions inhibited PGE2 production with IC50 of 86.5 µM for the 3,4-and 3,5-diCQAs 
fraction and 102.5 µM for the 4,5-diCQA fraction. The 3,4- and 3,5- diCQAs fraction 
suppressed COX-2/PGE2 pathway (IC50 = 86.5 µM for PGE2, and 80.0 µM for COX-2) 
more potently than the 4,5-diCQA fraction (IC50 = 102.5µM for PGE2, and 155.2 µM for 
COX-2). There were a few studies of the diCQAs on its anti-inflammatory activity and 
our results showed that the diCQAs fractions suppressed iNOS expression in dose-
dependent manner in agreement with result by Olmos et al. [34], who showed that the 
diCQAs isolated from Phagnalon rupestre (Asteraceae) at 100 μM reduced NO levels 
and the expression of NOS-2 in LPS-induced RAW 264.7 through inhibiting nucleus 
translocation of NF-κB [34]. Peluso et al. [35] also found that the 3,4-diCQA and 3,5-
diCQA from Tessaria integrifolia and Mikania cordifolia exhibited anti-inflammatory 
activity in vitro [35]. Park et al. [36] showed that the 4,5-diCQA, 3,5-diCQA and 3,5-
diCQA methyl ester inhibited expressions of iNOS and COX-2 more than caffeic acid. 
Shin et al. [37] suggested that hydrophobic structures were shown to suppress NF-κB 
activation more effectively than caffeic acid because of their ability to pass through the 
cell membrane [37]. Yoshimoto et al. [38] suggested that catechol structure played an 
important role in the antimutagenicity, increasing number of caffeoyl groups promoted 
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antimutagenicity [38]. Thus, CQA derivatives effectively inhibited the reverse mutation 
in proportion to the number of caffeoyl groups bound to quinic acid. 
Caffeic and quinic acids have been long known as antioxidant compounds, and 
the antioxidant mechanism might therefore contribute to their anti-carcinogenic 
properties [39, 40]. Antioxidants protect against oxidation and free radical scavenging 
that can lead to cancer [27]. Caffeic acid showed an inhibitory effect of matrix 
metalloproteinase (MMP)-9 activity, which is known to be involved in tumor cell 
invasion and metastasis [41], and anti-inflammatory activities [37]. Murayama et al. [42] 
identified the 3,5-diCQA, and 4,5-diCQA as antioxidant in edible chrysanthemums. The 
chemical conformation of the compound determines its degree of antioxidant capacity.  
The anti-inflammatory mechanism of the diCQAs fraction was exhibited by the 
inhibition of the nucleus translocation of NF-κB subunits p65 and p50. This observation 
suggests that the diCQAs may reduce the binding of NF-κB to its target DNA, thus 
inhibiting transcription of genes with pro-inflammatory properties, resulting in the 
decreased expression of both COX-2 and iNOS and the reduced production of PGE2 and 
NO. These results suggest that the diCQAs from Yerba mate leaves might play an 
important role as an anti-inflammatory, and could have potential anti-cancer effects.  
Although diCQAs derivatives have been isolated from various plants, there have 
been few reports on potential anti-cancer effects. Iwai et al. [1] isolated 3,4-diCQA, 3,5-
diCQA, and 4,5-diCQA from immature green coffee beans and these diCQAs exhibited 
more potent tyrosinase inhibitory activities compared to CQAs, arbutin, and ascorbic 
acid. They also showed these diCQAs exhibited antiproliferative activities in four cancer 
cell lines; human histiocytic lymphoma (U937), normal human diploid lung fibroblast 
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(WI38), SV40 virally transformed WI38 (WI38VA), human breast carcinoma (MCF-7), 
and human oral carcinoma (KB) (IC50 = 0.10-0.56 mM) [1].  Mishima et al. [43] isolated 
3,4-diCQA, 3,5-diCQA, and 4,5-diCQA from a water extract of propolis and these 
diCQAs inhibited human myeloid leukemia (HL-60) cell growth, which is partly 
attributed to the granulocytic differentiation leading to apoptosis. Kurata et al. [44] 
isolated diCQAs from sweet potato leaf and diCQAs dose-dependently depressed cancer 
cell proliferation of human stomach cancer (Kato III), colon cancer (DLD-1), and 
promyelocytic leukemia (HL-60) cells. 
We selected the RKO and HT-29 due to the importance of colon cancer and 
because there is limited research on these human colon cancer cell lines. The diCQAs 
fractions inhibited cell proliferation of RKO (IC50 = 182 µM for the 3,4-and3,5-diCQAs 
fraction and IC50 = 190 µM for 4,5-diCQA) and HT-29 (IC50 = 286 µM for the 3,4-and 
3,5-diCQAs fraction, IC50 = 295 µM for 4,5-diCQA) human colon cancer cells. We found 
that the two diCQA fractions were more potent than chlorogenic acid and caffeine in 
inhibiting cell proliferation of RKO and HT-29 colon cancer cells (data not shown). The 
diCQA fractions inhibited RKO and HT-29 cell proliferation by inducing apoptosis rather 
than arresting cell cycle. The diCQA fractions did not affect cell cycle arrest based on the 
expression of p21 and p27 that did not significantly change. Cell cycle is regulated by the 
activity of cyclin/cyclin-dependent kinase (CDK). This cyclin-CDK complex is regulated 
by CDK inhibitors such as p21 and p27 [45]. DiCQAs fraction increased the amount of 
RKO and HT-29 cells undergoing apoptosis by a time- and concentration-dependent 
manner.  
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Apoptosis can be induced either by an extrinsic (death receptors) or by intrinsic 
(mitochondria) pathways [46]. The death receptor-mediated pathway is initiated by 
interaction of the ligand with its death receptors, leads to cleavage and activation of 
initiator caspase-8 and -10, which in turn cleave and activate executioner caspase-3, -6, 
and -7, terminating in apoptosis. In this study, we found that the diCQAs fraction 
increased caspase-8 expression and activity in both RKO and HT-29 cells, which also 
contributes to activation of caspase-3, and indicated the activation of apoptotic extrinsic 
pathway.  
For the mitochondria pathway, the diCQA fractions inhibited HT-29 cell 
proliferation by inducing apoptosis through induction of the ratio of Bax:Bcl-2 protein 
expression. Bax controls mitochondrial permeability and cytochrome c expression, and 
increased Bax:Bcl-2 ratio inducing the release of cytochrome c from mitochondria to the 
cytoplasm and contribute to activation of caspase-3. The diCQAs induced the cleavage of 
procaspase-3 to active caspase-3 which is a key step of apoptosis.  Our results suggest 
that both extrinsic and intrinsic pathways are involved in the diCQAs fraction-mediated 
regulation of caspase-3 activation in colon cancer cells.  
The p53 protein expression was not affected by the diCQAs treatment in RKO 
cells, which contain wild-type p53 protein (data not shown). In addition, the diCQAs still 
induced apoptosis in HT-29 cells, which contain mutant p53. These results indicate that 
wild-type p53 is not involved in the diCQAs-induced apoptosis in colon cancer cells. The 
induction of apoptosis by the diCQAs was independent of the p53 pathway. 
Studies on bioavailability of CQA and diCQA from green coffee extract have 
shown that these compounds are absorbed and metabolized in humans [47]; they 
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quantified CQA, diCQAs and phenolics in plasma for up to 8 h after ingestion of 451 
µmol total chlorogenic acid. Olthof et al. [48] showed approximately 33% of chlorogenic 
acid was absorbed and 66% potentially reached the colon for further metabolism. The 
small intestine is a major site for absorption of phenolic acids for coffee metabolism and 
the colon/microflora play the major role in the absorption and metabolism of chlorogenic 
acid and phenolic acids from coffee [49]. Thus, the inhibition of inflammation and 
carcinogenic of the diCQAs may be specific to the colon. The diCQAs from yerba mate 
may be a potential anti-cancer agent in colon cancer therapy. 
In summary, yerba mate leaves contain biologically active CQA derivatives that 
exhibit anti-inflammatory and anticancer properties. The diCQAs from yerba mate leaves 
are composed of 3,4-diCQA, 3,5-diCQA and 4,5-diCQA; these compounds possess anti-
inflammatory activity through inhibition of NF-κB nucleus translocation which 
consequently down-regulates the NO/iNOS and PGE2/COX-2 pathways. The diCQAs 
inhibit proliferation of colon cancer cells RKO and HT-29 by activating apoptosis 
through induction of capase-8 and caspase-3 suggesting the possible value of the diCQAs 
against human colon cancer.  
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6.7 Figures and Tables 
 
(A) 
 
(B)     
Figure 6.1 Analytical HPLC chromatograms of (A) 3,4- and 3,5-diCQAs, (B) 4,5-
diCQA.  
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3,5-diCQA 
         4,5-diCQA 
107 
 
A  
 
iNOS  116 kDa    iNOS 116 kDa 
Actin  43 kDa      Actin  43 kDa 
 
B       C 
Figure 6.2 The 3,4- and 3,5- diCQAs and 4,5-diCQA fractions reduced (A) NO 
production. (B) 3,4- and 3,5-diCQAs fraction, and (C) 4,5-diCQA suppressed iNOS 
expression of LPS-induced RAW 264.7 cells. The data represent the mean ± SD of a 
triplicate from two independent experiments. Different letters indicate significant 
differences, p <0.05. 
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A 
COX-2 72 kDa       COX-2 72 kDa 
Actin   43 kDa       Actin   43 kDa 
  
B         C 
NF-κB p65 65kDa p50 50kDa 
Actin                      43 kDa 
 
D        E 
Figure 6.3 The 3,4- and 3,5-diCQAs and 4,5-diCQA fractions reduced (A) PGE2 
production. (B) 3,4- and 3,5-diCQAs fraction, and (C) 4,5-diCQA reduced COX-2 
expression. (D) 3,4- and 3,5-diCQAs fraction inhibited NF-κB subunits p65 and (E) p50 
nucleus translocation in LPS-induced RAW 264.7 macrophages. The data represent the 
mean ± SD of a triplicate from two independent experiments. Different letters indicate 
significant differences, p <0.05. 
109 
 
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
2.68% 0.02%
97.28% 0.02%
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.73% 3.26%
92.31% 3.70%
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.74% 7.84%
87.11% 4.31%
 
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
1.28% 3.11%
93.19% 2.42%
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.64% 6.35%
88.35% 4.66%
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.65% 26.04%
58.26% 15.05%
 
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.27% 11.67%
81.09% 6.97%
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.20% 9.71%
81.26% 8.83%
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.13% 11.30%
79.55% 9.01%
   
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.24% 8.50%
82.38% 8.89%
 FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.13% 11.30%
79.55% 9.01%
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.09% 9.18%
80.53% 10.21%
 
A              0 µM         10 µM                          100 µM        diCQAs 
 
B       C 
Figure 6.4 (A) The 3,4- and 3,5-diCQAs fraction induced apoptosis of RKO (B) and HT-
29 (C)  human colon cancer cells in a time- and concentration-dependent manner. Error 
bars indicate the standard deviation; different letters indicate significant differences, p 
<0.05, n = 6. 
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Figure 6.5 Effect of the 3,4- and 3,5-diCQAs fraction on p21expression in (A) RKO and 
(B) HT-29; p27 expression (C) RKO and (D) HT-29; and Bax:Bcl-2 ratio in (E) RKO 
and (F) HT-29 cells. The data represent the mean ± SD of a triplicate from two 
independent experiments. Different letters indicate significant differences, p <0.05. 
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  Actin                      43 kDa        1  
 1 
(A)          (B) 2  
Caspase-8         55 kDa     1 
Actin             43 kDa     2 
                        3 
 4 
(C)          (D) 5   
Figure 6.6 The 3,4- and 3,5-diCQAs fraction increased the activation of caspase-3 
cleavage in (A) RKO, (B) HT-29 and increased the expression of caspase-8 in (C) RKO, 
(D) HT-29 colon cancer cells. Error bars indicate the standard deviation; different letters 
indicate significant differences, p <0.05, n = 6. 
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A       B 
 
C       D 
Figure 6.7 Time course of caspase-3 activity (A) RKO, (B) HT-29 colon cancer cells 
treated with 100 µM 3,4- and 3,5-diCQAs fraction. Time course of caspase-8 activity in 
(C) RKO, (D) HT-29 colon cancer cells treated with 100 µM 3,4- and 3,5-diCQAs 
fraction. Data were represented as mean ± SD, n = 4. 
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Table 6.1 NMR spectra of 3,4-diCQA, 3,5-diCQA, and 4,5-diCQA 
1, 2, 3, 4, 5, 6,
 
7
 = may be reversed 
position 1H shift 13C shift 
 3,4-diCQA 3,5-diCQA 4,5-diCQA 3,4-diCQA 3,5-diCQA 4,5-diCQA 
1 - - - 73.8 73.3 74.6 
2 2.37 (15.4, 
3.7), 2.15 
(15.3) 
2.33 (13.8, 
3.8), 2.18 
(13.8, 7.0) 
2.31, 2.12 35.6 34.6 37.0 
3 5.65 (3.7) 5.45 (3.3) 4.38 68.8 71.1 67.9 
4 5.01 (9.1, 3.4) 3.99 (7.5, 3.2) 5.13 75.2 69.2 74.3 
5 4.39 (9.8, 4.4) 5.40 (7.9, 4.7) 5.63 64.4 70.1 67.6 
6 2.23, 2.10 
(13.4, 10.1) 
~2.24, ~2.24 2.26, 2.26 40.6 36.2 37.9 
7 - - - 176.5 175.9 175.3 
8 - - - 167.2 167.5 166.8 
9 6.26
1
 (16.0) 6.36 (15.9) 6.20 113.7 114.2 113.3 
10 7.56
2
 (16.0) 7.63 (15.9) 7.53 146.0
2 
145.6 148.2 
11 - - - 126.4
6 
126.5
1 
126.3 
12 7.05
3
 (2.0) 7.07 (1.5) 7.04
1 
113.6 113.9 113.8 
13 - - - 145.4 145.4 145.4 
14 - - - 148.1 148.2 148.3 
15 6.78
5
 (8.2) 6.79 (8.2) 6.77
2 
115.1 115.1 115.1 
16 6.94
5
 (8.2, 2.1) 6.97 (8.2, 2.0) 6.93
3 
121.8
7 
121.6 121.7 
17 - - - 167.1 167.0 167.1 
18 6.30
1
 (16.0) 6.28 (15.9) 6.30 113.7 113.7 113.3 
19 7.59
2
  7.59 (15.9) 7.61 145.9
2 
145.9 146.3 
20 - - - 126.3
6 
126.4
1 
126.3 
21 7.03
3
 (2.0) 7.07 (1.5) 7.02
1 
113.6 113.9 113.8 
22 - - - 145.4 145.4 145.4 
23 - - - 148.1 148.2 148.3 
24 6.74
5
 (8.2) 6.79 (8.2) 6.75
2 
115.1 115.1 115.1 
25 6.88
5
 (8.2, 2.1) 6.99 (8.2, 2.0) 6.92
3 
121.7
7 
121.6 121.7 
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Table 6.2 IC50
 a 
values of diCQA fractions on NO, iNOS, PGE2 and COX-2 production 
using RAW 264.7 macrophages and cytotoxicity
b
 of diCQA fractions on human colon 
cancer cells  
IC50 (µM) 3,4- and 3,5-diCQAs 4,5-diCQA 
RAW 264.7   
NO >200 >200 
iNOS 145.5 150.0 
PGE2 86.5 102.5 
COX-2 80.0 155.2 
Cytotoxicity (µM) 3,4- and 3,5-diCQAs 4,5-diCQA 
RKO   
IC50 182 190 
GI50 118 120 
TGI 198 202 
LC50 >300 >300 
HT-29   
IC50 286 295 
GI50 213 227 
TGI 274 281 
LC50 >300 >300 
a
 IC50 are the concentrations (μM) that resulted in 50% reduction of production/expression of pro-
inflammatory responses (mean ± SD, n =6). 
b
 Cytotoxicity to different human CRC cells was defined by the following parameters based on 
Monks et al. [50]:  
IC50 (inhibitory concentration, 50%): concentration resulting in 50% inhibition of net cell growth 
= %T/C (OD of treated cells/OD of control cells) x 100;  
GI50 (growth inhibition, 50%): concentration resulting in 50% reduction of net cell growth in 
comparison to untreated cells = 100[(T-T0)/C-T0)];  
TGI (total growth inhibition): concentration required to achieve complete halting of treated cell 
growth = T0;  
LC50 (lethal concentration, 50%): concentration lethal to 50% of treated cells = 100[(T-T0)/T0].  
OD = optical density, C=control optical density, T = test optical density, T0 = optical density at 
time zero. 
Abbreviations: NO, nitric oxide; iNOS, inducible nitric oxide synthase; PGE2, prostaglandin E2; 
COX-2, cyclooxygenase-2.  
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CHAPTER 7 
MATE SAPONINS INHIBIT CELL PROLIFERATION OF HUMAN COLON 
CANCER CELLS HT-29 AND RKO BY INDUCTION OF APOPTOSIS AND 
CELL CYCLE ARREST INDEPENDENTLY OF p53 STATUS 
4 
7.1 Abstract 
The aim of this study was to assess the anticancer properties of mate saponins using in 
vitro models. HT-29 (p53 mutant) and RKO (wild type p53) cell lines were treated with 
mate saponins (1- 200 μM). Mate saponins inhibited HT-29 and RKO cell proliferation, 
which was more pronounced in RKO cells with IC50 = 181.0 μM than HT-29 cells with 
IC50 = 201.8 μM. Mate saponins arrested HT-29 and RKO cells at G1 to S phase by 
upregulating significantly p21 and p27 proteins. Mate saponins caused HT-29 and RKO 
cells undergo apoptosis through induction of the ratio of Bax:Bcl-2 protein expression. 
Mate saponins significantly increased p53 protein expression in HT-29 but not 
significantly induced in RKO. Mate saponins induced apoptosis and cytotoxicity in 
human colorectal cancer cells independent of p53 status due to the capability in induction 
of p53 in mutated p53 cells. Our results demonstrate that mate saponins have potent 
preventive properties and specifically upregulate the p53 cascade. 
 
KEYWORDS: Saponins; Yerba mate; Apoptosis; Colon cancer; p53  
 
Abbreviations: CRC, colorectal cancer; CDK, cyclin/cyclin-dependent kinase. 
4 
The material in this chapter has not been published yet and it is intended to be submitted to 
Cancer Prevention Research, 2011. 
116 
 
7.2 Introduction 
Saponins are a class of tritepenoid or steroid compounds that are widely 
distributed in plants, such as soybean [1, 2], ginseng [3, 4] and yerba mate (Ilex 
paraguariensis St. Hilaire) [5, 6]. The primary saponins identified from Ilex 
paraguariensis were matesaponin 1 and 2 with ursolic acid as the triterpenoidal aglycone 
(Fig. 7.1). Recent studies have suggested that saponins from various plant sources affect 
the growth of colon cancer cells. Soy saponin prevents colon cancer by affecting cell 
morphology, cell proliferation enzymes, and cell growth of human colon cancer cells [7]. 
Tin et al. [8] investigated the anti-carcinogenic effects of total in HT-29 human colon 
cancer cells through induction of caspase-3 and in vivo using nude mice xenografts. The 
same group assessed Astragalus saponins on its anti-colon cancer mechanism by 
induction of the caspase-8 extrinsic apoptotic cascade and cause cell cycle arrest in HT-
29 cells by modulation of both mTOR and ERK signaling pathways, of which inhibition 
of NF-κB was important in the latter mechanism [9].  
Recently, we demonstrated that saponins extracted from mate dried leaves had 
anti-inflammatory activity in macrophages and inhibited HT-29 colon cancer cell 
proliferation by promoting apoptosis through activating caspase-3 activity [10]. However, 
whether saponins from yerba mate affect the growth of cancer cells by causing apoptosis 
or necrosis or cell cyle arrest is still not clear. 
Colorectal cancer (CRC) involves a multistep pathway of colonic mucosal genetic 
mutations. Over 1.2 million new cases and 608,700 deaths were attributed to CRC 
worldwide in 2008 making it the third and second most common cancer in males and 
females, respectively [11]. One gene plays an important role in late CRC progression, the 
tumor suppressor gene, p53. Loss of p53 protein activity has been observed in 70-80% of 
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colon adenocarcinomas suggesting that functional loss of p53 occurs late in 
tumorigenesis. Depending on the cell type and conditions, p53 regulates either cell cycle 
arrest or apoptosis. However, information about the mechanism of mate saponins on cell 
cycle arrest and mediators that regulate cell cycle, p21 and p27, and influence of p53 
remains poorly understood.   
The aim of the present study was to determine the mechanism underlying the anti-
colon cancer effects of mate saponins in vitro. We evaluated the activity of mate saponins 
on cell proliferation, apoptosis, and cell cycle regulations and focused on specific 
pathways mediated by p53 in human colon cancer cells. 
7.3 Materials and methods 
Chemicals and Cells 
 Human colon cancer cell lines HT-29, RKO, normal colon fibroblast CCD-33Co, 
McCoy 5A medium, Eagle’s Minimum Essential Medium and 0.25% (w/v) Trypsin- 
0.53 mM EDTA and Dulbecco’s Modified Eagle Medium with L-glutamine (DMEM) 
were purchased from American Type Culture Collection (Manassas, VA). Fetal bovine 
serum was purchased from Invitrogen (Grand Island, NY, USA). Bcl-2, Bax, p21, p27, 
p53 and actin mouse monoclonal antibodies were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA) and antimouse IgG conjugated horseradish 
peroxidase secondary antibody was purchased from GE Healthcare (Buckinghamshire, 
UK). Cisplatin (>99%) was purchase from Sigma (St. Louis, MO, USA). All other 
chemicals were purchased from Sigma (St. Louis, MO, USA), unless otherwise specified. 
Extraction and purification of mate saponins 
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 Saponins were extracted and fractionated from mate (Ilex paraguariensis) leaves, 
organically grown in Paraguay following the method as previously described [10].  
Confirmation of the identity of the mate saponins found in the mate extract fractions was 
performed by LC/ESI-MS analysis as previously described [10]. Mate saponins, for cell 
culture studies, were prepared by dissolve in DMSO at 10 mg/mL by weight as an initial 
stock and the initial stock was then diluted with culture medium to different 
concentrations (1- 200 µM) using the molecular weight of saponins equal to1,000 to 
calculate µM equivalent concentrations.  
HT-29, RKO, and CCD-33co cell culture and proliferation assay  
 HT-29 and RKO cells were cultured in McCoy 5A growth medium containing, 
1% penicillin/streptomycin, 1% sodium pyruvate and 10% fetal bovine serum at 37 °C in 
5% CO2/95% air. CCD-33Co colon fibroblasts were cultured in Eagle’s Minimum 
Essential Medium containing 10% FBS and 1% penicillin/streptomycin. A cell 
proliferation assay was performed using the MTS/PES CellTiter 96 Aqueous assay kit 
(Promega Corporation, Madison, WI, USA) as previously indicated [12]. For CCD-33Co, 
1 × 10
3
 cells per well were seeded in a 96-well plate and allowed to grow to confluence 
for one week with replacement of medium every other day. For HT-29 and RKO, 5x10
4
 
cells per well were seeded in a 96-well plate and total volume was adjusted to 200 µL 
with growth medium and allowed to grow for 24 h. Both cells were then treated with 
different concentrations of mate saponins (1- 300 μM), caffeine (≥ 99%), caffeic acid (≥ 
98%), quinic acid (≥ 95%), chlorogenic acid (≥ 95%), quercetin (≥ 98%), ursolic acid (≥ 
90%) (1- 300 μM), and mate tea extract (1- 300 µg/mL) for 24 h. The extraction method 
of mate tea was previously described [12].   
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Cell cycle distribution of HT-29 and RKO colon cancer cells 
Analysis of cell cycle distribution was performed using flow cytometry. Briefly, 
HT-29 and RKO cells were seeded at a density of 2 x 10
5 
cells per well in a 6-well plate 
and allowed to grow for 24 h at 37 °C in 5% CO2/95% air. The cells were then treated 
with different concentrations of mate saponins ranging from 1 to 200 µM for another 24 h 
at 37 °C in 5% CO2/95% air. After treatment, cells were fixed overnight with 70% 
ethanol at 4 °C and stained with propidium iodide solution (0.1% v/v). Cell cycle 
distribution analysis was performed using a LSR II flow cytometer (BD Biosciences, San 
Jose, CA, USA) at excitation wavelength of 488 nm. Fluorescence emission was 
measured using a 695/40 nm band pass filter. A total of 20,000 events were collected for 
each sample. The analysis was performed in triplicate. 
Analysis of apoptosis of HT-29 and RKO colon cancer cells 
 The apoptotic status of the HT-29 and RKO colon cancer cells was evaluated by 
determining the presence of phosphatidylserine on the cell membrane using an Annexin 
V-FITC apoptosis detection kit (Sigma-Aldrich, MO, USA) by flow cytometry. Briefly, 2 
x 10
5 
cells per well were seeded in a 6-well plate and allowed to grow for 48 h at 37 °C in 
5% CO2/95% air. The cells were then treated with mate saponins (1-100 µM) for 12 h at 
37 °C in 5% CO2/95% air. After treatment, cells were washed with PBS twice, 
trypsinized and suspended in binding buffer at a concentration of 1 x 10
6
 per mL. Five 
hundred microliters of treated and untreated cells were transferred into a plastic test tube 
and stained with 5 µL Annexin V-FITC and 10 µL propidium iodide (PI) solution for 10 
min. PI staining was performed concomitantly with Annexin V-FITC staining to 
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determine whether any DNA/nuclei were present in the colon cancer cells. The cells were 
analyzed immediately by LSR II flow cytometer (BD Biosciences, San Jose, CA, USA).  
The analysis was performed in triplicate. 
Western blot analysis of p21, p27, Bax, Bcl-2, and p53 protein expression  
 HT-29 and RKO cells were seeded at a density of 2 × 10
5
 cells per well in a six-
well plate for 24 h at 37 °C in 5% CO2/95% air. After 24 h incubation, cells were treated 
with mate saponins (1- 200 μM) for 24 h. After treatment, cells were trypsinized and 
suspended in lysis buffer composed of 62.5 mM Tris–HCl, pH 6.8, 25% glycerol, 2% 
SDS, 0.01% bromophenol blue, 5% β-mercaptoethanol and protease inhibitor cocktail 
(Thermo Scientific, Rockford, IL). Cell suspension was then used for Western blot for 
p21, p27, p53, actin, Bax and Bcl-2 using antibodies (1:200).  
Statistical analysis  
 Data are presented as means ± SD for the indicated number of independently 
performed experiments. Data were analyzed using one-way ANOVA and means were 
considered to be significantly different at p < 0.05 as determined by Tukey’s.   
7.4 Results 
Effect of mate saponins on cell proliferation of RKO colon cancer cells 
Fig. 7.2A shows that mate saponins inhibited RKO colon cancer cells 
proliferation in a concentration-dependent manner. The concentration of mate saponins 
that inhibit proliferation of HT-29 (IC50 = 201.8 µM) and RKO (IC50 = 181.0 µM) are 
shown in Table 7.1. Mate saponins, mate tea extract and its constituents did not cause any 
cytotoxicity to CCD-33co normal colon fibroblast up to 300 µM (data not shown). The 
inhibition of proliferation in RKO (wild-type p53) was greater than with mate saponins-
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treated HT-29 (mutated p53). As shown in Table 7.1, mate tea extract, chlorogenic acid, 
caffeic acid, quinic acid, and caffeine have a weak inhibition to both HT-29 and RKO 
cells. We also measure cytotoxicity of cisplatin (> 99%) which is a chemotherapeutic 
drug to HT-29 (IC50 = 80.6 μM) and RKO (IC50 = 68.5 μM). We found that ursolic acid 
was significantly the strongest anti-proliferative agent to both colon cancer cells with IC50 
= 30.2 μM for HT-29 and IC50 = 68.5 μM for RKO.  
Mate saponins induce G1 cell cycle arrest of HT-29 and RKO cells. 
The effects of mate saponins treatment on cell cycle progression were studied by 
flow cytometry. For HT-29, p53-deficient cells, mate saponins at 100 µM significantly 
increased cells in G1 and decreased cells in S phases, resulting in an overall G1 to S-
phase arrest (Fig. 7.2B). Mate saponins also caused an increase of G2/M phase at 200 
µM. For RKO, p53-proficient cell lines, mate saponins affected cell cycle by significantly 
arresting at G1 to S-phase, resulting in increased cells in G1 and decreased cells in S 
phase (Fig. 7.2C).    
Effect of mate saponins on p21 and p27 protein expressions in HT-29 and RKO 
cells. 
In order to investigate the mechanism by which mate saponins inhibit the growth 
of HT-29 and RKO colon cancer cells, we analyzed the protein expression of p21 and 
p27. Mate saponins significantly increased p21 protein expression in HT-29 at 200 μM 
(Fig. 7.3A) and RKO at 100 μM (Fig. 7.3B) and upregulated p27 protein expression in 
HT-29 at 1 μM (Fig.7.3C) and RKO at 200 μM (Fig. 7.3D), suggesting that mate 
saponins inhibit the cell proliferation by inducing cell cycle arrest. 
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Mate saponins increased apoptotic HT-29 and RKO cells by upregulating Bax:Bcl-2 
protein expression. 
To determine whether the cell death of HT-29 and RKO is due to apoptosis, we 
treated RKO cells with mate saponins at 50 and 100 µM for 24 h. Fig. 7.4 shows that 
mate saponins treatment led to significant increase on apoptotic HT-29 and RKO cells. 
Mate saponins at 100 μM increased apoptotic cells of HT-29 from 4.7% (control) to 
14.7% and RKO from 2.0% (control) to 9.1%. We then analyzed induction of apoptosis 
by assaying the protein expression of apoptosis mediators, Bax and Bcl-2. Fig. 7.5 shows 
that mate saponins significantly increased the ratio of Bax/Bcl-2 expression in RKO cells 
at 1 µM.  
Effect of mate saponins on p53 protein expression in HT-29 and RKO cells 
Fig. 7.6 shows that mate saponins at 1 μM significantly induced p53 expression in 
HT-29 (Fig. 6A) but no significant changes were observed in RKO cells (Fig. 7.6B). 
7.5 Discussion 
Finding a compound that would work both in p53 mutated and wild-type cancer 
cells would be very useful, because approximately 50% of cancer cells are p53 mutated 
and the other half are p53 wild type. Also, inactivation of p53 causes resistance to various 
cancer therapies including the use of an angiogenesis inhibitor [13] and 5-fluorouracil 
[14]. The effect of mate saponin on p53 wild-type colonic cancer cells has not been 
reported. Thus, in the current study, we investigated the effects of mate saponins on cell 
growth and cell cycle arrest in p53 wild type colonic adenocarcinoma RKO cell lines 
which is known to be DNA mismatch repair defective, and p53 mutated colonic 
adenocarcinoma HT-29 cell lines.  
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We found that ursolic acid is the strongest anti-proliferative bioactive compound 
to both colon cancer cells. Ursolic and oleanolic acids have been shown to have a 
protective effect against colon carcinogenesis in vivo [15]. Mate saponins are amphiphilic 
compounds and categorized as triterpenoic saponins as soy saponins which have been 
shown to be able to interact with the cancer cell membranes that are rich in phospholipids 
and cholesterol and with the hydroxyl groups on the aglycone moiety [16]. Our results 
showed that chlorogenic acid has a weak inhibition to both HT-29 and RKO cells which 
is consistent with Park et al. [17] indicated that chlorogenic acid did not protect against 
AOM-induced tumorigenesis. Moreover, we found that cisplatin inhibited HT-29 and 
RKO cell proliferation with IC50 values consistent with published data [18-21]. 
Because mate saponins reduced cell growth and caused cell cycle arrest in both 
cell lines, the influence of mate saponins on p21 was studied because of the suggested 
critical role of p21 in suppressing cell growth. Cell cycle is regulated by the activity of 
cyclin/cyclin-dependent kinase (CDK). This cyclin–CDK complex is regulated by CDK 
inhibitors such as p21 and p27. Mate saponins caused a dose-dependent increase in the 
expression of p21 and p27 in both HT-29 and RKO cells; p21 is well known as a p53 
response gene capable of inhibiting multiple CDKs, resulting in the induction of G1 or G2 
cell cycle arrest. Our results clearly demonstrated that G1 arrest via p21, by mate 
saponins, was through the upregulation of p53.  
Mate saponins increased the amount of RKO and HT-29 cells undergoing 
apoptosis in a concentration-dependent manner. Members of the Bcl-2 family of proteins 
are critical regulators of the apoptotic pathway [22, 23]. These proteins consist of the 
major anti-apoptotic proteins, Bcl-x (L) and Bcl-2, and the major pro-apoptotic proteins 
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Bax and Bak. Bax controls mitochondrial permeability and cytochrome c expression, and 
the release of cytochrome c from mitochondria to the cytoplasm is a key step in the 
initiation of apoptosis. As a downstream product of cytochrome c, caspases are critical 
mediators of the principal factors found in apoptotic cells [24]. In the present study, mate 
saponins inhibited colon cancer cells proliferation by inducing apoptosis through 
increasing Bax/Bcl-2 ratio. These findings suggest that apoptosis induction in mate 
saponins-treated RKO cells involves the activation of the mitochondrial pathway. 
Consistent with our previous study, HT-29 cells with mate saponins resulted in a dose-
dependent decrease in the anti-apoptotic Bcl-2 protein and increase in the expression of 
pro-apoptotic Bax protein [10]. Our findings suggest the possible value of mate saponins 
against human colon cancer by promoting apoptosis of cancer cells.  
  Cellular stress and DNA damage typically trigger the p53 tumor suppressor gene 
to mediate a series of antiproliferative strategies by inducing both cell cycle arrest and 
apoptosis. One important link between p53 and apoptosis is based on the transcriptional 
control of proapoptotic members of the Bcl-2 family, such as Bax. The relationship 
between p53 protein and the HT-29 cell death is still not clear [25]. Shen et al. [26] have 
found that 2’-OH flavanone inhibits the growth of HT-29 cells via increasing the 
expression of p21, but it has no effect on p53 protein. Tsai et al. [7] did not find any 
inhibitory effect of soy saponin on the p53 protein of WiDr cells (wild type p53 human 
colon cancer cells), consistent with our results. The p53 protein expression was not 
affected by mate saponins treatment in RKO cells, which contain wild-type p53 protein 
but mate saponins induced p21 in this cell line. These results indicate that wild-type p53 
is not involved in the mate saponins-induced apoptosis in colon cancer cells. This 
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mechanism of mate saponins action is independent of the status of the p53 tumor 
suppressor gene. In addition, mate saponins still induced apoptosis in HT-29 cells, which 
contain mutant p53. We found mate saponins could enhance the p53 cascade and prevent 
the expansion of mutated epithelial cells.  
Understanding the mechanism by which mate saponin induces cell cycle arrest in 
colonic adenocarcinoma cells has the potential of providing information needed to 
prevent or reduce the growth of colonic tumors. This might provide an understanding of 
how mate saponins reduce colonic epithelial cell growth in vitro. Further study of mate 
saponins on tumor growth in vivo is yet still needed. An explanation for this mechanism 
of mate saponins in vitro and in vivo may guide rational approaches for preventing 
colonic carcinogenesis in humans.  
In summary, we proposed the mechanism by which mate saponins inhibit HT-29 
and RKO colon cancer cell proliferation by induction of cell cycle arrest and apoptosis 
via p53 cascade (Fig. 7.7). Mate saponins arrest G1 cell cycle by induced p21 and p27 
CDK inhibitors. Mate saponins induce mitochondrial apoptosis by increasing the 
expression of the pro-apoptotic protein Bax, and decreased the expression of anti-
apoptotic protein Bcl-2, result an increase caspase-3 activity shown previously [10]. In 
addition, the ability of mate saponins to suppress cell growth of colonic tumorigenic cells 
is independent of the p53 status of the cells. This eliminates the need to screen 
tumorigenic colonic tissue for p53 status before treatment with mate saponins. Our 
findings suggest the possible value of matesaponin against human colon cancer by 
inducing cell cycle arrest and promoting apoptosis. In particular, our study has focused 
on the relationship between biomarkers of apoptosis, such as expression of Bax, Bcl-2, 
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and p53 protein, cell cycle such as p21 and p27, indicates that mate saponins might be an 
effective agent in the prevention of CRC.  
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7.7 Figures and Tables 
 
A     
 
     
B 
Figure 7.1 (A) Aglycone of saponins (ursolic or oleanolic acids) with sugars attach at R, 
R1, R2, or R3 (B) LC-MS of an analytical run of mate saponins. 
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Figure 7.2 (A) Dose-response curve of mate saponins on proliferation of RKO cells. Cell 
distribution (%) of cells treated with mate saponins in (B) HT-29 and (C) RKO. Means 
with different letters are significantly different from each other (n = 3, p < 0.05). 
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Figure 7.3 Effect of different concentrations of mate saponins on protein expression of 
p21 in (A) HT-29 (B) RKO, and p27 in (C) HT-29 and (D) RKO were assessed by 
Western blots. Actin was used as a protein loading control. The data represent the mean ± 
SD of a triplicate from three independent experiments. Different letters indicate 
significant differences, p < 0.05. 
 
 
132 
 
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
4.66%
 
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
9.04%
 
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
14.69%
 
   Control    Saponins 50 μM       Saponins 100 μM 
 
A 
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.18% 3.38%
94.45% 1.99%
 
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
1.18% 2.48%
87.41% 8.93%
 
FITC-A
P
I-
A
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0.17% 8.41%
82.30% 9.12%
 
    Control   Saponins 50 μM        Saponins 100 μM 
 
 
 
 
 
 
 
 
 
 
 
 
B 
Figure 7.4 Effect of mate saponins on apoptotic (A) HT-29 and (B) RKO cells. 
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     Bax     23 kDa 
     Bcl-2   26 kDa 
 
 
Figure 7.5 Effect of different concentrations of mate saponins on (A) protein expression 
of ratio Bax/Bcl-2 in RKO assessed by Western blots. Actin was used as a protein 
loading control. The data represent the mean ± SD of a triplicate from three independent 
experiments. Different letters indicate significant differences, p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
134 
 
p53   53 kDa  p53   53 kDa 
actin  43 kDa actin  43 kDa 
 
 
 
 
 
      
 
A       B 
Figure 7.6 Effect of different concentrations of mate saponins on protein expression of 
p53 in (A) HT-29 and (B) RKO assessed by Western blots. Actin was used as a protein 
loading control. The data represent the mean ± SD of a triplicate from three independent 
experiments. Different letters indicate significant differences, p < 0.05. 
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Figure 7.7 Proposed mechanism through which mate saponins induce apoptosis and cell 
cycle arrest via upregulating p53. 
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Table 7.1 * IC30 and IC50
 
of mate tea compounds on human colon cancer cells  
Compound HT-29 (µM) RKO (µM) 
                   IC30      IC50             IC30        IC50 
        Ursolic acid 16.2 30.2
c
 13.5 29.5
d
 
Cisplatin 44.0 80.6
b
 40.2 68.5
c
 
Quercetin 53.2 81.5
b
 83.2 189.4
a
 
Saponins  82.3 201.8
a
 57.5 181.0
b
 
Mate tea extract (µg/mL) 204.2 >300 198.2  >300 
Caffeine 200.2 >300 200 >300 
Chlorogenic acid >300 >300 >300 >300 
Caffeic acid >300 >300 180 >300 
Quinic acid >300 >300 150 >300 
* IC30 and IC50 are the concentrations (μM) that resulted in 30%, and 50% inhibition  
of cell proliferation (mean ± SD, n = 2). 
Different letters indicate significant differences comparing differences within column, 
p < 0.05. 
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Table 7.2 Cytotoxicity
a
 (µM) of mate tea compounds against colon cancer cells. 
 
Compound HT-29 RKO 
IC50 GI50 TGI LC50 IC50 GI50 TGI LC50 
        Ursolic acid 30 35 12 45 30 38 12 36 
Cisplatin 81 90 >100 >100 68 80 >100 >100 
Quercetin 82 90 104 100 189 190 190 >300 
Saponins  202 235 284 >300 181 190 220 >300 
Mate tea extract 
(µg/mL) 
>300 290 >300 >300 >300 255 >300 >300 
Caffeine >300 >300 >300 >300 >300 >300 >300 >300 
Chlorogenic acid >300 >300 >300 >300 >300 >300 >300 >300 
Caffeic acid >300 >300 >300 >300 >300 >300 >300 >300 
Quinic acid >300 >300 >300 >300 >300 >300 >300 >300 
 
a
Cytotoxicity to different human CRC cells was defined by the following parameters 
(Monks et al., 1991):IC50 (inhibitory concentration, 50%): concentration (μM) resulting 
in 50% inhibition of net cell growth = %T/C (OD of treated cells/ OD of control cells) x 
100; GI50 (growth inhibition, 50%): concentration (μM) resulting in a 50% reduction in 
the net cell growth in comparison to untreated cells = 100 [(T -T0)/C - T0)]; TGI (total 
growth inhibition): concentration (μM) required to achieve complete halting of treated 
cell growth = T0; LC50 (lethal concentration, 50%): concentration (μM) lethal to 50% of 
treated cells = 100 [(T - T0)/T0]. OD = optical density, C = control optical density, T = 
test optical density, T0 = optical density at time zero. 
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CHAPTER 8 
YERBA MATE (ILEX PARAGUARIENSIS ST. HILAIRE) AQUEOUS EXTRACT 
AND MATE SAPONINS MODULATE WNT/β-CATENIN AND NF-κB 
PATHWAYS PREVENTING ABERRANT CRYPT FOCI IN AZOXYMETHANE-
INDUCED COLORECTAL CARCINOGENESIS 
5 
8.1 Abstract 
We examined the effect of yerba mate aqueous extract and purified mate saponins on the 
development of colon pre-neoplastic lesions, aberrant crypt foci (ACF), in the 
azoxymethane (AOM)-induced model using male F344 rats. The animals received a basal 
diet and a yerba mate aqueous extract (2% w/v) as drinking fluid, or mate saponins 
(0.01%, w/w) mixed with the basal diet 2 weeks before AOM injection and throughout 
the experimental period 6 weeks after first AOM injection. The mate aqueous extract (2% 
w/v) significantly decreased the number of AOM-induced ACF when compared to the 
control (21.1% reduction, p < 0.05).  Mate aqueous extract and mate saponins 
significantly suppressed iNOS (54.5% and 30.6%, respectively) and COX-2 expression 
(56.6% and 38.6% inhibition, respectively) through inhibition of NF-κB p65 activity 
(88.8% and 81.7% inhibition, respectively). Yerba mate aqueous extract and mate 
saponins also reduced β-catenin activity (68.3% and 54.5% inhibition, respectively) by 
increasing glycogen synthase kinase 3β (GSK3β) activity (41.1% and 11.7% induction, 
respectively). Yerba mate aqueous extract inhibited AOM-induced colon carcinogenesis 
by downregulating NFκB p65 activity, decreasing iNOS and COX-2 proinflammatory 
5
 The material in this chapter has not been published yet and it is intended to be submitted to 
Cancer Prevention Research, 2011. 
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mediators and β-catenin pathways by increasing GSK-3β activity. This was further 
reflected in decreased ACF in proximal and middle portions of the colon suggesting 
decreased tumor development.  All these factors highlight the potential preventive role of 
yerba mate in colon carcinogenesis.  
Keywords: Yerba mate tea; Mate saponins; Aberrant crypt foci; Inflammation  
8.2 Introduction 
 Yerba mate (Ilex paraguariensis, A. St. Hilaire) is a plant native to South 
America, and it is widely consumed in that region traditionally as a hot aqueous infusion, 
generally known as yerba mate tea. The consumption of this aqueous yerba mate extract 
is spreading to other countries as a substitute for tea (Camelia sinensis) or coffee (Coffea 
arabica). Yerba mate contains high amounts of purine alkaloids (caffeine), caffeolyquinic 
acid derivatives, flavonoids (quercetin and rutin) and triterpenoid saponins [1]. Yerba 
mate tea has been reported to have various biological activities; these have been related to 
its high content of polyphenols. Some of the pharmacological properties attributed to 
yerba mate include antioxidant capacity [2, 3, 4], vasodilatation [5], anti-inflammation [6, 
7], anti-microbial [8], inhibition of glycation and atherosclerosis [9], thermogenic effects 
[10], anti-obesity effects [11] and beneficial effects on glucose absorption and 
metabolism [12].  
 There have been some in vitro and in vivo studies on the antitumor effects of 
yerba mate extracts. Extracts induced cytotoxicity in human squamous carcinoma cell 
line SCC-61 [13], in premalignant human skin keratinocytes cell line HaCaT and in 
human hepatoma cell line HepG2 with potential inhibition of topoisomerase II activity 
[14], as well as in human colorectal adenocarcinoma cells CaCo-2 and HT-29 [15]. Yerba 
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mate tea administered during the initiation phase of carcinogenesis induced by 
diethylnitrosamine, inhibited DNA damage and the development of preneoplastic and 
neoplastic lesions in the esophagus and liver of male Wistar rats [16]. Yerba mate tea 
reduced colon carcinogenesis in 1,2-dimethylhydrazine-induced ACF in female Swiss 
mice [17]. However, the active compounds were not identified and no mechanism of 
action has been proposed. We found that saponins extracted from yerba mate had anti-
inflammatory effects in macrophages [18] and the mechanism by which they inhibited 
colorectal carcinogenesis in vitro was through anti-inflammatory and pro-apoptotic 
activities [19]. In spite of these in vitro investigations, the in vivo anti-tumorigenic action 
of mate saponins against colon carcinogenesis needs further studies. 
 Colorectal cancer (CRC) is one of the leading causes of cancer death in the United 
States and its incidence is increasing globally [20]. One approach to control colorectal 
cancer is prevention and studies have shown that the risk of developing CRC can be 
prevented by diet [21]. The use of herbal beverages such as yerba mate tea and its 
naturally occurring compounds saponins as adjuvants for colorectal cancer therapy is 
promising.  
 The objective was to investigate the effect of yerba mate tea and mate saponins, 
as potential natural products for colorectal prevention on the development of 
azoxymethane (AOM)-induced aberrant crypt foci (ACF), considered as putative 
preneoplastic lesions for colonic adenocarcinoma, using a short-term rat ACF bioassay.  
In addition, we also evaluated the mechanism of action via NF-κB and β-catenin 
signaling pathways. We showed in this work, for the first time, that yerba mate tea 
reduced β-catenin activity by increasing glycogen synthase kinase 3β (GSK-3β) activity, 
141 
 
inhibited AOM-induced colon carcinogenesis by downregulating NF-κB p65 activity, 
decreasing iNOS and COX-2 proinflammatory mediators. 
8.3 Materials and Methods 
Animals 
 The protocol was approved by the Institute of Animal Care and Use Committee at 
the University of Illinois at Urbana-Champaign. Fifty two 6-week-old male Fisher 344 
rats were purchased from Harlan Laboratories. All rats were housed singly in wire cages 
with free access to drinking water and a standard powdered diet, AIN-93G (Harlan 
Laboratories, Madison WI).   
Treatments of rats 
 The experimental design is shown in Fig. 1. All rats were acclimated for one 
week, weighed and arranged by randomization into five treatment groups.  Rats in groups 
1-3 were injected with AOM (s.c injection, 15 mg/kg body weight) (MRIGlobal, Kansas 
City, Missouri) once a week for 2 weeks. Two weeks before the injections of AOM, rats 
in groups 2 and 4 were offered ad libitum, instead of water, yerba mate aqueous extract at 
2% (w/v). Rats in groups 3 and 5 were fed the diets containing 0.01% mate saponins ad 
libitum. The concentration of the tea was determined based on the American style of 
preparation of one cup of tea (2%, w/v). Also, from existing literature in which 2% (w/v) 
mate tea extract showed a reduction in the incidence of ACF and ACF with multiplicity 
[17]. The mate saponins concentration used represents what is normally present in one 
cup of 2% (w/v) mate tea. Body weight was recorded twice weekly and diet consumption 
was recorded daily. The experiment was terminated at 6 weeks after the first AOM 
injection and all rats were sacrificed under CO2 asphyxiation. Colons were removed, 
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length recorded, longitudinally sectioned, rinsed with PBS, cut into three sections 
(proximal, middle, and distal) in equal length and fixed flat between two sheets of filter 
paper with 10% buffered formalin overnight. The mucosa of three rats per group was 
scraped with a glass slide and flash frozen (storage at -80ºC) for Western blot analysis.  
Preparations of the yerba mate tea aqueous extract and mate saponins  
 Organically grown mate (Ilex paraguariensis) leaves from Paraguay were kept in 
plastic bags and refrigerated at 4 °C until used. In order to avoid variation in lot-to-lot 
preparation and to maximize consistency in analytical and efficacy studies, two large 
batches of instant aqueous mate leaves extracts were obtained by adding 20 g of mate dry 
leaves to 1,000 mL of deionized boiling water (100 ºC) (2%, w/v) and allowed to stand 
for 10 min, and then filtered through cheese cloth. The resulting aqueous extracts were 
combined and subsequently frozen at -10 ºC overnight and then dried by vacuum dryer 
(Vacudyne corporation, Chicago, IL, USA) at 70 ºF, 30 psi and stored at 4 ºC. Total 
polyphenol content of the mate aqueous extract was 360 mg chlorogenic acid 
equivalent/g dried leaves. Based on the total polyphenol content, the mate aqueous 
extract to be used in the animal experiment was prepared fresh daily by dissolving 3 g of 
the vacuum dried instant powdered mate extract in 500 mL of water, thus achieving an 
extract concentration of 2% (w/v). An isocratic high-performing liquid chromatogram of 
the mate tea extract was obtained as previously described [18] showing that the major 
phenolic components are caffeine, chlorogenic acids and dicaffeoylquinic acids (Figure 
8.2), the triterpenoid saponins were also important components, but are not shown in this 
chromatogram.  
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 Mate saponins (0.01% w/w) were quantified and purified from mate dry leaves 
and identified by their spectra data, which was identical to the one described from our 
previous work [19]. Experimental diet was prepared daily by mixing mate saponins 
(0.01%, w/w) in the AIN-93G basal diet using a hand mixer.  
Identification of aberrant crypt foci (ACF)  
 The formalin-fixed colon tissues were stained in a 0.05% filtered methylene blue 
solution (Sigma Aldrich) for 5 min, and then briefly washed with PBS. The number of 
ACF per colon and number of crypts in each ACF were counted under a light microscope 
at x40 magnification according to the criteria described by Bird [22]. After measurement 
of ACF, the formalin-fixed colon tissues were then processed, embedded in paraffin, 
sectioned at 5 µm, mounted on glass slides and stained with hematoxylin and eosin (H & 
E). Stained slides were visualized using Nanozoomer Digital Pathology (Olympus 
Hamamatsu, Bridgewater, NJ).    
Analysis of NFκB, iNOS, COX-2, GSK-3β, and expression of β-catenin in colonic mucosa 
by Western blot 
  The total colonic mucosa was homogenized and lysed in RIPA buffer (20 mM 
Tris HCL pH 7.5, 1 mM EDTA, 150 mM NaCl, 1 mM EGTA (Sigma Aldrich) 
containing Protease Inhibitor Cocktail (Thermo Scientific) at 4 ºC. Following 
centrifugation at 14,000 x g for 15 min at 4 ºC, the supernatant was removed and 
quantified for total protein with Protein DC Assay (Biorad Laboratories, Hercules, CA, 
USA). Fifty micrograms of total mucosa proteins were incubated at 95 ºC for 5 min and 
lamina sample loading buffer (Biorad Laboratories, Hercules, CA, USA) containing β-
mercaptoethanol and loaded onto a 4-20% Tris-HCl ready gels (Biorad Laboratories, 
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Hercules, CA, USA). Proteins were transferred to an PVDF membrane (Millipore Corp.) 
and blocked in 5% nonfat dry milk in TBST (1xTBS, 0.1% Tween-20) for 1 h. Blots 
were incubated overnight at 4 ºC with NOS-2 (epitope mapping near the N-terminus), 
COX-2 (epitope mapping amino acids 50 -111), PCNA (epitope mapping amino acids 1-
261), phospho-NFκB-p65 (epitope mapping short amino acid sequence containing 
phosphorylated Ser 311), phospho- glycogen synthase kinase 3β (GSK-3β, epitope 
mapping short amino acid sequence containing phosphorylated Tyr 216), phospho-β-
catenin (epitope mapping synthetic phosphopeptide containing phosphorylated Tyr 86), 
or β-actin (epitope mapping near the C-terminus) (Santa Cruz Biotechnology, CA, USA) 
antibodies. Blots were then washed 5 times with TBST and incubated with goat anti-
mouse IgG HRP or donkey anti-rabbit IgG HRP (GE Healthcare, Buckinghamshire, UK) 
for 3 h at room temperature. After incubation and repeated washings, the protein 
expression was visualized using a chemiluminescent reagent (GE Healthcare, 
Buckinghamshire, UK) following the manufacturer’s instructions. The membrane picture 
was taken with a Kodak Image station 440 CF (Eastman Kodak Co., New Haven, CT). 
Statistical analysis 
 Analysis of all data (aberrant crypt foci and aberrant crypt foci with multiplicity 
quantifications, body and organ weights) was performed using the computer software 
SAS version 9.2. Overall significant differences among experimental groups were 
determined by ANOVA and means differences between experimental groups were 
analyzed by Tukey’s test. p < 0.05 were considered statistically significant. 
8.4 Results   
Yerba mate tea and mate saponins did not alter food consumption or body weight 
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 All animals remained healthy and none developed colon tumors throughout the 
experimental period. Food consumption (g/day/rat) did not differ significantly among the 
groups (data not shown). The yerba mate aqueous extract preparation was well accepted 
by the rats. No significant alterations on body weight gain were observed in yerba mate 
aqueous extract or mate saponins treated groups during the experimental period. There 
were no significant differences in mean liver and kidney weights among groups (data not 
shown).   
Inhibition of ACF formation by yerba mate aqueous extracts and mate saponins 
 Table 8.1 summarizes the number of ACF per rat, crypt multiplicity, and 
distribution in each group. AOM treatment developed ACF in the colon of all rats of 
group 1-AOM alone; group 2, AOM + 2% mate aqueous extract; and group 3, AOM + 
0.01% mate saponin.  None of the rats in group 4, 2% mate aqueous extract alone, and 
group 5, 0.01% mate saponins alone, developed ACF by the end of the experiment. The 
mean total number of ACF per rat in group 1 was 113.3 ± 4.5. The ACF formation in 
group 2 (mate aqueous extract) was significantly lower than that of group 1 (p = 0.0014), 
with a mean number of ACF per rat of 89.4 ± 3.0. Dietary administration of 0.01% mate 
saponins did not significantly reduce ACF formation (p > 0.05), with the number of ACF 
per rat being 100.2 ± 4.7. On the other hand, there were no significant differences in crypt 
multiplicity of ACF among groups (p > 0.05). The ACF distribution in all groups was 
highest in the middle colon and next highest in the distal colon, with proximal colon have 
the fewest ACF. Yerba mate aqueous extract, however, significantly reduced ACF 
formation in the proximal (p = 0.0039) and the middle colon (p = 0.0032) but did not 
significantly reduce ACF in the distal colon (p > 0.05). Figure 8.3 shows the typical 
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morphology of colon tissues after H & E staining in control rats without AOM injection 
(Figure 8.3A). Colons of rats treated with mate aqueous extract alone, and mate saponins 
alone were identical (Figure 8.3C, and 8.3E, respectively). The typical morphology of 
ACF in AOM-treated groups 1-3 shown in Figure 8.3B, 8.3D, and 8.3F. The branching 
nature of the aberrant crypts (circled) is evident. 
Yerba mate aqueous extract and mate saponins induced iNOS and COX-2 expression 
through down regulation of NF-κB signaling 
 As shown in Figure 8.4, mate aqueous extract and mate saponins significantly 
reduced iNOS (p = 0.0024) and COX-2 (p = 0.0036) protein levels in colonic mucosa 
compared with the AOM-alone group. AOM-treatment upregulated the phospho-NF-κB 
p65
 ser311
 (Figure 8.5A), and the mate aqueous extract and mate saponins significantly 
suppressed the level of phospho-NF-κB p65 ser311 in colon mucosa of AOM-treated rats (p 
= 0.0012). These results suggest that mate aqueous extract and mate saponins inhibit 
inflammatory molecules iNOS and COX-2 expression in rat colon via targeting NF-κB 
signaling. Moreover, mate aqueous extract group significantly reduced the cell 
proliferation index (PCNA) (Figure 8.5B) (p = 0.0042). 
Yerba mate aqueous extract and mate saponins induced β-catenin signaling and GSK-3β 
expression 
 As presented in Figure 8.6A, phospho-β-cateninTyr 86 was markedly reduced in 
aqueous mate extract (p = 0.0016) and mate saponins (p = 0.0039) treated groups as 
compared with AOM-alone. Moreover, Figure 6B shows phospho-GSK-3β at Tyr 216 (as 
an active form) was significantly increased in the mate aqueous extract group (p = 
0.0025) and mate saponin group (p = 0.0048) suggesting a significant activation of GSK-
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3β in response to the mate aqueous extract and the mate saponins treatments. Yerba mate 
aqueous extract and mate saponins treatment induced phospho-GSK-3β which resulted in 
facilitating the degradation of β-catenin thereby, inhibiting the activation of nuclear β-
catenin in the rat mucosa.  
8.5 Discussion 
 The present study was undertaken to investigate in vivo the possible beneficial 
effects of a mate aqueous extract, equivalent in concentration to one cup of mate tea 
human consumption and mate saponins, on the early stages of colon carcinogenesis. Both 
ACF and ACF multiplicity (with four or more aberrant crypts within focus) are putative 
pre-neoplastic lesions with the potential for development into colonic adenomas or 
carcinomas. The findings from this study suggest that ingestion of a yerba mate aqueous 
extract significantly reduced the number of ACF compared to a positive control (AOM 
only) group; in agreement with a previous study [17]. However, mate saponins did not 
significantly reduce the number of ACF compared to the control group, probably because 
the concentration of mate saponins used in this study was too low. In addition, adverse 
effects of consuming the mate aqueous extract or mate saponins were not observed as 
indicated by unaltered food consumption, body and organ weights, and colon 
morphology. 
 We found that ACF developed after AOM injection and appeared predominantly 
in the medial colon during early time points, consistent with the findings of others [23, 
24]. Our data showed that mate aqueous extract significantly inhibited the total number of 
ACF and that this reduction was concentrated in proximal and middle regions of the 
colon; however mate aqueous extract did not alter crypt multiplicity. These may imply 
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that mate aqueous extract could inhibit the action of AOM exposure on the target site, but 
not slow the development of the lesion once induced. However, these data only reflect a 
short-term study in which high multiplicity ACF, purported to be a more accurate 
indicator of future tumor development, did not have sufficient time to develop. Optimal 
time for high multiplicity ACF to develop in the Sprague Dawley rat is 8 weeks after 
AOM injection [22]; whereas in this study, rats were terminated 5 weeks after the last 
AOM injection. Therefore, it can only be concluded that yerba mate aqueous extract can 
inhibit the initiation stage, but not the promotion phase of AOM-induced colon 
carcinogenesis. To confirm this conclusion, further long-term studies will be necessary.    
 The exact mechanism involved in the protective effect of the mate aqueous extract 
against colon carcinogenesis is not clearly understood, because yerba mate is a complex 
mixture with numerous phenolic and non-phenolic compounds including saponins. 
However, this protection could be explained by its anti-inflammatory capacity. We 
evaluated COX-2 and iNOS and observed to be elevated in the control group. The 
inflammatory molecules, iNOS and COX-2 have been considered involved in colonic 
carcinogenesis [25]. Overexpression of iNOS and COX-2 enzymes can contribute to 
promoting tumorigenesis by induction of inflammation, abnormal cell proliferation and 
decreasing apoptosis [25]. In the current study, we showed that the mate aqueous extract 
significantly inhibited AOM-induced increase of protein levels iNOS and COX-2. Even 
though the mate saponins treated group did not experience a significant reduction in 
ACF, we found significant suppression of iNOS and COX-2 expressions. iNOS and 
COX-2 are regulated by activating NF-κB signaling pathway and NF-κB activation is 
critical for inflammation and cancer development [26]. The yerba mate aqueous extract 
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and mate saponins significantly reduced phosphorylation of NFκB p65ser311; this is 
involved with its kinetics and nuclear import indicating mate aqueous extract and mate 
saponins are able to inhibit its activity. However, further direct evidence of NF-κB p65 
ser311
 nuclear localization is required. These results suggest that mate aqueous extract and 
mate saponins inhibit inflammatory molecules iNOS and COX-2 expression in rat colon 
through targeting NF-κB signaling and might be related to their preventive activity as 
demonstrated by inhibiting AOM-induced colonic carcinogenesis.  
 Cell proliferation is an important condition in multistage for experimental and 
human carcinogenesis and the changes of colonic epithelial cell proliferation are 
considered to be indicators of increased risk of colon cancer [27]. It has been reported 
that AOM-induced colon carcinogenesis enhanced cell proliferation [28]. PCNA is a non-
histone nuclear acidic protein expressed in the nuclei of proliferating cells during G1 and 
S-phase and is used as a proliferation index. Our results showed that mate aqueous 
extract significantly reduced the PCNA expression associated to the lower ACF number 
in the colon suggesting that mate aqueous extract has an anti-proliferative value. 
 β-Catenin is a multifunctional protein that regulates proliferation, differentiation 
and apoptosis in intestinal epithelial cells and is commonly dysregulated in colon ACF 
and tumors [29, 30]. β-Catenin is a downstream effector and functions as a transcription 
factor of the canonical Wnt/β-catenin/T-cell factor (Tcf) signaling pathway. Several 
studies have reported that over expression and nuclear accumulation of β-catenin is an 
early event in colon carcinogenesis [29, 31]. In normal cells, cytoplasmic β-catenin levels 
are kept low through continuous degradation by ubiquitin-proteasome pathway, which is 
controlled by a complex containing GSK-3β, adenomatous polyposis coli (APC), and 
150 
 
axin. In malignant cells, the binding of Wnt proteins inhibits GSK-3β phosphorylation 
activity, which prevents β-catenin ubiquitination and degradation, so that β-catenin 
accumulates in the cytoplasm and translocates to the nucleus. This β-catenin is then free 
to bind to transcription factors from the LEF/Tcf family, and activates transcription of a 
variety of target genes, such as cyclin D1 and c-Myc which are growth-promoting genes. 
β-Catenin that lack GSK-3β phosphorylation sites are associated with forms of cancer 
[29] and studies link mutations in β-catenin, APC, or axin as an early critical event in the 
development of colon carcinogenesis [28, 32], suggesting that activated GSK-3β 
complexes may function as tumor suppressors in normal cells by promoting β-catenin 
degradation. Dysregulation levels of GSK-3β have been found both in human colon 
cancer cell lines and in primary colon tumors [32]. Thus, the inactive expression of GSK-
3β may promote neoplastic transformation by promoting cytosolic β-catenin 
accumulation and subsequent translocation into the nucleus that regulates transcription of 
genes. Our results showed that mate aqueous extract and mate saponins induced 
phosphorylate GSK-3β Tyr 216 which is an active form. Phosphorylation of β-catenin at 
tyrosine residues is involved with dissociation of β-catenin/cadherin complexes leading to 
β-catenin nuclear translocation. This study showed, for the first time, that both yerba 
mate aqueous extract and mate saponins decreased expression of tyrosine phosphorylated 
β-catenin as compared to AOM-induced group, suggesting their role in inhibition of 
AOM-induced colorectal carcinogenesis by decreasing AOM-induced cellular 
proliferation probably through β-catenin regulation. Patel et al. [33] reported that 
polyphenols from black tea have the ability to suppress the accumulation of β-catenin in 
the nucleus.   
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In addition, yerba mate aqueous extract and mate saponins suppressed NF-κB 
phosphorylation. This reduction in NF-κB transcriptional activity may be due to 
increased phosphorylation of GSK-3β following mate aqueous extract and/or mate 
saponins treatment as described by Agarwal et al. [34] and Umar et al. [35]. Agarwal et 
al. [34] showed inappropriate constitutive activation of NFκB and β-catenin by the 
AKT/IKKα pathway in CRC. Mutation of PTEN, K-ras, and/or other oncogenic 
alterations in CRC can trigger the aberrant activation of PI3K and AKT. The activated 
AKT can then trigger the IKKα to induce the constitutive activation of both NFκB and β-
catenin transcription factors. IKKα, in response to the PI3K/AKT pathway, further 
upregulates the transcriptional function of β-catenin in addition to the increase in the 
stability of β-catenin induced by APC mutations during the process of CRC progression. 
Activated AKT could potentially also contribute to increased β-catenin levels by 
phosphorylating GSK-3β on inhibitory sites preventing GSK-3β phosphorylation activity 
and causing stabilization of β-catenin. Both NFκB and β-catenin activated by the 
AKT/IKKα pathway can increase the expression of genes such as COX-2, IL-8, which 
can promote angiogenesis, metastasis, and progression of CRC. Umar et al. [35] 
suggested a cross-talk between NFκB/β-catenin pathways. They treated mice with 
NEMO peptide (an inhibitor of IKKα, β/NFκB activation) and analyzed colonic crypts. 
NEMO treatment significantly blocked β-catenin suggesting β-catenin signals 
downstream to the IKKα, β/NFκB pathway. NEMO peptide treatment increased in 
Tyr216 phosphorylation of GSK-3β (its catalytic domain) leads to its activation. They 
suggested a significant increase in the levels of cellular/nuclear β-catenin in proximal 
crypts of mice may be secondary to activated IKKα, β/NFκB and perhaps mediated by 
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the loss of activating phosphorylation of GSK-3β on the Tyr216 moiety. Moreover, β-
catenin alteration may also be involved in increasing expression of iNOS because the 
evidence showed iNOS expression detected in almost all lesions in which β-catenin 
alterations are observed, indicating a possible direct or indirect relationship [36]. 
However, it has been shown that NF-κB positively regulates the β-catenin/Tcf pathways 
in human glioblastoma cell lines [37]. Negative regulation of NF-κB by β-catenin has 
also been reported in some cancer cell lines [38, 39]. There is evidence for a direct 
relationship between GSK-3β activity and the NF-κB signaling pathway [40]. GSK-3β is 
required for the expression of certain NF-κB target genes [41], suggesting that the nature 
of the cross-talk between NF-κB and β-catenin may be cell-specific and perhaps 
stimulus-specific. Further investigation of cross-talk between the Wnt/β-catenin pathway 
and NF-κB pathway in colon carcinogenesis in vivo is needed. At present, our results 
suggest that mate saponins may be one of the compounds responsible for the anti-
inflammatory effects of mate aqueous extract on AOM-induced ACF. Several 
compounds from yerba mate have been observed as protective against AOM-induced 
ACF formation in F344 rats. These compounds include chlorogenic acids [42, 43], 
caffeine and quercetin [44], and saponins, which are major constituents from yerba mate 
[19]. Recently, we isolated saponins and dicaffeoylquinic acids from yerba mate leaves 
and found that they have anti-inflammatory capacity in RAW 264.7 macrophages and 
inhibit proliferation of colorectal cancer cell lines in vitro [19, 45 ]. However, it is 
difficult to evaluate the relative importance of individual constituents for the anti-colon 
carcinogenesis effect of the complex mate aqueous extract seen in this in vivo study. We 
have demonstrated synergistic effects of some compounds from yerba mate in anti-
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inflammatory in RAW 264.7 macrophages [18]. We suggest that the strong protective 
effect obtained by mate aqueous extract is mainly due to the distinct diversity of its 
constituents. These might alter their cancer preventive properties and theirs capacity to 
modulate immune parameters by antagonistic, additive and/or synergistic mechanisms. 
Researchers have indicated that whole foods, rather than isolated food components, have 
preventive activity [21].  
 In summary, we demonstrated that the preventive effect of a yerba mate aqueous 
extract and mate saponins were associated with a decrease of inflammation through the 
NF-κB pathway as well as modulation of the intermediate β-catenin signaling pathways 
in colon of rat a mechanism is proposed in Figure 8.7. Because the concentration of the 
mate aqueous extract was comparable to that commonly consumed by people in the form 
of yerba mate tea, these findings suggest a potential preventive role of yerba mate tea and 
its saponin constituents against colon carcinogenesis. These data also suggest that yerba 
mate and mate saponins can effectively target both the Wnt/β-catenin and NF-κB 
pathways, this being a potential mechanism through which yerba mate infusions and mate 
saponins may exert their preventive efficacy. 
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8.7 Figures and Tables 
                  -1            0             1              2             3             4             5      6  weeks 
 
Group1                      (15 rats) 
 
Group 2                  (15 rats)  
 
Group 3                  (15 rats)    
  
 
Group 4                  (3 rats)  
 
Group 5                  (3 rats)  
 
            Control diet;         Mate tea (2% w/v);            Mate saponins (0.01%);  
           AOM 15 mg/kg bw s.c.;      Sacrifice  
 
Figure 8.1 Experimental animal protocol. ↓, Azoxymethane (15 mg/kg body weight s.c. 
injection); ↑, sacrifice; group 1, AOM alone; group 2, AOM + 2% mate extract; group 3, 
AOM + 0.01% mate saponin; group 4, 2% mate extract  alone; group 5, 0.01% mate 
saponins alone. 
 
159 
 
 
 
 
Figure 8.2 Analytical HPLC chromatogram of mate aqueous extract.  
Caffeine 
Chlorogenic acid 
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Figure 8.3 Morphology of colon tissues of H & E stained sections from rats (A) No 
AOM injection, (B) AOM alone, (C) Mate extract  alone, (D) Mate extract  +AOM, (E) 
Mate saponins alone, (F) Mate saponins + AOM (magnification, x 100) 
ACF 
50 μm 50 μm 
ACF 
50 μm 50 μm 
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50 μm 50 μm 
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iNOS               130 kDa 
β-actin             43 kDa    
      C1         C2     M1      M2      M3   S1 S2       S3     
A  
COX-2             72 kDa 
β-actin             43 kDa 
                             C1       C2     M1      M2      M3   S1 S2       S3    
B  
Figure 8.4 Inhibitory effects of yerba mate extract and mate saponins on AOM-induced 
expression of inflammatory enzymes in the rat. Protein lysates from colonic mucosa were 
extracted and subjected to Western blot analysis for (A) iNOS and (B) COX-2 protein 
expression as described in Section 2. The letters represent group treatments; C-control 
group, M-mate tea group, S-mate saponins group. The values indicate band intensity 
normalized to β-actin. Data are present as mean ± SE at least two independence 
experiments (n = 2 for control group, n = 3 for yerba mate extract and mate saponins 
groups). An example of Western blot is presented as an inset from three different 
replicates with similar results. 
162 
 
p-NFκB p65     65 kDa 
β-actin               43 kDa 
                              C1       C2     M1     M2     M3  S1     S2       S3    
A  
PCNA             36 kDa 
β-actin             43 kDa    
                C1       C2     M1      M2     M3  S1      S2       S3    
B  
Figure 8.5 Effects of yerba mate extract and mate saponins on AOM-induced expression 
of inflammatory and proliferation-related proteins in the rat. Protein lysates from colonic 
mucosa were extracted and subjected to Western blot analysis for (A) p-NFκB p65 and 
(B) PCNA protein expression as described in Section 2. The letters represent group 
treatments; C-control group, M-mate tea group, S-mate saponins group. The values 
indicate band intensity normalized to β-actin. Data are presented as mean ± SE from at 
least two independence experiments (n = 2 for control group, n = 3 for yerba mate extract 
and mate saponins groups). An example of Western blot is presented as an inset from 
three different replicates with similar results. 
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p-β-catenin    92 kDa 
β-actin            43 kDa 
              C1      C2  M1      M2       M3  S1        S2       S3    
A   
p-GSK-3βTyr 216   47 kDa 
β-actin                43 kDa 
                   C1       C2       M1      M2      M3     S1       S2       S3    
B  
Figure 8.6 Effects of yerba mate extract and mate saponins on expression levels of (A) p-
β-catenin and (B) p-GSK3β Tyr 216 in the rat. Protein lysates from colonic mucosa were 
extracted and subjected to Western blot analysis for as described in Section 2. The letters 
represent group treatments; C-control group, M-mate tea group, S-mate saponins group. 
The values indicate band intensity normalized to β-actin. Data are presented as mean ± 
SE from at least two independent experiments (n = 2 for control group, n = 3 for yerba 
mate extract and mate saponins groups). An example of Western blot is presented as an 
inset from three different replicates with similar results. 
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Figure 8.7 Proposed mechanism by which mate tea inhibits colon carcinogenesis through 
NFκB and β-catenin signaling pathways. 
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Table 8.1 The effects of mate tea extract and mate saponins on AOM-induced ACF in Fisher 344 male rat colon  
 
Note: All values are shown as mean ± SE (n = 12). 
Values in the same column with different superscript indicate significant different by Tukey’s test (p < 0.05) 
 
 
 
 
Group 
no. 
Treatment 
Total No. of 
ACF/colon 
Crypts multiplicity of ACF ACF distribution 
1 crypt 2 crypts 3 crypts ≥4 crypts Proximal Middle Distal 
1 AOM alone 113.3 ± 4.5
a 
33.5 ± 3.6
a 
48.7 ± 3.7
a 
21.8 ± 1.8
a 
9.2 ± 1.2
a 
13.8 ± 2.4
a 
70.8 ± 5.0
a 
28.7 ± 2.3
a 
2 Mate tea + AOM 89.4 ± 3.0
b 
25.7 ± 2.0
a 
39.9 ± 2.0
a 
17.0 ± 1.5
ab 
6.8 ± 1.0
a 
5.3 ± 1.2
b 
51.2 ± 2.5
b 
32.9 ± 3.0
a 
3 Saponins + AOM 100.2 ± 4.7
ab 
32.8 ± 2.6
a 
49.3 ± 3.0
a 
12.3 ± 1.5
b 
5.8 ± 0.8
a 
7.7 ± 1.2
b 
60.5 ± 3.3
ab 
32.0 ± 2.9
a 
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CHAPTER 9 
CONCLUSIONS 
 Yerba mate tea constituents, quercetin, saponins and diCQAs have anti-inflammatory 
activity through inhibition of NF-κB nuclear translocation that consequently 
downregulates NO/iNOS and PGE2/COX-2 pathways.  
 Quercetin and mate saponins have the most potent anti-inflammatory effect when 
combined showing a synergistic effect.  
 A combination of chlorogenic acid/mate saponins, and chlorogenic acid/matein 
resulted in an antagonistic effect.  
 The mate tea extract did not show potent anti-inflammatory effect due to the 
antagonistic effect of other compounds. 
 Yerba mate leaves contained 12 mg/g (1.2%) extractable saponins, mostly in the form 
of matesaponins 1 and 2.  
 Mate saponins inhibited HT-29 and RKO colon cancer cell proliferation by induction 
of cell cycle arrest and apoptosis via the p53 cascade.  
 Mate saponins induced mitochondrial apoptosis by increasing expression of the pro-
apoptotic protein Bax, and decreased expression of anti-apoptotic protein Bcl-2 
resulting in increased caspase-3 activity.  
 Mate saponins arrested G1 cell cycle by induction of p21 and p27 CDK inhibitors.  
 The diCQAs from yerba mate leaves are composed of 3,4-diCQA, 3,5-diCQA and 
4,5-diCQA.  
167 
 
 The diCQAs in yerba mate inhibited HT-29 and RKO cell proliferation by inducing 
apoptosis through activation of capase-8 and caspase-3 rather than arresting the cell 
cycle, based on the expression of p21 and p27 that did not change significantly.  
 The p53 protein expression was not affected by the diCQAs treatment in RKO cells, 
which contains wild-type p53 protein. The diCQAs still induced apoptosis in HT-29 
cells that contain mutant p53, suggesting that the induction of apoptosis by diCQAs 
was independent of the p53 pathway. 
 The preventive effect of a mate aqueous extract and mate saponins was associated 
with a decrease of inflammation through the NF-κB pathway as well as modulation of 
the intermediate of Wnt/β-catenin signaling pathways in vivo. This is a potential 
mechanism of a preventive role of yerba mate tea and its saponins constituents 
against colon carcinogenesis.  
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CHAPTER 10 
INTEGRATION AND FUTURE WORK 
Since CRC is associated with dietary patterns and lifestyle and the development 
of cancer extends for about 10 – 15 years, there is great opportunity to prevent this fatal 
disease. Furthermore, cancer prevention is a better and more effective way to decrease 
cancer-related death than traditional cancer chemotherapies. To date, colon cancer 
prevention guidelines have focused on screening and monitoring high risk patients. 
Chemopreventive strategies are limited and any chemopreventive strategy must be 
effective in the early phases of the development of cancer. Thus, one approach to control 
CRC is to find safe preventive agents with proven efficacy that could have potential in 
treating CRC. It is rational to identify novel preventive constituents from natural sources 
of different geographical locations. Yerba mate is widely consumed and is one of the 
most important commercialized plants in South America. Furthermore, the popularity of 
yerba mate drink has been increasing around the world. Data generated from the present 
research shows potential health benefits of yerba mate, and demonstrated that it has a 
positive preventive effect against colon cancer. Nonetheless, it is also necessary to 
understand the molecular mechanisms by which yerba mate constituents are effective.  
Scientific evidence from preclinical and clinical studies suggests that chronic 
inflammation may lead to cardiovascular disease, diabetes, metabolic syndrome, and 
cancer. This study showed that saponins and quercetin, the most potent components in 
yerba mate inhibit inflammation and their combination exhibited synergistic anti-
inflammatory effects. This finding suggests that combination of the most potent yerba 
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mate constituents, saponins and quercetin, rather than any one alone may reduce the risk 
of chronic inflammation, and ultimately lead to treatment of inflammatory-related 
diseases including cancer. Further study to elucidate the effects of combination of these 
two bioactives from yerba mate using on in vivo model is needed. A combination of 
compounds that work through complementary pathways may be required to develop a 
cancer preventing diet or intervention. We propose that using a mechanistic approach for 
the identification of chemopreventive agents is a useful strategy. 
Yerba mate may represent a potential agent for primary prevention although yerba 
mate tea has weak anti-inflammatory and anti-colon cancer capabilities in vitro. 
Nonetheless, our intervention studies in animals provide strong evidence for the anti-
inflammatory effects of yerba mate. We demonstrated that administration of yerba mate 
aqueous extract prior to exposure of the known carcinogen (AOM) reduced the incidence 
of pre-neoplastic lesions (ACF) involved in colon carcinogenesis in vivo. Yerba mate 
aqueous extract reduced inflammation through inhibition of the activity of NF-κB 
subunits. This inhibition prevents transcription of inflammatory genes resulting in 
reduced inflammation. Our data suggest that dietary intake of mate tea may regulate pro-
inflammatory cytokine activity in inflammatory-related diseases. 
The concentration of mate tea used in the animal study was based on the 
American style of preparation of one cup of tea (2%, w/v) and from existing literature. 
The animals drank yerba mate tea as their only source of liquid which is equivalent to 
approximately 10 cups of tea per day for human consumption. Because the concentration 
of the mate aqueous extract was comparable to that commonly consumed by people in the 
form of yerba mate tea, these findings suggest a potential preventive role of yerba mate 
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tea against colon carcinogenesis. There are few human intervention studies of yerba 
mate; these mainly concentrate on its antioxidant capacity and modulation of lipid 
metabolism [1-4]. However, there is no human study on the anti-inflammatory capacity 
of yerba mate; human interventional studies using yerba mate tea should be conducted in 
order to guide and provide scientifically based efficacy information necessary to reduce 
inflammation and prevent colon carcinogenesis in human.  
The mate saponin concentration (0.01% w/w) used in our animal study represents 
the amount of mate normally present in one cup of 2% (w/v) mate tea. Mate saponins did 
not significantly reduce ACF but were able to modulate protein expressions that regulate 
cell proliferation and inflammation in vivo. This mechanism of mate saponins might 
contribute to the efficacy of yerba mate extract in reduction of ACF. Yerba mate and 
mate saponins can effectively target both the Wnt/β-catenin and NF-κB pathways, this 
being a potential mechanism through which yerba mate infusions and mate saponins may 
exert their preventive efficacy. 
Our data showed that saponins and diCQAs from yerba mate inhibit colon cancer 
cell proliferation in HT-29 and RKO, which are cells from advanced stages of colon 
cancer. We also demonstrated the mechanism of mate saponins and diCQAs was 
associated with their ability to modulate key signaling proteins related to cell 
proliferation and apoptosis, such as p21, p27, Bax, Bcl-2, p53, caspase-3 and -8. Future 
studies of potential prevention by yerba mate and mate saponins on colon carcinogenesis 
should be conducted in a long term study of later stages of carcinogenesis in vivo. 
Initiation, promotion, and progression experiments may demonstrate at which stage yerba 
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mate and mate saponins are most advantageous in the prevention of colonic epithelial 
alterations.  
Data from our animal study has confirmed the anti-inflammatory activity and 
inhibitory effect of yerba mate in an early preneoplastic lesion of colon carcinogenesis. 
Examination of the genes altered by yerba mate in preneoplastic lesions and/or gene 
profiles would also be beneficial for understanding in more specific mechanistic 
signaling pathways.  
In conclusion, our experiments provide support for the beneficial effects of mate 
consumption on chronic diseases with inflammatory components and provide the 
foundation for future studies on the benefits of yerba mate and its potential role in 
prevention of colon carcinogenesis. 
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 Appendix A Body weight of rats 
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Appendix B Daily food intake of rats in (A) control and (B) mate saponins groups. 
A  
 
B  
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Appendix C  (A) Daily food intake and (B) daily mate tea intake of rats in mate tea 
treatment. 
A  
 
B 
 
 
 
175 
 
Appendix D Rats body weight, organ weights and colon length on the necropsy day. 
Animal I.D. # Body Weight (g) Colon length (c.m.) Liver weight (g) Kidney weight (g) 
C9 289.7 19.5 16 2.88 
M1 276 18 12.4 2.44 
S18 285.2 18 15.31 2.6 
M14 265 18 15.9 2.86 
M10 249.6 18 14.8 2.83 
S7 322.6 19 13.9 2.28 
S16 290.1 20 14.67 2.35 
S1 267 18 15.95 2.05 
S2 300.2 18 14.62 2.04 
M3 325.6 18 13.22 1.96 
M2 285 20 13.6 2.2 
C1 297.3 21 13.83 2.13 
C2 273.2 18 13.26 2.08 
S3 283.6 19 11.52 1.75 
S4 290.4 19 11.5 1.85 
M4 349.1 21 19.06 2.44 
M5 346.2 19 15.2 2.41 
C4 310.7 20 13.7 2.1 
C3 320.4 18 13.38 2.1 
S5 322.9 19 12.4 1.93 
S6 330 20 13.76 2.23 
M7 307.6 19 13.6 2.1 
M6 342.6 20 15.62 2.31 
C5 310.8 20 13.56 2 
C6 295.2 18 12.12 1.88 
S8 316.9 20 10.86 1.96 
S9 289 21 11.39 1.95 
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Appendix D Continue 
Animal I.D. # Body Weight (g) Colon length (c.m.) Liver weight (g) Kidney weight (g) 
M12 309.5 18 12.43 2.17 
M11 319.8 20 11.1 2.19 
C10 298.4 18 9.51 1.92 
C8 302.7 20 11.19 1.83 
S12 284.7 20 9.4 1.7 
S11 297.2 18 11.4 1.9 
M8 288.6 20 11.45 1.9 
M9 292.3 19 12.61 2.01 
C11 289.2 17 10.46 1.76 
C9 316.1 20 12.05 2.1 
S13 276.8 18 11.2 1.9 
S10 302.2 20 12.39 2.22 
M15 328.5 20 13.8 2.23 
M13 328.5 20 12 2.12 
C13 331.9 21 11.9 2.34 
C14 302.4 20 12.55 1.8 
S17 265.8 18 9.35 1.67 
S15 274.7 18 9.75 1.76 
S14 299.5 20 11.7 1.87 
M17 315.4 21 11.3 1.94 
M18 275.4 18 12.45 1.8 
M16 286.8 19 10.35 1.95 
C15 278.9 18 9.95 1.78 
C16 283.8 18 11.21 1.83 
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Appendix E Interpretation of NMR results for 3,4- and 3,5-diCQA fraction 
Spectra were collected on a Bruker Avance 500 with a 5 mm BBO probe and 
Topspin 1.3. All spectra were acquired at 27 ºC in methanol with standard Bruker pulse 
sequences. Shifts are listed as ppm from TMS based on the lock solvent. NMR spectral 
simulations were performed with the HNMR and CNMR Predictor software suite version 
12.01 by Advanced Chemistry Development, Inc., (Toronto, ONT.) The key assignment 
in this compound lies in the identification of protons 3, 4 and 5. Spectral simulations 
show that for all three isomers (3,4-, 3,5- and 4,5-dicaffoyl quinic acid), the proton at the 
unsubstituted position will have a shift of about 4.5 ppm. Both substituted positions will 
have shifts between 5.0 and 5.5 ppm. From inspection of the proton spectrum it seems 
that the minor component is one of the asymmetric isomers (either 3,4- or 4,5- dicaffoyl 
quinic acid), but which is not obvious. Focusing on the minor component, the NOESY 
spectrum has a strong NOE cross peak that could only occur between protons on the 
same side of the ring. Since the NOE cross peak indicates proximity of the substituted 
proton at 5.01 and a substituted one at 5.65 ppm, these must be positions 3 and 4, 
respectively, of the 3,4-substituted quinic acid. There is an antiphase artifact arising from 
strong J-coupling between the protons on opposite sides of the ring (protons 4 and 5, 5.01 
and 4.39 ppm respectively), but no NOE cross peak. The COSY spectrum allows 
assignment of protons 2 and 6, through their couplings to protons 3 and 5. In the minor 
component proton pairs 9-10 and 18-19 show a coupling of 16.0 Hz, indicating E- or 
tran- configuration of the double bond. There was sufficient overlap with the major 
component peaks to prevent distinction of the caffoyl moieties, as was done with the 4,5- 
isomer. HSQC, HMBC and COSY spectra were used to complete the assignment. The 
major component has nearly identical chemical shifts for the two substituted protons, 
which agree well with proton NMR simulations for 3,5-dicaffoyl quinic acid. 
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Appendix E Continue 
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Appendix E Continue 
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Appendix F Interpretation of NMR results of 4,5-diCQAs 
Spectra were collected on a Bruker Avance 500 with a 5 mm BBO probe and 
Topspin 1.3. All spectra were acquired at 27 ºC in methanol with standard Bruker pulse 
sequences. Shifts are listed as ppm from TMS based on the lock solvent. NMR spectral 
simulations were performed with the HNMR and CNMR Predictor software suite version 
12.01 by Advanced Chemistry Development, Inc., (Toronto, ONT.) The key assignment 
in this compound lies in the identification of protons 3, 4 and 5. Spectral simulations 
show that for all three isomers (3,4-, 3,5- and 4,5-dicaffoyl quinic acid), the proton at the 
unsubstituted position will have a shift of about 4.5 ppm. Both substituted positions will 
have shifts between 5.0 and 5.5 ppm. From inspection of the proton spectrum it seems 
that this is one of the asymmetric isomers (either 3,4- or 4,5-dicaffoyl quinic acid), but 
which is not obvious. The NOESY spectrum has a strong NOE cross peak that could only 
occur between protons on the same side of the ring. Since the NOE cross peak indicated 
proximity of the unsubstituted proton at 4.38 and and a substituted one at 5.13 ppm, these 
must be positions 3 and 4 respectively of the 4,5-substituted quinic acid. There is an 
antiphase artifact arising from the strong J-coupling between the protons on opposite 
sides of the ring (protons 4 and 5, 5.13 and 5.63 ppm respectively), but no NOE cross 
peak. The COSY spectrum allows assignment of protons 2 and 6, through their couplings 
to protons 3 and 5. Proton pairs 9-10 and 18-19 show a coupling of 15.9 Hz, indicating E- 
or trans- configuration of the double bond. HMBC spectra showed correlations between 
protons 4 and 5 to carbonyl carbons 17 and 8 respectively, which allowed the 
differentiation of the caffoyl moieties. HSQC, HMBC and COSY 
spectra were used to complete the assignment. 
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Appendix F Continue 
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Appendix F Continue 
 
 
 
 
183 
 
Appendix G Flow diagram of purification of saponins and dicaffeoylquinic acids from 
yerba mate (Ilex paraguariensis). 
 
Yerba mate (Ilex paraguariensis) dry leaves 
Extract with methanol in a Soxhlet extractor for 72 h., extracts 
reduced by rota-evaporation (40 ºC), pooled and concentrated by 
evaporation (37 ºC) under the hood. 
 
 
Saponins 
Preparative flash 
chromatography 
Fractions were pooled based on 
UV absorbance peaks at 210 nm. 
 
Dicaffeoylquinic acids  
Preparative Chromatography 
Phenomenex Luna C18 semi-preparative 
reversed-phase column (10 µ, 100Å, 250  
50 mm). Peaks were detected at 360 nm 
and collected. 
HPLC 
LC/ESI-MS 
NMR Analysis 
HPLC UV at 210 nm 
LC/ESI-MS 
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Presentations 
Sirima Puangpraphant, Mark Berhow, Elvira Gonzalez de Mejia. Saponins from Yerba 
Mate (Ilex paraguariensis St. Hilaire) leaves inhibit markers of inflammation in vitro 
through NFκB pathways. Eperimental Biology 2010, Aneheim, CA. 
 
Saponins are naturally occurring phytochemicals present in Yerba mate and other plant 
sources that have been associated with several health benefits. The objective was to 
extract and partially purify saponins from yerba mate dry leaves and assess their anti-
inflammatory effects on macrophages (RAW 264.7). HPLC and LC/ESI-MS-MS were 
used to identify saponins in chromatographic fractions of methanol extracts. Six fractions 
A, B, C, D, E, and F, were obtained. Fractions D, E and F had characteristic mate saponin 
spectra between 800-1200 m/z and major saponins in these fractions were matesaponin 1 
[M-H]- =911and matesaponin 2 [M-H]- =1057, with minor amounts of matesaponin 3 
[M-H]-=1073, matesaponin 4 [M-H]- =1219, and matesaponin 5 [M-H]- =1383. It was 
determined that dry yerba mate leaves have 10-15 mg total saponins/g, predominately 
matesaponins 1 and 2. Fractions A, B, and C did not reduce inflammatory markers. 
Fractions D, E, and F significantly inhibited iNOS (IC35 = 36.3, 29.5, 43.7 μM), PGE2 
(IC35 = 23.1, 22.3, 11.7 μM) and COX-2 (IC35 = 45.7, 32.4, 17.0 μM). Treatments with 
fraction F (25 μM) resulted in the reduction of LPS-induced nuclear translocation of 
nuclear factor-κB (NFκB) subunits p50 (49.8%) and p65 (49.0%) indicating that mate 
saponins inhibit inflammation through NFκB pathways. Chemical structure of saponins 
influenced the inhibition of inflammatory markers in vitro. 
Research Board, University of Illinois. 
 
Gregory Potts, Sirima Puangpraphant, and Elvira González de Mejía. Purification and 
anti-inflammatory capacity of dicaffeoylquinic acids in yerba mate (Ilex paraguariensis) 
dry leaves. The American Chemical Society. 2010. San Franscisco 
Mate tea (MT) has high antioxidant capacity, and caffeoyl derivatives are partially 
responsible for this activity; however, they have not been isolated.  The objective was to 
purify dicaffeoylquinic acids (diCQAs) from MT leaves and to study their potential anti-
inflammatory capacity in vitro. Dry MT leaves were extracted with 100% methanol, 
partitioned in water and n-hexane (50/50 v/v), and chromatographed using an MCI gel® 
CHP20P column with water and methanol gradient elutions (20%-100%).  Fractions 
(40% and 60%) were collected and eluted on an ODS gel column with water and 
methanol (20%-70%).  Twelve fractions were passed through RP-HPLC using a C18 
silica column, and caffeine, rutin, 3,4-diCQA, 3,5-diCQA, and 4,5-diCQA were 
identified by LC-MS (MH+/MH-). The main fractions presented a range of 0.73-2.8 mM 
as chlorogenic acid equivalents.  Fractions with the highest diCQA concentrations 
produced significant inhibition of iNOS enzymes, demonstrating their anti-inflammatory 
potential.  Isolated diCQAs warrant study of their mechanism of action. 
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Sirima Puangpraphant and Elvira Gonzalez de Mejia. Yerba mate tea phytochemicals 
inhibit inducible nitric oxide synthase/nitric oxide and cyclooxygenase-2/prostaglandin 
E2 pathways in lipopolysaccharide-induced macrophages. The IFT Annual Meeting was 
held in Anaheim, CA from June 6-June 9, 2009. 
Yerba mate tea (Ilex paraguariensis) has been considered a health-promoting beverage 
and it is gaining popularity in the United States. Some studies in the literature suggest 
that mate tea consumption is related to cancer prevention. Since inflammation is linked to 
cancer development, the objective of this study was to investigate the anti-inflammatory 
effect of mate tea extracts and its phytochemicals. A mate tea extract [1-300 µM 
chlorogenic acid (CH) eq.], a decaffeinated mate tea extract (1-300 µM CH eq.), CH (1-
300 µM), matein (1-300 µM), quercetin (1-200 µM), mate saponins (1-300 µM), ursolic 
acid (1-100 µM) and oleanolic acid (1-100 µM) were tested by measuring their ability to 
inhibit COX-2/PGE2 and iNOS/NO pathways in LPS-induced RAW 264.7 macrophages. 
Mate tea extract, decaffeinated mate tea extract, matein and chlorogenic acid inhibited 
less than 50% COX-2/PGE2 and iNOS/NO pathways even at high concentration (300 
µM). Mate saponins (IC50 = 20 µM) and oleanolic acid (IC50 = 80 µM) significantly 
inhibited iNOS/NO pathways, while ursolic acid showed inhibition only at higher 
concentration (IC50 = >200 µM). Mate saponins, ursolic acid and oleanolic acid inhibited 
COX-2/PGE2 pathways at high concentration (IC50 = >200 µM, >100 µM, >100 µM, 
respectively). Of the eight mate phytochemicals studied, quercetin was the highest 
inhibitor of pro-inflammatory responses at a concentration 10 times lower than the 
concentration used for the other compounds (IC50 = 11.6 μM for NO, 7.9 μM for iNOS, 
and 6.5 μM for PGE2 ). Furthermore, no antagonistic effects were observed among the 
different phytochemicals. This report demonstrated the efficiency of mate tea 
phytochemicals in inhibiting pro-inflammatory responses which could be associated with 
the prevention of certain types of cancer.  
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